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Abstract  
Neutrophils are the first cells to reach infection sites and are able to kill pathogens. Therefore, their 
ability to quickly migrate to infection loci is essential and rely on actin structures called the 
lamellipodium at the front of the cell and the uropod at the rear.  Actin cytoskeleton dynamics are 
crucial for the formation of these structures, and mutations in actin cytoskeleton regulators in immune 
cells can result in severe primary immunodeficiencies. These defects are good models to understand 
the role of actin regulators in neutrophil migration. To allow accurate monitoring of neutrophil 
migration, a new protocol, based on the Dunn chamber system, was developed. In particular, the 
stabilization of the chemoattractant gradient over long durations was achieved by embedding it in 
agarose, which allowed to reliably monitor neutrophil migration and was used throughout the 
different projects. It was first employed to assess the effect of constitutively activated Wiskott-Aldrich 
syndrome protein (CA-WASp) which is responsible for an excess of polymerized actin throughout the 
cytoplasm. Neutrophils expressing CA-WASp displayed a reduced migration speed together with an 
increased contractile activity. The development of this system further allowed us to identify a 
neutrophil migratory defect and correlate it to a mutation in Megakaryoblastic Leukemia 1 (MKL1). 
MKL1 is a transcription cofactor which regulates the expression of numerous actin genes. Study of 
MKL1 knockdown in neutrophils showed that MKL1 deficient neutrophils displayed severely 
impaired migration and dramatically reduced levels of globular and polymerised actin. MKL1 
deficiency also altered the expression of numerous other actin cytoskeleton regulators indicating that 
the migratory defect was the consequence of the alteration of several actin cytoskeleton components. 
Finally, the potential for the modified Dunn chamber protocol to be used as a routine assay to monitor 
the migration of neutrophils from patients with unknown causes of immunodeficiency was assessed. 
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Chapter 1  Introduction 
1.1 Neutrophils in immunity 
Neutrophils are usually the first leukocytes to reach the site of infection and are capable of clearing 
pathogens by several means. It has been shown that neutrophils are essential to clear the infection and 
that reduction of neutrophil numbers in the blood stream results in severe immunodeficiency in 
humans. 
1.1.1 Maturation in bone marrow and egression into blood circulation 
Neutrophils are produced in the bone marrow and their population can be subdivided into three 
groups: the stem cell group, the mitotic group and the post-mitotic group, according their 
differentiation stage. The stem cells group is made of undifferentiated hematopoietic stem cells while 
the mitotic group consists of granulocyte progenitor cells going through cell proliferation and 
differentiation. Finally, the post mitotic group is composed of neutrophils in the last stages of 
maturation that no longer divide. Once fully mature, neutrophils are held into the bone marrow as 
reservoir of cells available for mobilisation into the blood stream. Hematopoietic stem cells are 
located in the bone marrow and held in niches that are provided essentially by perivascular cells 
expressing both the membrane bound form of stem cell factor and the chemokine CXCL12 (SDF-1) 
(Ding et al., 2012; Ding and Morrison, 2013) which bind to CD117 (c-Kit) and CXCR4 receptors, 
respectively. Immature neutrophils are held into the bone marrow by two signals: CXCR4 transduces 
the retention signal expressed by the perivascular cells in the hematopoietic stem cell niche while 
CXCR2 transduces the release signal. During neutrophil maturation, CXCR4 expression progressively 
decreases until finally disappearing. However, expression of CXCR2 - which binds to CXCL1 
(neutrophil-activating protein 3), CXCL2 (macrophage inflammatory protein 2-alpha), CXCL3 
(macrophage inflammatory protein-2-beta), CXCL5 (epithelial-derived neutrophil-activating peptide 
78), CXCL6 (granulocyte chemotactic protein 2) and CXCL8 (Interleukin 8) - increases over time and 
delivers a release signal leading to the egress of mature neutrophils from the bone marrow into the 
blood circulation (Furze and Rankin, 2008; Bachelerie et al., 2014). 
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1.1.2 Neutrophil recruitment cascade 
When recruited, leukocytes must first exit the blood flow and migrate through the blood vessel 
endothelium to reach the tissue. This process is well characterised and, in most tissues, includes the 
following steps: tethering (capture), rolling, adhesion, crawling, and finally, transmigration (Figure 
1-1).  
1.1.3 Tethering 
The tethering of free circulating neutrophils is achieved through changes on the surface of the 
endothelium triggered by inflammatory molecules such as histamines, leukotrienes and cytokines 
secreted by resident sentinel leukocytes when they encounter pathogens in the tissues (reviewed in 
Phillipson and Kubes, 2011; Sadik et al., 2011). Endothelial cells can also detect pathogens directly 
through pattern recognition receptors (PRRs) which stimulate the upregulation of prestored P-selectin 
within minutes. Activation of endothelial cells also stimulates the synthesis of E-selectin that will be 
upregulated within 90 minutes (Ley et al., 2007; Petri et al., 2008). The combination of E- and P-
selectin at the endothelial cell surface amplifies neutrophil recruitment by binding to glycosylated 
ligands, such as P-selectin glycoprotein ligand 1 (PSGL1), expressed on neutrophil surface allowing 
the tethering of free circulating neutrophils to the endothelial surface of blood vessel. Similarly, L-
selectins on neutrophil surface bind to PSGL1 expressed by endothelial cells and contribute to 
neutrophil tethering (Bargatze et al., 1994).  
1.1.4 Rolling  
Once tethered, neutrophils roll along the blood vessel in the direction of the blood flow and are 
subjected to a shear stress of 1 to 10 dynes/cm
2
 (Sundd et al., 2012, 2011). To maintain a smooth 
rolling in such conditions, a rapid formation and successive breaking of adhesive bonds is necessary 
(Ramachandran et al., 2004) and the dissociation of the cell rear from the endothelium needs to be 
stabilised with the creation of a new at attachment at the leading edge (Sundd, 2010). At first, the 
front bond does not endure any load and it is only when the bond is transferred to the back of the 
rolling cell that it is forced to support the shear stresses exerted on the cell. The rolling of neutrophils 
also involves the formation of long tethers at the rear of the cell that “sling” to the front of the cell 
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(Sundd et al., 2012). The sling is attached to endothelial cells through selectins, and during cell 
rolling, the sling-selectin bonds are peeled of the sling. Moreover, lymphocyte function-associated 
antigen 1 (LFA1), that binds to intracellular adhesion molecule 1 (ICAM1) and ICAM2 expressed on 
the endothelium, is expressed at the surface of tethers and slings and allows the rolling of neutrophils 
to the endothelium. This interaction could possibly slow down neutrophils further and lead to their 
arrest (Zarbock et al., 2011; Zarbock and Ley, 2008). 
1.1.5 Adhesion 
Chemokines are attached to endothelial cells by binding heparin sulphates which act as anchors to 
avoid the detachment of these molecules by the shear forces of circulating blood (Massena et al., 
2010). During the rolling step, neutrophils enter in contact with the chemokines presented at the 
endothelium surface and this induces their activation. Full activation could be described as a two steps 
process consisting of, first, a priming step, characterised by an enhanced responsiveness to subsequent 
stimuli, followed by the full activation. The priming is essential for maximal NADPH oxidase 
pathway activity and neutrophil degranulation (Condliffe et al., 1998; Guthrie, 1984) and is initiated 
by pro-inflammatory cytokines, such as tumour necrosis factor-a (TNF-α) and interleukine-1β (IL-
1β), or through contact with activated endothelial cells followed by an exposure to pathogens 
associated molecular patterns (PAMPs), growth factors or chemoattractants (Condliffe et al., 1998). 
Another molecule involved in neutrophil activation is CXCL8 (IL-8) which signals via the CXCR2 
receptor and triggers neutrophil adhesion to the endothelium. Activation of the G-protein-coupled 
chemokine receptor (GPCR) CXCR2 promotes the change of conformation of integrins expressed at 
the cell surface which then display a higher affinity to their ligands such as ICAM1 and ICAM2. 
Neutrophils express high levels of CD11a (also known as LFA1, α1β2 integrins) and CD11b integrins 
(also known as MAC1, αMβ2 integrins) which, after changing their conformation, bind molecules 
expressed at the endothelial cell surface, for instance ICAM1 and ICAM2 (Phillipson et al., 2006). It 
is important to note that there are exceptions to the classical tethering-rolling-adhesion paradigm. In 
sinusoidal capillaries of the liver, neutrophils do not roll but adhere directly to the hepatic endothelial 
cells (Wong et al., 1997). Another example is the neutrophils circulating in the lung  
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Figure 1-1: Neutrophil adhesion cascade 
Leucocyte migration through the blood vessel is necessary to reach the infection site and, in most 
tissue, occurs through a succession of specific events: tethering (capture), rolling, adhesion, crawling, 
and transmigration. The tethering of free circulating neutrophils is achieved through changes on the 
surface of the endothelium in response to a pathogen that trigger the neutrophil binding. Once 
tethered, neutrophils roll along the blood vessel in the direction of the blood flow through a series of 
rapid formation and breaking of these adhesive bonds. During this step, contact of neutrophils with 
the chemokines at the endothelium surface induces their activation. Neutrophils then crawl to reach a 
transmigration site, typically at the endothelial cell-cell junction, where they can finally cross the 
endothelium and the basement membrane. (figure modified from Kolaczkowska and Kubes, 2013). 
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microvasculature. The thin diameter of lung microvasculature suggests that neutrophils need to 
dramatically change shape to be able to circulate through these thin capillaries (Looney et al., 2011) 
and highlight the hypothesis that sequestration of neutrophils into the lungs is only due to the 
mechanical properties of the microvasculature and is independent of integrins and selectins. 
1.1.6 Transmigration 
Once the neutrophils are adherent on the vascular endothelium, they are ready to transmigrate. 
However, the transmigration does not necessarily occur at the location where the neutrophils stopped. 
Some neutrophils display a probing behaviour and send out pseudopods to probe their vicinity while 
being firmly attached at a specific point of the endothelium (McDonald et al., 2013). Neutrophils 
typically transmigrate at an endothelial cell-cell junction to which they migrate to. The shear forces 
due to the blood flow are responsible for the elongated shape of the endothelial cells in the direction 
of the blood flow (Malek and Izumo, 1996). Under these conditions, neutrophils tend to migrate 
perpendicularly to the endothelial cell long axis since it is the shortest distance from the neutrophil 
adhesion position to a cell-cell junction. This migration is dependent of the interaction between 
ICAM1 on the endothelium surface and CD11b on the neutrophil surface (Phillipson et al., 2006). 
Neutrophil migration under shear stress is still poorly understood but has been shown to be dependent 
of a succession of changes in cell shape that allow the cells to be continuously attached to the 
endothelium while both creating new bonds at their front and detaching their rear at the same time. 
Such phenomenon involves remodelling of the actin cytoskeleton through the VAV1 and CDC42 
pathway which strengthen the high affinity of β2 integrins to their ligands and in return results in an 
enhanced interaction between integrins and actin cytoskeleton (Hepper et al., 2012). Migration on the 
endothelium does not require a chemokine gradient as it has been shown that under shear stress and in 
the absence of chemoattractant gradient neutrophils migrate in straight line in perpendicular direction 
to the shear forces and return to random migration behaviour as soon as the shear flow is stopped 
(Phillipson et al., 2009). Nevertheless, various chemokines are present on the vascular endothelial cell 
surface and may also contribute to define a gradient (Massena et al., 2010; Phillipson et al., 2009) that 
26 
 
guide neutrophil migration through haptotaxis (directional migration through a gradient of cellular 
adhesion or substrate-bound molecules) towards specific transmigration sites (McDonald et al., 2010). 
Once the neutrophils reach a transmigration site, they can leave the vasculature by first crossing the 
endothelium and then the basement membrane (Ley et al., 2007). Passage through the endothelial cell 
layer takes place either paracellularly, i.e.between cells, or intracellularly, i.e. through a cell. It has 
been shown that, in vitro, paracellular transmigration usually happens at tricellular junctions of the 
endothelium where fewer junctional proteins are present and the endothelium is less well organised 
(Burns et al., 2000; Woodfin et al., 2011). Neutrophils preferentially use the paracellular migration 
(Petri et al., 2008; Woodfin et al., 2011) but also use the transcellular migration even though being 
less efficient and slower (Phillipson et al., 2008). The transcellular migration is a process where 
endothelial cells use microvilli projections to create a transmigration cup or dome that covers and 
seals the neutrophil away from the blood flow. This process depends on the leukocyte specific protein 
1 (LSP1) which, upon endothelial cell activation, reorganises actin filaments into bundles (Petri et al., 
2011). Neutrophil transmigration is also dependent of L-selectin, as the loss of its expression results in 
impaired neutrophil transmigration (Hickey et al., 2000) probably due to defective cell polarisation 
(Rzeniewicz et al., 2015). The transmigration ends when the neutrophils migrate through the 
extracellular matrix proteins of the basement membrane probably using proteases such as MMPs 
(Kolaczkowska and Kubes, 2013). It has been shown that neutrophils transmigrate preferentially 
through basement membrane regions that are characterised by low levels of ECM (Wang et al., 2006). 
These regions also show a gap between the pericytes that wrap around the endothelial cells creating 
an interface between the vasculature and the interstitial space, suggesting that neutrophils seek regions 
with the least resistance to emigrate (Proebstl et al., 2012). 
1.1.7 Emigration.  
Once neutrophils have emigrated, they must be able to move away from the gradient of chemokines 
that triggered the transmigration and move in the direction of the infection site. The chemoattractants 
that are secreted in the surroundings of the infected tissues, such as N-formyl-methionyl-leucyl-
phenylalanine (fMLP) and the complement C5a, override the chemotactic signals (IL-8 and LTB4) 
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produced by intermediary sites, such as the endothelium. Hence, chemoattractants can be classified 
into two groups: intermediary and end-target, the latter over-riding the former. Unlike transendothelial 
migration which is β2 integrin dependent, migration in tissues is not (Lammermann et al., 2008). 
When the first wave of neutrophils reaches the infection site, they secrete leukotriene B4 (LTB4) 
which drives a second wave of neutrophils from more than 200 µm away from the infection site. The 
LTB4 is once again an intermediary signal that is then superseded by local signals such as fMLP 
(Lämmermann et al., 2013). 
1.1.8 Destruction of pathogens.  
Neutrophils are able to kill both intra- and extra-cellular pathogens by several mechanisms. The most 
well-known mechanism is phagocytosis which consists of the engulfment of the pathogen by the 
neutrophil into an intracellular vesicle called phagosome. Once the pathogens are encapsulated in the 
phagosomes, the cells kill them using reactive oxygen species produced by the NADPH oxidase 
machinery or through the fusion of the phagosome with azurophil granules that deliver antibacterial 
proteins such as cathepsins, defensins, lactoferrin and lysozyme (reviewed in Borregaard, 2010) to the 
phagosome. The antibacterial proteins can be released directly into the phagosomes containing the 
pathogens or into the extracellular environment destroying both intra- or extra-cellular pathogens. The 
destruction of extracellular pathogens may be accompanied by the destruction of the surrounding 
tissues by the granules content secreted by the neutrophils.  
Neutrophils possess another mean to eliminate extracellular microorganisms by the use of neutrophil 
extracellular traps (NETs). NETs are fibrous networks constituted by a DNA core to which are bound 
histones, proteins (lactoferrin, cathepsins,…) and enzymes (MPO, elastase,…). NETs restrain the 
pathogens preventing them from spreading through the organism and also facilitate the subsequent 
phagocytosis of the imprisoned pathogens. It has been shown that NETs could directly kill bacteria 
through its antibacterial activity due to the proteases and histones bound to the DNA core 
(Papayannopoulos and Zychlinsky, 2009). This suggests that NETs may also be used by neutrophils 
to directly kill pathogens in vivo and would be consistent with the observation that patients with an 
inherited deficiency in the formation of NETs suffer from repeated infections (Bianchi et al., 2009). 
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1.1.9 Neutrophils and the adaptative immunity 
Recently, accumulating evidences has indicated that neutrophils also modulate adaptative immunity 
through several distinct mechanisms. It has been shown that they can enter lymphoid organs where 
they seem to inhibit CD4+ T cell and B cell response to immunisation (Yang et al., 2010). It has also 
been reported that myeloperoxidase (MPO) - one of the main proteins of neutrophil azurophils 
granules inhibits the proliferation and activation of dendritic cells (DCs), reducing their numbers in 
draining lymph nodes. During infection by M. Tuberculosis (M. Tb), neutrophils are the first cells to 
phagocyte and accumulate M. Tb and secrete cytokines that attract DCs. These DCs then ingest the 
M. Tb-loaded neutrophils preventing the downregulation of CCR7 receptor, which then results in an 
accelerated DCs migration to the draining lymph nodes to activate CD4+ T cells (Blomgran and 
Ernst, 2011). Another example is that neutrophils may acquire antigens from dermis, bypassing the 
draining lymph nodes and transporting it directly to the bone marrow where resident macrophages 
phagocytose the antigen loaded neutrophils and present the antigen to CD8+ T cells to generate 
memory T cells (Duffy et al., 2012). Finally, neutrophils also regulate natural killer (NK) cell 
maturation. Altered granulopoiesis or congenital neutropenia result in diminished NK cell activity and 
altered NK cell repertoire (Jaeger et al., 2012). 
1.1.10 Reverse neutrophil migration 
It was believed that during inflammation, neutrophils would die in the infected tissues before being 
phagocyted by macrophages. This hypothesis is now challenged as it has been shown in zebrafish 
embryos that, under sterile inflammatory conditions, neutrophils mobilised to a wound in the embryo 
tail could reverse migrate and mount an effective response to a subconsequent S. Aureus aggression 
(Elks et al., 2011; Ellett et al., 2015). In mouse, emigrated neutrophils were observed to reverse  
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transmigrate and re-enter the vasculature, contributing to the dissemination of systemic inflammation 
(Elks et al., 2011; Ellett et al., 2015; Mathias et al., 2006; Woodfin et al., 2011). 
This process may happen due to the downregulation of a junctional adhesion protein, which usually 
prevents reverse transmigration (Woodfin et al., 2011). It has further been reported that as small 
subpopulation (1-2%) of neutrophils in patients with rheumatoid arthritis were capable of reverse 
transmigrate and these neutrophils were also more resistant to apoptosis (Buckley et al., 2006). The 
consequences of the reverse transmigration are so far unknown as it may be a way to preserve 
neutrophils when there is no more need to fight the infection or it could also spread inflammation into 
other organs with possible deleterious consequences. 
The actin cytoskeleton regulates the changes of cell shape and therefore is an essential component that 
controls neutrophil functions, from migration to phagocytosis.  
 
1.2 Actin cytoskeleton 
1.2.1 Actin polymerisation 
Actin is a globular protein of 42 kDa found in nearly all eukaryote cells where it is the subunit of 
microfilaments. In cells, it can be found either as free monomers (G-actin) or as part of 
microfilaments (F-actin). Actin monomers constituting the filament are organised in a double helix 
which allows a monomer newly added to one extremity to interact with two subunits of the 
microfilament. In order to start the assembly of actin filament, a nucleus composed of a trimer of actin 
monomer is necessary. The spontaneous nucleation of actin is an unfacilitated process due to the 
instability of the intermediate actin dimers needed in the formation of the actin trimer; thus the 
formation of actin dimers is then considered as the limiting step in actin polymerisation (Pollard and 
Borisy, 2003). The instability of the actin dimer together with the interaction of actin with specific 
actin-binding proteins that can sequester actin monomers in the cell cytoplasm prevent unregulated 
nucleation of actin in the cell. Once the nucleation of an actin trimer is completed, the elongation of 
the actin filament is a favourable and fast process. The two ends of the actin filament are characterised  
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Figure 1-2: Actin polymerisation by the Arp2/3 complex and formins 
The actin cytoskeleton is a highly dynamic structure that undergoes continuous cycles of 
polymerisation and depolymerisation. Actin monomers incorporated in F-actin are initially bound to 
ATP. Once present in F-actin, ATP is converted in (ADP+Pi), and then in ADP. These differences in 
hydrolysis states of ATP bound to F-actin create differences in polymerisation kinetics between the 
two ends of the actin filament (the barbed end and the pointed end). F-actin assembly in various 
specific structures to respond to the cell needs requires the participation of actin nucleators such as 
Arp2/3 complex and formins. Remarkably, Arp2/3 complex nucleates new filaments with a 70° Y-
branch angle after binding to an existing filament, allowing the arrangement of F-actin in complex 
branched structures, while formins trigger the nucleation of unbranched actin filaments. 
 
 
31 
 
by different polymerisation dynamics, with the barbed end showing faster dynamics than the pointed 
end resulting in a favourable extension of the actin filament at the barbed-end. In cells, the continuous 
cycles of actin polymerisation and depolymerisation create a highly dynamic actin cytoskeleton which 
can rapidly respond to stimuli allowing the cells to quickly change shape. Monomers of actin that are 
incorporated in F-actin are bound to ATP but once included in the filament, the ATP spontaneously 
hydrolyses into ADP + inorganic phosphate (ADP + Pi) and subsequently into ADP. The different 
states of hydrolysis of the ATP bound to actin in the filament can influence the binding of proteins to 
F-actin that regulate actin dynamics. Depending on the cell’s needs, F-actin can be assembled into 
specific structures such as bundles or branched networks. Actin polymerisation and assembly into 
structures is highly dynamic and is dependent on numerous proteins such as actin nucleators (the 
Arp2/3 complex, formins), nucleation promoting factors (WASp, WAVE), and regulating proteins 
(coronins, cofilin, LSP1). The importance of these actin-polymerisation regulators in the immune 
response has been largely demonstrated by the description of immunodeficiencies associated with 
mutations in these proteins. While in the section below, a brief description of the key actin 
cytoskeleton regulators is provided, the section 1.3 focuses in more details on describing the immune 
function impairment due to the reported mutations in the actin cytoskeleton regulators and associated 
proteins (i.e. WASp WIP, DOCK8, Rac2, RhoH, β-actin, and LSP1). 
1.2.2 The Arp2/3 complex 
The actin related protein complex 2/3 (Arp2/3) was the first actin nucleator to be identified 
(Machesky et al., 1994). Arp2/3 is a protein complex constituted of seven subunits, is highly 
conserved in nearly all organisms and has a molecular weight of 220 kDa. The seven subunits include 
ARP2 and ARP3 that are associated with five additional subunits ARPC1, ARPC2, ARPC3, ARPC4 
and ARPC5. The Arp2/3 complex is unique as it possesses the aptitude to nucleate actin filaments and 
arrange then into branched networks. By itself, Arp2/3 has little biochemical activity and needs to 
interact with nucleation promoting factor (NPF) proteins to be activated, leading to the binding of 
Arp2/3 to an existing actin filament and the nucleation of a new actin filament from Arp2/3 with an 
Y-branch angle of 70
o
 between the existing and new filaments (Amann and Pollard, 2001; Mullins et 
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al., 1998). Structural studies suggest that ARPC2 and ARPC4 establish an essential contact with the 
mother filament whereas the barbed-end of ARP2 and ARP3 associate together with the pointed end 
of the growing filament acting as a template  (Beltzner and Pollard, 2004; Rouiller et al., 2008). The 
interaction between the mother filament and the whole Arp2/3 complex require conformational 
changes from the filament and the complex (Rouiller et al., 2008) that possibly orient ARP2 and 
ARP3 to act as the first two monomers of the daughter filament. Arp2/3 activity is increased by three 
mechanisms: the binding with the actin filament, phosphorylation of Threonine and Tyrosine residues 
in ARP2 (LeClaire et al., 2008) and the activation of the complex by nucleation promoting factors 
(NPFs). Arp2/3 is usually activated by NPFs through the VCA domain which is organised in three 
regions constituted of one or more verprolin homology domains (also known as WASp homology 2 
domain) that bind actin monomers, a central amphipathic region (also known as cofilin homology 
domain), and an acidic region that, together with the central region, binds Arp2/3.  In cells, the Arp2/3 
complex regulates the dynamics of the actin cytoskeleton at the cell cortex, in migratory actin 
structures such as the lamellipodia and podosomes, and in numerous other actin structures. 
1.2.3 WASp and N-WASp 
The Wiskott-Aldrich Syndrome protein (WASp) is a 502 amino acid protein whose expression is 
restricted to hematopoietic cell linages (Thrasher and Burns, 2010). WASp is constituted of five 
different domains: N-terminal Ena-VASP homology domain (EVH1), a basic domain, the GTPase 
binding domain (GBD), the polyproline domain, and the C-terminal VCA domain comprising the 
verprolin homology, a central and an acidic region (Figure 1-3). The neuronal Wiskott-Aldrich 
Syndrome protein (N-WASp) is the ubiquitously expressed homologue of WASp and both proteins 
show 46% identity and 72% homology at the amino acid level and 80% identity in the functional 
domains. In the cytoplasm, WASp is found in an auto-inhibitory conformation where the VCA 
domain, the active domain of WASp, is bound to the GBD domain. Once activated, WASp releases its 
VCA domain from autoinhibition and the VCA domain is then free to activate the Arp2/3 complex to 
trigger the nucleation of a new branched   
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actin filament. WASp can be activated by the cell division control protein 42 homolog (CDC42), 
phosphatidylinositol 4,5-bisphosphate (PIP2), phosphorylation on tyrosine 291 and numerous kinases 
adapters and actin-binding proteins (Campellone and Welch, 2010; Thrasher and Burns, 2010). The 
high number of WASp activators indicates that WASp integrates a broad range of signals and 
highlights the complex regulation of its activity. WASp activity is also regulated by WIP which 
stabilises WASp (Chou et al., 2006; de la Fuente et al., 2007) and by the phosphorylation of tyrosine 
291 which controls the proteolysis of the protein. Proteosomal and/or calpain-mediated degradation of 
WASp is important for podosome disassembly and regulation of WASp activity in the immune 
synapse in T cells and seems to be regulated by the phosphorylation of tyrosine 291 (Blundell et al., 
2009; Reicher et al., 2012) but this mechanism is not fully understood yet. Thus the phosphorylation 
of tyrosine may regulate both WASp activation and degradation and therefore control the spatio-
temporal activity of WASp. 
1.2.4 WASp family 
Arp2/3 can be stimulated by several NPFs classified in five groups: WASP and N-WASp; the WASp-
family verprolin homologue (WAVE) isoforms; the WASp and SCAR homologue factors (WASH); 
the WASp homologue associated with actin, membranes and microtubules (WHAMM) and the 
junction-mediating regulatory protein (JMY). All these NPFs activate Arp2/3 through VCA domains 
but their regulation and functions differ from each other as they comprised varied domains. 
1.2.4.1 WAVE 
The WAVE group is composed of three isoforms that are expressed in numerous tissues. WAVEs are 
not autoinhibited and thus are fully active when produced and purified as recombinant proteins. One 
of the main differences with WASp is that WAVE NPFs do not possess a GBD domain and they also 
possess distinctive regulatory domains from N-WASp. WAVEs are involved in the formation of 
membrane protrusions and cell migration where they activate Arp2/3 at the leading edge membrane. 
WAVE2 deficient cells show severe impairment in membrane ruffling, formation of lamellipodia and 
cell migration (Innocenti et al., 2004; Steffen et al., 2006; Yamazaki et al., 2003). In the absence of  
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Figure 1-3: WASp family 
WASp is a 502 amino acid protein, restrictively present in hematopoietic cell linages and constituted of 
five different domains: the N-terminal Ena-VASP homology domain (EVH1), a basic domain, the GTPase 
binding domain (GBD), the polyproline domain, and the C-terminal VCA domain (WCA): verprolin 
homology/WASp homology 2 domain (W), central amphipathic region/cofilin homology domain (C), and 
the acidic region (A). With 80% identity in the functional domains, N-WASp is the ubiquitously expressed 
homologue of WASp. All WASp family members such as WAVE isoforms, WASH, WHAMM and JMY, 
also possess the VCA domain required for Arp2/3 activation, but the function and regulation of the domain 
are specific to each of these proteins. B: basic region; CC: coiled-coiled region; N: N-terminal domain; P: 
polyproline; PRD: Pro-rich domain; SHD: SCAR homology domain; TBR: tubulin-binding region; 
WAHD1: WASH homology domain; WMD: WHAMM membrane interaction domain 1. (Figure modified 
from Campellone and Welch, 2010). 
35 
 
WAVE1, cells exhibit defective migration through the extracellular matrix. WAVE1 and WAVE2 
expression is the most extensive through the different tissues but is at its highest in the brain.  
1.2.4.2 WASH 
As for all members of the WASp family, WASH possesses a VCA domain that activates the Arp2/3 
complex. WASH is also constituted of the N-terminal WASH homology domain 1 (WAHD1) and the 
tubulin-binding region (also known as WAHD2). It has been shown that, in mammalians, WASH 
activity regulates the shape of early and recycling endosomes and also affects trafficking towards late 
endosomes, the endosomal recycling to the plasma membrane and the retrograde trafficking of 
endosomes to the trans-Golgi network (Derivery et al., 2009; Duleh and Welch, 2010; Gomez and 
Billadeau, 2009). 
1.2.4.3 WHAMM 
Similarly to other NPFs of the WASp family, WHAMM is composed of a C-terminal VCA domain 
flanked by a polyproline region. It also possesses central regions, that are predicted to form coiled 
coils, and an N-terminal WHAMM membrane interaction domain (WMD). The WHAMM VCA 
domain is similar to N-WASp as it has two verprolin homology domains but results showed that 
WHAMM has a weaker NPF activity that N-WASp. It has been shown that, in vitro, WHAMM is 
constitutively active and does not have an autoinhibited conformation (Campellone et al., 2008). In 
cells, WHAMM interacts with actin and microtubules and regulates membrane transport and 
dynamics at the cis-Golgi and at the endoplasmic reticulum (Campellone et al., 2008). 
1.2.4.4 JMY 
Despite 35% of identity with WHAMM, JMY differs at its C-terminal region by the presence of three 
verprolin homology domains allowing it, with the addition of an actin monomer-binding linker, to 
nucleate actin filament in the absence of Arp2/3 (Zuchero et al., 2009). JMY is involved in cell 
motility by translocating to the lamellipodium but also translocates to the nucleus in response to DNA 
damage (Coutts et al., 2009; Zuchero et al., 2009). Further studies are still needed to understand the 
activity and spatio-temporal regulation of JMY.  
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1.2.5 Formins  
Formins are actin nucleators that generate unbranched actin filaments and are characterised by their 
formin homology domains FH1 and FH2. By itself, the FH2 domains are enough to start the 
nucleation of filaments from purified actin monomers and they are active only as homodimers (Harris 
et al., 2006; Li and Higgs, 2005; Moseley et al., 2004). Any mutation that disrupts the dimerisation of 
the FH2 domains results in the loss of the ability to polymerise actin (Copeland et al., 2004; Moseley 
et al., 2004; Xu et al., 2004). The actin nucleation mechanism used by formins relies on the FH2 
domain binding the barbed end of an actin filament where it behaves as a processive cap, avoiding the 
inhibition of filament elongation by other capping proteins (Harris et al., 2006; Moseley et al., 2004). 
The formin nucleation mechanism is therefore different than the mechanism Arp2/3 uses, which only 
caps the pointed end of the filaments. The two FH2 monomers are connected by a flexible tether 
forming a ring and each FH2 binds two actin monomers. The FH2 dimer is dynamic and changes 
conformation over time by firstly binding the barbed end of the filament that does not allow the 
incorporation of actin while the FH1 domain recruits profilin-actin heterodimers. Then, one after the 
other, the FH1 domains incorporate the actin monomers at the end of the filament. It is still debated if 
the incorporation of actin at the filament precedes or follows the stepping forward of the FH2 dimer 
but once the actin is incorporated and the FH2 has stepped forward, the FH2 domains are in closed 
conformation preventing the capping of the actin filament by other proteins. It is only when the FH1 
domain recruits actin monomers that the FH2 dimer changes conformation to allow the incorporation 
of new actin subunits in the filament (Otomo et al., 2005; Paul and Pollard, 2008). The classification 
of formins has been established on the differences in the sequence of the FH2 domain. There are 
seven groups of formins: Diaphanous (DIA), Dishevelled-associated activators of morphogenesis 
(DAAMs), formin homology, formin-related proteins in leukocytes (FRLs), domain proteins 
(FHODs), formins (FMNs), delphilin and inverted formins (INFs) (Higgs, 2005).  
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1.2.6 Coronins 
Coronins are actin regulatory proteins conserved in all eukaryotes characterised by the presence of a 
WD40-repeat containing β-propeller (Appleton et al., 2006). The β-propeller gives coronins the 
ability to bind F-actin through interaction between the surface of the β-propeller and the actin filament 
(Cai et al., 2007). The affinity of coronins for F-actin is dependent on the hydrolysis of actin 
monomers in the filament. Coronin1B has an affinity 50 fold higher for actin filaments containing 
ATP/ADP+Pi actin, which are present close to the barbed ends of F-actin, compared to ADP actin 
filaments present closer to the pointed end of F-actin. Coronins also interact with Arp2/3 through their 
C-terminus acidic domain that is similar to WASp VCA domain but missing the verprolin homology 
domain used to bind G-actin. The ability to bind F-actin and Arp2/3 without activating it, allows 
coronins to regulate the nucleation of branched actin filament by either inhibiting the attachment of 
the Arp2/3 complex (Cai et al., 2008) or directly facilitating debranching (Weaver et al., 2001). 
1.2.7 Cofilin/WDR1 
Cofilins are part of the actin-depolymerisation factor (ADF)/cofilin family that is expressed in all 
eukaryotes. These small (15-20 kDa) actin binding proteins are formed by a unique folded domain 
called ADF-homology domain (ADF-H) (Van Troys et al., 2008). In mammals, three extremely 
similar paralogs are expressed: cofilin-1, cofilin-2 and ADF (Ono et al., 1994). Cofilins can promote 
actin filament assembly or disassembly depending on the relative concentration of cofilin to actin and 
other actin-binding proteins (Van Troys et al., 2008). It has been shown that in vitro, low 
concentrations of cofilin per actin filament result in severing of the actin filament (Bobkov et al., 
2006). At high concentrations of cofilin, severing is not observed anymore and the actin dissociation 
rate at the pointed end is similar to actin dissociation without cofilin. When cofilin is present at very 
high concentration, it promotes actin assembly (Andrianantoandro and Pollard, 2006). The different 
functions that cofilins can perform allow them to regulate the actin turn-over and therefore impact the 
dynamics of F-actin.  
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Figure 1-4: MKL1 regulates actin cytoskeleton gene expression 
MKL1 continuously shuttles between the nucleus and the cytoplasm. MKL1 interaction with G-actin 
promotes its nuclear export resulting in a mainly cytoplasmic localisation in resting cells. When 
stimuli lead to actin polymerisation, G-actin monomers are integrated in actin filament resulting in the 
decrease of G-actin concentration throughout the cells. The drop of G-actin concentration reduces the 
interaction between G-actin and MKL1 which leads to MKL1 accumulation in the nucleus where it 
associates with SFR to activate gene transcription (Esnault et al., 2014; Miralles et al., 2003; 
Vartiainen et al., 2007).   
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It has been shown that cofilins are involved in many processes such as T-cell activation, phagocytosis, 
endocytosis, receptor recycling and cell migration (Van Troys et al., 2008). 
WD Repeat Domain 1 (WDR1), also known as actin interacting protein 1 (AIP1) is ubiquitously 
expressed in eukaryotes and helps actin filament disassembly by cofilin. The mechanism by which 
WDR1 helps F-actin disassembly is not fully understood and so far two models have been proposed: 
WDR1 may cap actin filaments preventing their elongation but also cap freshly severed actin 
filaments to prevent their reannealing. WDR1 may also directly sever actin filaments on which 
cofilins are bound. It has been shown that WDR1 is involved in cell migration, cytokinesis and in 
inflammatory diseases (Kato et al., 2008; Kile et al., 2007). 
1.2.8 MKL1  
The megakaryoblastic leukemia 1 (MKL1) protein belongs to the myocardin-related transcription 
factor (MRTF) protein family (Olson and Nordheim, 2010). MKL1 has the ability to bind monomeric 
actin via its RPEL domains and to constantly translocate in and out of the nucleus. MKL1 interaction 
with G-actin encourages its export from the nucleus resulting in a mainly cytoplasmic localisation in 
unstimulated cells. Extracellular stimuli that bind to receptors, activate different Rho GTPases which 
in turn stimulate actin polymerisation. The incorporation of G-actin into new actin filaments results in 
a drop of concentration of G-actin in the cell disrupting MKL1 interaction with G-actin and promoting 
MKL1 accumulation in the nucleus (Miralles et al., 2003; Vartiainen et al., 2007). Once in the 
nucleus, MKL1 binds the serum response factor (SRF) and activates the transcription of genes (Figure 
1-4). It has been shown that SRF regulates numerous actin cytoskeleton related genes including genes 
that are MKL1 dependent (Esnault et al., 2014). Notably, among the genes, the MKL1-SRF pathway 
regulates beta actin, integrin beta1, myosin light and heavy chain 9, vinculin, and cofilin1 (Olson and 
Nordheim, 2010). It is then not a surprise that it has been shown that MKL1 is involved in cell 
adhesion, spreading and migration of metastatic cells (Medjkane et al., 2009), the formation of 
platelets (Gilles et al., 2009), the maintenance of actin levels within cells (Salvany et al., 2014), and 
the formation of actin structures such as filopodia, lamellipodia and stress fibres (Esnault et al., 2014; 
Gilles et al., 2009). 
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1.2.9 Non-muscle myosin II  
Myosins are a superfamily of motor proteins that can generate tension on, walk along, or drive the 
sliding of actin filaments and they are essential in numerous cellular activities requiring force and 
translocation (Krendel and Mooseker, 2005). Myosin activity relies on the hydrolysis of ATP, which 
is performed by catalytic ATPase sites usually located in the head, the N-terminal region, of the 
myosins. The tail, C-terminal region, possesses specific activities that depend on the type of myosin. 
For example, it can bind to cargo or self-associate into filaments allowing the head to bind actin and 
apply tension (Krendel and Mooseker, 2005; Vicente-Manzanares et al., 2007). Non-muscle myosin II 
(NM II) belong to the class II which contains most of myosins. NM II are smiliar in structure and 
function to muscle myosins and are composed of three pairs of subunits, or chains: two heavy chains 
(230 kDa), two regulatory light chains (20 kDa) regulating NM II activity and two essential light 
chains (17 kDa) that stabilise the heavy chain structure. NM II is essential in cellular processes that 
rely on cell shape changes and movement such as cell migration, cell adhesion and cell division 
(Vicente-Manzanares et al., 2007). 
1.2.10 Actin cytoskeleton in migration 
Cells can sense extracellular signalling molecules called chemokines and migrate in the direction of 
increased concentrations of chemokine, a process called chemotaxis (Keller et al., 1977). Chemotaxis 
can be defined as the sum of three events: a directional sensing that allows the cell to respond to a 
chemokine gradient, the formation of pseudopods and the cell polarisation which increases the 
sensitivity of the cell leading edge compared to the trailing edge.  
Directional sensing 
When cells are migrating in a chemokine gradient, new pseudopod  are usually formed at the side of 
the cell facing the source of chemoattractant indicating that the cells sense the direction of the 
chemoattractant source.  
Formation of pseudopod 
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When not stimulated with chemoattractants, neutrophils are not polarised and do not generated 
protrusions. Upon stimulation, nucleation of new actin filaments is promoted and a dynamic 
protrusion called pseudopod is extended from the cell body.   
Cell polarisation 
Once stimulated, neutrophils become polarised with the formation of pseudopod at the leading edge 
and of a uropod at the trailing edge (Figure 1-5). When using a pointed source of chemoattracant, 
modification of the localisation of the chemokine source results in the formation of an additional 
pseudopod at the leading edge. The cell then uses this new protrusion to make a U-turn towards the 
new localisation of the chemoattractant source. Cells do not need to be in a gradient of chemokine to 
become polarised since they also polarise when uniformly stimulated and then show a persistent 
migration in random directions, a process called chemokinesis (Keller et al., 1977).  
Formation of pseudopod, cell polarisation and directional sensing all require signal transduction from 
the chemokine in the extracellular environment together with a regulation of the actin cytoskeleton in 
order to form actin based structures that alllow the cell movement. 
 
1.2.10.1 Actin in the pseudopod and in the uropod 
To migrate, cells break symmetry and extend sheet-like projections called pseudopods at the leading 
edge and a uropod, a specific protrusion at the rear. The pseudopod is constituted of actin filaments 
oriented with their barbed-end towards the cell membrane and the pointed end in the direction of the 
cell interior (Fritz-Laylin et al., 2017; Pollard and Borisy, 2003). Actin polymerisation at the barbed-
end pushes the cell membrane to adapt to the actin filament growth and results in the extension of the 
cell leading edge. F-actin polymerisation is initiated at the cell membrane by WASp or WAVE 
proteins that activate the Arp2/3 complex and trigger the nucleation of branched actin filaments 
(Machesky and Insall, 1998; Rogers et al., 2003; Weiner et al., 2006). The actin cytoskeleton in the 
pseudopod is composed of short branched filaments nucleated by Arp2/3 but also of unbranched 
filaments polymerised by formins (Shi et al., 2009b). Recent data suggest that pseudopods are   
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Figure 1-5: Polarisation of a neutrophil 
When stimulated with a chemokine, neutrophils become polarised. A pseudopod is formed at the leading edge, 
the side of the cell in the direction of migration, while a uropod is formed at the trailing edge of the cell. 
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composed of multiple lamella and are needed to probe the environment for migration cues (Fritz-
Laylin et al., 2017). The uropod is the membrane protrusion that is formed at the trailing edge of the 
leukocytes in response to stimulation with a chemoattractant. The uropod is enriched with specific 
organelles, cytoskeleton proteins, and with adhesion and signalling receptors and has a role in cell 
migration, vesicle recycling and intercellular communication (Sánchez-Madrid and Serrador, 2009). 
The actin filaments localised in the uropod are oriented in parallel to the axis of migration and interact 
with actin binding proteins such as the ezrin–radixin–moesin (ERM) proteins (Alonso-Lebrero et al., 
2000) and myosin motor proteins such as the non-muscle myosin IIA (Eddy et al., 2000). The myosin 
activity is regulated by the phosphorylation of the myosin light chain by the myosin light chain kinase 
or by the RhoA-ROCK pathway but also by the integrin CD11b. When neutrophils polarise, CD11b is 
redistributed at the uropod in a CDC42 dependent manner where it modulates myosin light chain 
phosphorylation and activity, preventing the formation of lateral protrusions (Szczur et al., 2009). 
Although the role of the uropod in cell migration is still not completely understood, the cell trailing 
edge retraction that is mediated through RhoA is important for cell locomotion (Eddy et al., 2000). To 
allow the cell to migrate, the uropod needs to detach from the substratum before the cell body can 
retract. Neutrophils reduce uropod adhesion by reducing β1 and β2 integrin expression at the cell rear 
via the junctional adhesion molecule A (JAM-A) (Cera et al., 2009). Together, the decreased integrin 
expression and the force generated by the non-muscle myosin IIA allow the detachment of the rear of 
the cell from the substratum. The myosin II also generates forces that squeeze the uropod and cause a 
flow of intracellular material towards the leading edge of the cell. These waves of contractility also set 
the direction of migration indicating that, in neutrophils, the uropod has an active role in chemotaxis 
(Smith et al., 2007). 
The regulation of cell polarisation and actin polymerisation during chemotaxis is a complex process 
that involves numerous actors. These processes are detailed below. 
1.2.10.2 Signalling in cell migration  
Neutrophil polarisation and chemotaxis in response to fMLP or IL-8 are regulated by receptors from 
the seven transmembrane domain receptor coupled to G-proteins (GPCR). The formyl peptide 
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receptor 1 (FPR1) responds to very low fMLP concentrations (Le et al., 2002) and transduces fMLP 
signal to the actin cytoskeleton regulators through a cytoplasmic heterotrimeric G protein complex 
constituted of Gα, Gβ and Gγ proteins. Upon FPR1 activation by fMLP, the G protein complex 
dissociates into Gα and Gβγ complexes which activate numerous proteins involved in neutrophil 
polarisation and chemotaxis such as Rho family small GTPases, the phospholipase Cβ2 (PLCβ2), 
phosphoinositide-3-kinase (PI3K), MAP kinases and Tyrosine kinases. For clarity, only the main Rho 
GTPases and PI3K pathway will be developed here.  
1.2.10.3 Phosphoinositide-3-kinase 
Four classes I PI3K are expressed in neutrophils and are further divided in two classes: the class IA 
contains PI3Kα, β and δ while PI3Kγ belongs to the class IB. It has been shown that PI3Kγ and δ have 
regulatory functions in neutrophil chemotaxis (Hannigan et al., 2002; Hirsch et al., 2000; Puri et al., 
2004; Sadhu et al., 2003; Sasaki et al., 2000). PI3Kγ is activated by the G protein complex Gβγ and 
uses phosphatidylinositol 4,5-bisphosphate (PIP2) to generate the second messenger 
phosphatidylinositol 3,4,5-triphosphate (PIP3) that accumulates at the leading edge of the cell and 
activates GTPases from the Rho family (Figure 1-6-A). Spatio-temporal accumulation of PIP3 is also 
regulated by PIP3 phosphatases such as the phosphatase and tensin homologue (PTEN) and SH2-
containing inositol-5'-phosphatase 1 (SHIP1). It has been shown in human and murine neutrophils that 
PTEN localisation at the rear of the cells is dependent of RhoA and Rho-associated protein kinase 
(ROCK) and that PTEN is required for the migration towards bacterial products in an environment 
with multiple chemotactic cues (Heit et al., 2008). Nevertheless, PTEN deficient murine neutrophils 
displays an increased extravasation and recruitment to the inflammation site (Sarraj et al., 2009; 
Subramanian et al., 2007). The discrepancy between these studies suggests that PTEN role might be 
not identical in human and mouse and that it is important to consider the infection model and type of 
chemoattractant used when analysing the results (Heit et al., 2008). It has also been shown that SHIP1 
regulates neutrophil adhesion, spreading and chemotaxis in vitro. These results were supported by in 
vivo results showing an increased recruitment of neutrophils in inflamed lungs  
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(Mondal et al., 2012; Nishio et al., 2007; Strassheim et al., 2005).   However, in human neutrophils, 
only the reduction of migration speed has been shown when SHIP1 is inhibited (Sapey et al., 2014). 
The results obtained from murine studies allowed to understand the role of PTEN and SHIP1 in 
murine models but the differences between murine and human neutrophils suggest that the exact roles 
of PTEN and SHIP1 in human neutrophils are not fully understood and need further investigation. 
Many of the PI3K and G proteins effectors are small GTPases that regulate the actin cytoskeleton and 
the cell polarisation. 
1.2.10.4 Small GTPases 
Small GTPases are proteins that relay the signal from a GPCR to numerous effectors. GTPases 
(Figure 1-6-B) cycle between an active state when they are bound to GTP and an inactive state when 
bound to GDP. The spatio-temporal activation of GTPases is tightly regulated resulting in only a 
small fraction of the GTPases that are activated at any given time. The cycling between the GTP 
bound and GDP bound states is regulated by Guanine nucleotide exchange factors (GEFs) and by 
GTPase-activating proteins (GAPs). GEFs catalyse the replacement of GDP with GTP allowing the 
activation of the GTPases whereas the GAPs increases the hydrolyse activity of the GTPases resulting 
in hydrolysis of GTP into GDP and the inactivation of the GTPase.  
Rho subfamily 
The Rac (Ras-related C3 botulinum toxin) subfamily of the Rho GTPases is composed of Rac1, Rac2 
and Rac3. Rac1 and 3 are ubiquitous whereas Rac2 is hematopoietic specific but the three Rac 
proteins are highly homologous with more than 90% of amino acid identity. In neutrophils, both Rac1 
and Rac2 are present, with Rac2 constituting more than 96% of the Rac expressed, and they regulate 
the polymerisation of branched actin filaments via the Arp2/3 complex (Sun et al., 2007). When 
activated, Rac mainly localises at the leading edge of neutrophils and regulates cell polarisation and 
chemotaxis. While Rac2 is the main Rac isoform activated for chemotaxis when neutrophils are 
stimulated with high concentration of fMLP, Rac1 seems to be the dominant isoform when cells are 
stimulated with low concentration of fMLP. This suggests a differential role of Rac1 and Rac2 in 
relation with the distance between the neutrophils and the infection site (H. Zhang et al., 2009). In 
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Figure 1-6: Signalling in cell migration 
A) Localisation of the intracellular phosphoinositides gradients. PI3K generates PIP3 from PIP2 at the 
leading edge of the cell while PIP2 is restricted at the back of the cell. B) Signal transduction from the 
GPCR to the actin polymerisation. When a ligand binds the GPCR, it triggers the release of Gβγ and 
Gα subunits. Gβγ activates RacGEFs leading to Rac activation and actin polymerisation via the 
WAVE complex. Gβγ also activates PI3K which generates PIP3 resulting in the activation of WASp 
via CDC42 and PIX. The generation of PIP3 also results in the inhibition of RhoA and cell 
contractility at the front edge of the cell. Long distance signalling (dashed lines) by Gα causes the 
activation of RhoA at the trailing end of the cells that regulates cell contractility via ROCK and 
myosin II. ARAP3: ArfGAP With RhoGAP Domain, Ankyrin Repeat And PH Domain 3; DOCK2: 
Dedicator of cytokinesis 2; GPCR: G-protein couple receptor; Gα and Gβγ: G protein complex α and 
βγsubunits; GEF: Guanine nucleotide exchange factors; PI3K: phosphoinositide-3-kinase; PIP2: 
Phosphatidylinositol 4,5-bisphosphate ; PIP3: Phosphatidylinositol 3,4,5-triphosphate;  PIX: Pak 
interacting exchange factor; PTEN: phosphatase and tensin homologue; Rac: Ras-related C3 
botulinum toxin; RhoA: Ras Homolog Family Member A; ROCK: Rho-associated protein kinase; 
WASp: Wiskott-Aldrich Syndrome protein; WAVE: WASp-family verprolin homologue. 
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mouse, Rac1 deficient neutrophils displays impaired polarisation and directionality while Rac2
-/-
 
neutrophils showed defective actin polymerisation and chemotaxis (Glogauer et al., 2003, p. 1; 
Roberts et al., 1999; Sun et al., 2004). These results confirm the role of Rac1 in neutrophils but are to 
be taken with precaution as Rac1 expression in mouse is much higher than in human (Glogauer et al., 
2003), suggesting a more important role of Rac1 in mouse than in human.  It has also been shown that 
Rac is involved in a positive feedback loop with PI3K that results in the accumulation of PIP3 at the 
cell leading edge which is important for the establishment of cell polarity during chemotaxis 
(Srinivasan et al., 2003; Weiner et al., 2002; Yoo et al., 2010). In addition to its role at the front of the 
cell, Rac is also implicated in RhoA regulation and cell contractility at the rear of the cell. This 
ensures the stable polarisation of the cell and the correct retraction of the uropod (Gardiner et al., 
2002; Pestonjamasp et al., 2006). Rac can be activated by several GEFs such as P-Rex, Vav1, 
DOCK2 (Dedicator of cytokinesis 2) and ArhGAP15 that lie downstream of PI3K and Gβγ subunits. 
It has been shown in mice that P-Rex can be activated by both PIP3 and Gβγ and is an important 
regulator of neutrophil function but its activity seems to be not essential for in vitro neutrophil 
chemotaxis (Welch et al., 2005). Murine Vav1 has also been shown to be required in vivo for 
neutrophil intraluminal crawling and recruitment to the periphery whereas Vav1 has a lesser role in in 
vitro neutrophil chemotaxis (Gakidis et al., 2004; Lawson et al., 2011). In mouse, DOCK2 is recruited 
to the plasma membrane in a PI3Kγ-dependent manner and regulates the localisation of actin 
polymerisation together with neutrophil polarisation, directionality and distance migrated in in vitro 
chemotaxis experiments (Kunisaki et al., 2006). Finally, ArhGAP15 also has been shown in mouse to 
be recruited at the plasma membrane but ArhGAP15 knock-out neutrophils displayed, in vitro, 
increased chemotaxis, polarisation and improved directionality when stimulated with a single 
chemoattractant. These cells displayed a reduced ability to change direction when stimulated 
successively with two chemoattractants suggesting that the greater polarisation increased chemotactic 
speed but reduced the cell ability to effectively migrate in an environment with several chemotactic 
cues (Costa et al., 2011).  
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Cdc42 
It has been shown that the inactive form of Cdc42 localises at the leading edge of migrating 
neutrophils where it is activated by the complex PAK1/PIXα, previously recruited by the Gβγ subunit 
upon fMLP stimulation. The localisation of Cdc42-GTP is dependent on PIP3 generated by PI3Kγ; 
and PIXα seems to be involved in the exclusion of PTEN from the leading edge, reinforcing the PIP3 
gradient (Li et al., 2003). Migration of dHL-60 neutrophil-like cells expressing a dominant-negative 
form of Cdc42 displays multiple and unstable leading edges and poor directionality (Srinivasan et al., 
2003). These results were then confirmed in Cdc42
-/-
 primary murine neutrophils (Szczur et al., 2009). 
It has also been shown that local Cdc42 signal directs cell turning during chemotaxis and de novo cell 
polarisation, reinforcing the role of Cdc42 as compass in neutrophil migration (Yang et al., 2016). 
Cdc42 controls cell polarity via a cross-talk between the leading edge and the rear of the cell with 
Cdc42-GTP at the front regulating CD11b/CD18 integrin at the back of the cell. It has been shown 
that the clustering of CD11b/CD18 integrins at the rear is mediated via WASp (Kumar et al., 2012). 
RhoA 
In mouse and HL-60 neutrophil like cells, active RhoA is excluded from the leading edge of the cell 
and confined to the side and rear (Li et al., 2005; Wong et al., 2006). RhoA-GTP co-localises with 
microtubules, phosphorylated myosin light chain (pMLC) and PTEN at the neutrophil uropod where it 
regulates cell polarisation. Perturbation of RhoA activity results in alteration of cell morphology, 
localisation of PIP3 and polymerised actin in migrating neutrophil-like cells (Xu et al., 2003). It has 
been shown that RhoA regulates cell migration through two of its effectors, the Rho Kinase (ROCK) 
and the formin mDia. ROCK regulates the phosphorylation of myosin light chain which controls cell 
contractility needed for the translocation of the cell body during migration. In human cells, inhibtion 
of RhoA or ROCK results in altered migration characterised by a uropod-retraction defect (Alblas et 
al., 2001; Worthylake et al., 2001). mDia regulates, at the cell front, the polymerisation of unbranched 
actin filaments. The knock-out of mDia severely impairs murine neutrophil migration and affects the 
RhoA-ROCK signalling. mDia
-/-
 neutrophils are also characterised by disturbed localisations of F-
actin, pMLC, Rho-GTP and the RhoA GEF LARG. Both mDia and LARG are localised at the leading 
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edge of murine cell where they interact in a positive feedback loop (Kitzing et al., 2007; Shi et al., 
2009a). RhoA can be activated by different GEFs such as Lsc and PDZRhoGEF that are both coupled 
to the Gα subunit. Lsc localises at both the uropod and leading edge of neutrophils and regulates the 
adhesion, polarisation and chemotaxis. In mice, cells lacking Lsc displayed a faster migration 
associated with poor directionality and generation of concurrent simultaneous pseudopods. Despite 
this, the knock-out of Lsc does not alter the recruitment of neutrophils to inflammatory sites (Francis 
et al. 2006). PDZRhoGEF is also needed for the correct polarisation of the cells as neutrophils lacking 
the protein produce multiple pseudopods, migrate slower and show a reduced polarisation together 
with an altered pMLC distribution (Wong et al., 2006). RhoA GAP can also play an important role in 
regulating neutrophil chemotaxis. Knock-out of Rhoa GAP ARAP3 leads to an alteration of β2-
integrin signalling resulting in the impairment of murine neutrophil migration associated with a 
defective directionality (Gambardella et al., 2013, 2011). On the other hand, in vitro chemotaxis and 
in vivo recruitment of p190RhoGAP
-/-
 neutrophils are not affected (Németh et al., 2010). Mutations in 
the adapter protein Hax-1 lead to a congenital neutropenic syndrome known as Kostmann disease. It 
has been shown in human neutrophil like cell line that Hax-1 regulates RhoA at the uropod and Rac at 
the leading edge, and that the knockdown of the protein results in Rhoa/ROCK/integrin-dependent 
uropod retraction impairment (Cavnar et al., 2011). 
Despite the fact that RhoA-GTP has repeatedly been shown to be confined at the side and rear of 
neutrophils, several of its regulators and effectors have been reported to be localised at the front of the 
cells suggesting a possible RhoA activity at the front of neutrophils. 
1.3 Actin defects and immunodeficiency 
Performance of immunological task by immune cells relies on cell shape changes driven by 
reorganisation of the actin cytoskeleton making any alteration of the actin filament dynamics and/or 
structure a possible threat to the correct protection of the organism. It is not surprising that mutations 
in actin cytoskeleton regulators are responsible for defects in specific immune functions causing 
primary immunodeficiencies (PIDs). Defects in immune functions caused by actin cytoskeletal 
impairment impact almost every step of the immune response: hematopoietic cell proliferation in the 
50 
 
bone marrow, migration and endothelial transmigration to the infection foci, cellular interactions 
needed for the development of mature and effective immune cells, fast changes in cell shape required 
for the phagocytosis of pathogens, presentation of antigens and direct cell-to-cell interactions essential 
for signalling and for killing infected cells. As shown in Figure 1-7 (see page 52), mutations in several 
actin cytoskeleton regulators that lead to immunodeficiencies have been reported. They mainly affect 
the Arp2/3 dependent actin polymerisation with mutations in WASp, WIP and DOCK8 (WASp 
pathway) and in RAC2 and RhoH (WAVE pathway). It has further been shown that a mutation in 
coronin 1A that regulates of the nucleation of branched actin filament by competing with Arp2/3 or 
by unbranching already formed filament could also lead to immunodeficiency. Mutations in LSP1 and 
β-actin itself also have been reported and affect actin filament rearrangement and interaction between 
actin and actin regulators, respectively. This section describes these immunodeficiencies in more 
details. 
 
1.3.1 Immunodeficiencies due to mutations in the WASp pathway 
Mutations affecting actin polymerisation regulated by the WASp pathway have been described in 
WASp, WIP and DOCK8. Immunodeficiencies due to mutations in WASp can be divided into two 
categories: the Wiskottt-Aldrich Syndrome (WAS) that results in a loss of function and the X-linked 
neutropenia (XLN) which leads to a gain of function. Both conditions result in severe immune 
function impairment and are described below. 
1.3.1.1 Wiskottt-Aldrich Syndrome (WAS) 
More than 300 unique mutations responsible for PID have been described in the WAS gene and novel 
mutations causing the WAS are frequently identified (Safaei et al., 2012) and added to the database 
WASPbase (Schwarz et al., 1996). The mutations in WASp are accountable for three distinct 
pathologies (Jin et al., 2004; Massaad et al., 2013): classical WAS, X-linked thrombocytopenia 
(XLT), and X-linked neutropenia (XLN). Mutations in the WAS gene are essentially located in the 
EVH1 domain (Jin et al., 2004) preventing its interaction with the chaperone protein Wiskott 
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Interacting protein (WIP), which protects WASp from proteolysis, and results in a reduced expression 
or absence of WASp (Chou et al., 2006; de la Fuente et al., 2007; Konno et al., 2007; Stewart et al., 
1999). The classical WAS is generally caused by either the expression of truncated WASp or the 
nearly complete absence of the protein. Mutations in WAS that allow the partial but significantly 
decreased expression of the protein results in the development of XLT, a milder form of WAS. Other 
mutations allow the expression of functionally defective WASp, that for example could not correctly 
bind to the Arp2/3 complex at similar level as the wild-type protein (Austen Worth, personal 
communication) The X-linked neutropenia is the only Wiskott Aldrich syndrome that is not caused by 
a loss of function but results from mutations in the GBD domain that disturb the auto-inhibited 
conformation of the protein engendering a constitutively active form of WASp. So far four different 
mutations have been described to generate the constitutive form of WAS and causing XLN: L270P, 
S272P, I294T, and I276S (Ancliff et al., 2006; Beel et al., 2009; Devriendt et al., 2001; Thrasher and 
Burns, 2010). Classical WAS is characterised by microthrombocytopenia, which is defined by low 
platelet number together with a reduced platelet size, with persistent eczema and recurrent infections, 
which depending of the patient varies in severity and frequency and may often be worsened by 
autoimmunity and occasionally with occurence of lymphoid malignancy. The symptoms of the 
mildest form of the disease, XLT, are usually restricted to microthrombocytopenia or, in the matter of 
the severe form of XLT, associated with mild transient eczema and intermittent mild infections.  
WAS is the result of defects that strike almost every immune cell types and impact, at different 
magnitudes, most of the stages of the immune response. The combination of all these defects creates a 
multi-lineage disease constituted of immunodeficiency, autoimmunity and susceptibility for 
malignancy.  
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Figure 1-7: Actin defects and immunodeficiency 
Immunodeficiencies can be caused by mutations in the β-actin gene or in genes encoding actin 
cytoskeleton regulators. Mutations in both the WASp pathway (WASP, WIP, DOCK8) and the 
WAVE pathway (RAC2, RhoH) affect Arp2/3-dependent actin polymerisation and have dramatic 
consequences on the function of immune cells. A mutation in Coronin 1A which limits nucleation of 
branched actin filaments by competing with Arp2/3 or by helping in filament unbranching has also 
been reported. Mutations in LSP1, a protein regulating actin filament bundling also result in actin 
defect impairing immune functions. 
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Microthrombocytopenia is a regular symptom in WAS and XLT and results in a predisposition for 
bleeding that can lead to morbidity and mortality (Mahlaoui et al., 2013). WAS patients show an 
extremely low expression of WASp in platelets probably due to the limited de novo protein synthesis 
in these cells (Shcherbina et al., 1999). In vitro studies indicate that WAS megakaryocytes generate 
normal size and numbers of pro-platelets and platelets (Haddad et al., 1999) whereas in vivo, WASp 
null megakaryocytes prematurely release pro-platelets (Sabri et al., 2006). Thrombocytopenia in WAS 
patients seem to be caused by the more rapid clearance of platelets by macrophages in the spleen, 
bone marrow and liver (Marathe et al., 2009; Prislovsky et al., 2013, 2008). 
Investigation of WAS impact on patient derived cells and mouse myeloid cells showed that these cells 
failed to reorganise their actin cytoskeleton. WASp null macrophages, dendritic cells and neutrophils 
display impaired chemotaxis towards inflammatory chemokines and chemoattractants such as c5a, 
MCP-1, CSF-1, and fMLP respectively (Badolato et al., 1998; Ochs and Slichter, 1980; Snapper et al., 
2005; Zicha et al., 1998). When studied in vitro under shear flow, these defects are more substantial. 
These results are supported by migration studies in WAS knockout mice and WAS knockdown 
zebrafish embryos (Cvejic et al., 2008; Snapper et al., 2005; Zhang et al., 2006). The decreased levels 
or complete absence of WASp are responsible for reduced oxidative burst and degranulation in 
neutrophils and inhibit the formation of podosomes that are necessary for cell adhesion to the 
surrounding tissues (Burns et al., 2004; Linder et al., 1999; Tsuboi, 2007; Tsuboi and Meerloo, 2007; 
Zhang et al., 2006). During migration, WAS cells fail to maintain directional protrusions and are 
unable to direct and cluster CD11b integrins at the uropod which result in an incorrect polarisation of 
the leading protrusion and the uropod (Ishihara et al., 2012; Kumar et al., 2012). These migratory 
defects do not totally abrogate the capacity of WAS cells to reach infection sites but WASp deficient 
cells also display impaired phagocytosis of pathogens and apoptotic cells, due to an altered actin-
driven formation of the phagocytic cup (Leverrier et al., 2001; Lorenzi et al., 2000; Tsuboi, 2007). 
WASp deficiency also affects natural killer (NK) cells which are lymphoid innate cells that migrate 
towards sites of infection and inflammation, where they detect and kill, through the release of 
cytotoxic proteins, virally infected cells, parasites, and malignant cells (Shi and Pamer, 2011). 
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Activation of NK cells is dependent on the formation of an immune synapse which relies on actin 
polymerisation driven by WASp. Consequently, activation of NK cells is defective in WAS patients 
(Orange et al., 2002). The absence of normal expression of WASp also impacts the number of 
invariant natural killer T cells (iNKT), which are NK cells expressing receptors that are typical of 
both NK and T cells. Taken together, the defective NK cells and low number of iNKT cells may 
participate to the disease.  
Antigen presentation is also greatly affected by WASp deficiency. WAS dendritic cells (DCs) show a 
defect in migration due to the combination of the failure of polarisation and the impaired formation of 
podosomes needed to migrate over the endothelium (Bouma et al., 2007; Burns et al., 2004, 2001; de 
Noronha et al., 2005). This impaired migration may prevent the correct localisation of WAS DCs in 
the secondary lymphoid tissues and may also allow DCs to maturate before reaching the lymph node 
leading to ectopic release of cytokines and chemokines that could recruit other immune cells and 
participate to inflammatory processes such as eczema (Bouma et al., 2007; de Noronha et al., 2005). 
The development of thymic T lymphocytes is generally intact in WAS patients with few abnormalities 
detected (Cotta-de-Almeida et al., 2007). Mature WASp deficient T cells are morphologically 
different from controls with fewer microvilli, although the impact of these changes is not well 
established (Majstoravich et al., 2004). WAS T cells also exhibit defective migration and an absence 
of response to CC19 and CCL21 chemokine stimulation (Snapper et al., 2005). One of the most 
important defects in WAS T lymphocytes is that, when activated following T cell receptor (TCR) 
ligation or when forming an immune synapse (IS), fail to proliferate (Ochs and Slichter, 1980; Zhang 
et al., 1999). The IS is the interface between a lymphocyte and an antigen-presenting cell or a target 
cell, which is characterised by three concentric rings of receptors called supramolecular activation 
cluster (SMAC): the central SMAC (cSMAC) concentrates the TCR and CD28 is surrounded by the 
peripheral SMAC (pSMAC) composed of integrins encircled by large glycoproteins, such as CD43 
and CD45, which constitute the distal SMAC (Dustin and Depoil, 2011). The IS abnormal formation 
is a consequence of a defect in actin polymerisation together with an inability to mobilise lipid rafts 
and defective recruitment of protein involved in signalling that depend on WASp to localise correctly 
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to the TCR (Badour et al., 2003; Dupré et al., 2002). The immune synapse is a dynamic structure that 
cycles through a WASp dependent stable symmetrical form, described as three concentric SMAC 
having a radial symmetry (similarly as rings), and a WASp independent asymmetrical form where 
pSMAC opens and forms a crescent (Sims et al., 2007). Thus, in WAS T cells, the formation of the IS 
may initially be normal but its inability to sustain symmetry result in an unstable structure. The 
signalling downstream of TCR ligation requires the EVH1 domain of WASp, but is independent of 
the actin polymerisation activity of WASp, to translocate the transcription factor nuclear factor of 
activated T cells to the nucleus. Therefore, this signalling pathway is also altered in WAS cells 
(Trifari et al., 2006). These defects in the TCR signalling pathway impact cytokine production, with 
WAS T cells exhibiting reduced amount of T-helper 1 (Th1) cytokines (IFN-γ and tumor necrosis 
factor-α (TNF-α)), although Th2 cytokine (IL-4, IL-5, and IL-10) production remains near normal 
(Trifari et al., 2006).  
B cell function in WAS patients has been less studied than other cell types despite a broad range of 
humoral immune defects such as low immunoglobulin M (IgM) levels, elevated IgA and IgE, levels 
and increased incidence of B-cell malignancy (Sullivan et al., 1994). Deeper investigation of defects 
in WAS B cells showed that these cells exhibit defective aggregation, spreading, polarisation, and 
migration towards CXCL13 in vitro, while low number of microvilli and delayed humoral immune 
response were observed in mice (Westerberg et al., 2005, 2001). These finding were supported by 
results showing that human pre-B cells display reduced adhesion together with abnormal actin 
cytoskeletal architecture, impaired IS formation, and increased apoptosis (Sato et al., 2012). 
Developing B-cells can partially compensate WASp absence through N-WASp (Westerberg et al., 
2012) thus defects in B cells are mostly visible in mature cells where WASp is usually at its highest 
expression level (Meyer-Bahlburg et al., 2008). A common feature in WAS is the production of auto-
antibodies but the mechanism driving this process is yet poorly understood (Imai et al., 2004). 
1.3.1.2 X-linked neutropenia 
Patients with XLN display recurrent bacterial infections due to severe neutropenia and 
monocytopenia, altered CD4+/CD8+ T-cell ratio and significant decrease in NK cells (Devriendt et 
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al., 2001). Mutations in the GBD domain of WAS are causing the disease, so far four mutations have 
been described: L270P, S272P, I276S, and I294T (Ancliff et al., 2006; Beel et al., 2009; Devriendt et 
al., 2001). These mutations disrupt the auto-inhibited conformation of WASp making the protein 
constitutively active (CA-WASp) resulting in unregulated polymerisation of actin throughout the cell 
and increasing the cellular F-actin content. CA-WASp alters the cell cytoskeletal dynamics ensuing 
abnormal phagocytosis, cell migration and podosome dynamics (Devriendt et al., 2001). Neutrophils 
expressing the mutant WASp display a reduced oxidative burst in response to bacterial peptide 
(fMLP) or E. Coli stimulation but no alteration of the oxidative burst in response to PMA suggesting 
that cells fail to correctly assemble receptors at the cell membrane (Devriendt et al., 2001). B cells are 
also impacted by CA-WASp and display an abnormal shape, impaired rolling ability on L-selectin and 
reduced spreading (Burns et al., 2010; Westerberg et al., 2010). T cells also display reduced spreading 
and proliferation when stimulated with CD3. Expression of CA-WASp increases Fas-mediated 
apoptosis of lymphocytes and spontaneous apoptosis of bone marrow-derived progenitor cells. In 
vitro studies using lentiviruses to express WASp I294T have shown that the excess of F-actin in the 
cell cytoplasm obstructs mitosis and cytokinesis, triggering apoptosis and genomic instability 
resulting in reduced cell proliferation and cytopenia (Moulding et al., 2007). The unregulated activity 
of CA-WASp throughout the cytoplasm triggers the nucleation of new branched actin filaments not 
only at the cell cortex, where it usually happens, but also throughout the cell.  
1.3.1.3 WIP 
A female patient with the classical symptoms of WASp was found to display normal WAS gene 
sequence and mRNA levels but complete absence of WASp expression (Lanzi et al., 2012). Since 
WASp is stabilised through its interaction with WIP, WIP expression was measured and found absent 
in the patient whereas the parents showed approximately 50% of residual expression of WIP. 
Sequencing of the WIPF1 gene exposed a homozygous nonsense mutation in the patient. The 
truncated WIP of 435 amino acids lacked the WASp binding domain which is located between the 
amino acids 451 and 485 (Ramesh et al., 1997). The results from this patient highlight that WASp 
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deficiency is not always the result of a mutation in WASp and therefore proteins interacting with 
WASp should be investigated in patients with WAS syndrome but unaltered WASp. 
1.3.1.4 DOCK8 
Dedicator of cytokinesis 8 (DOCK8) is a guanine exchange factor (GEF). GEFs regulate Rho 
GTPases by assisting the change from the inactive GDP-bound state to the active GTP-bound state. 
The Rho GTPases then integrate extracellular signalling and transduce it to effector proteins to 
generate cytoskeletal responses; for example the GTP-bound form of Cdc42 activates WASp 
(Miyamoto and Yamauchi, 2010). It has been shown that DOCK8 interacts with Cdc42 and binds 
RhoJ, RhoQ and Rac1 (Ruusala and Aspenström, 2004). The expression of DOCK8 mRNA is 
ubiquitous and strong expression of the protein has been observed in hematopoietic cells and 
peripheral blood mononuclear cells (PBMCs). Mutations in the DOCK8 gene have been described as 
the source of severe immunodeficiency in both human and mice (Engelhardt et al., 2009; Randall et 
al., 2009; Q. Zhang et al., 2009). DOCK8 deficiency is characterised by severe allergies, otitis media, 
pneumonia or bronchitis, eczema, eosinophilia, IgE dysregulation, and severe cutaneous viral 
infections mostly caused by human papilloma virus (HPV), molluscum contagiosum virus, herpes 
simplex virus and varicella-zoster virus (Engelhardt et al., 2009; Randall et al., 2009; Q. Zhang et al., 
2009). DOCK8 is an important regulator of actin cytoskeleton and, as such, localises at the leading 
edge of cells during lamellipodium formation (Ruusala and Aspenström, 2004). Deficiencies in 
WASp and DOCK8 share numerous clinical similarities which could be explained by the fact that 
WASp is an effector of Cdc42 and thus is likely to be downstream DOCK8 suggesting the 
overlapping of DOCK8 and WASP signalling pathways. This implies that WASp activity could be 
diminished in DOCK8 deficiency but cannot explain the complete features of DOCK8 deficiency, 
indicating that other effectors might be involved in the disease.  
1.3.2 Immunodeficiencies due to mutations in the WAVE pathway 
Alterations in the activity of regulators of WAVE-dependent actin polymerisation also result in 
immunodeficiencies. As mentioned above, Rac2 is an important regulator of the WAVE pathway and 
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mutations in the protein severely impair immune functions. More recently, loss-of-function of RhoH, 
that is thought to interact with Rac, has also been described. 
1.3.2.1 Rac2 
The Ras-Related C3 Botulinum Toxin Substrate 2 (Rac2) is a Rho GTPase whose expression is 
restricted to hematopoietic cell lineages and is highly expressed in neutrophils where it constitutes 
96% of the total Rac content (Ambruso et al., 2000). Mutation in the RAC2 gene is responsible for 
neutrophil immunodeficiency syndrome in humans (Ambruso et al., 2000; Williams et al., 2000). To 
date, only three cases have been described and all patients shared the same D57N mutation located in 
the DX2G motif leading to the expression of a dominant negative Rac2 protein. In response to fMLP 
stimulation, patient neutrophils display poor chemotaxis, lack of actin polarisation, no oxidative burst 
and decreased granule release. Nevertheless, oxidative burst could be achieved by directly activating 
PKC in the cells (Accetta et al., 2011; Ambruso et al., 2000; Williams et al., 2000). The oxidative 
burst is the quick release of reactive oxygen species (ROS) by immune cells when they are activated 
by their interaction with pathogens and it allows for example the degradation of internalised bacteria. 
Immune cells generate ROS via the gp91phox system composed of the catalytic gp91phox and the 
regulatory subunits p22phox, p40phox, p47phox, p67phox and Rac1/2. The assembly of the 
gp91phox with the regulatory subunits into an active complex regulates the generation of ROS by the 
gp91phox system. Three different signals are involved in the activation of the gp91phox system 
resulting in the assembly of the membrane associated subunits gp91phox and gp22phox together with 
cytoplasmic regulatory subunits p40phox, p47phox and p67phox. The three triggers of the p91phox 
system assembly are: 1) the phosphorylation of the autoinhibitory region of p47phox by protein 
kinases such as protein kinase C and AKT allowing p47phox to interact with p22phox and with lipids 
via its SRC-homology 3 (SH3) domain and its Phox homology (PX) domain, respectively; 2) the 
binding of p47phox and p40phox PX domain to PIP3 and phosphatidic acid produced by PI3K and 
phospholipase D, respectively; 3) the activation of Rac1/2 that promotes the addition of a membrane 
anchor to Rac1/2 via geranylgeranylation resulting in the association of Rac1/2 to the membrane 
where it binds to p67phox, helping in the assembly of the complex.  
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The extreme rarity of the Rac2 disorder limits the study of the disease in humans and the only other 
cellular defect detected is the impairement of thymic T-cell production, possibly related to defective 
T-cell integrin function (Accetta et al., 2011). Studies using Rac2 KO mice confirmed the neutrophil 
defects observed in patients but also the importance of Rac2 in the capture of L-selectin and cell 
rolling, generation of F-actin and activation via chemoattractant signalling  of p38 and p42/44 
MAPKs (Roberts et al., 1999). Mouse models expressing the D57N dominant negative Rac2 or Rac2 
KO also revealed the extensive impact of Rac2 deficiency on almost all immune functions (Mulloy et 
al., 2010). Hematopoietic stem cells show a rise of apoptosis, associated with an impaired retention in 
the bone marrow (Gu et al., 2003, 2001; Yang et al., 2001). T lymphocytes display a decreased 
activation following TCR activation together with an absence of Th1 signalling and production of  
IFN-γ (B. Li et al., 2000; Yu et al., 2001) whereas B-cell show defective development, activation via 
the BCR, and migration toward chemokines (Arana et al., 2008; Walmsley et al., 2003). Both T and B 
cells also show defective cytoskeletal reorganisation.  Similarly to neutrophils, macrophages display 
phagocytotic and oxidative burst impairment (Yamauchi et al., 2004), while CD8+ dendritic cells also 
lack oxidative burst capacity (Savina et al., 2009), and eosinophils have defective migration and actin 
polymerization (Fulkerson et al., 2005). 
1.3.2.2 RhoH 
RhoH is an atypical Rho family GTPase whose expression is restricted to hematopoietic cells. It does 
not possess any GTPase activity but inhibits other GTPases. A loss of function mutation in RhoH was 
recently identified in two patients who had recurrent infectious diseases and chronic 
epidermodysplasia verruciformis related human papillomavirus (EV-HPV) infections. T cells 
populations were skewed towards effector memory cells and showed restricted TCR usage together 
with  a poor T cell receptor  signaling. The lack of  β7 integrin expression  impaired T-cell homing, 
which may explain the persistent EV-HPV infections (Crequer et al., 2012). 
1.3.3 Immunodeficiencies due to mutations in Coronin 1A 
Coronin 1A is an actin regulatory protein specifically expressed in hematopoietic cells that regulates 
actin filament branching. By inhibiting the attachment of Arp2/3 or directly helping debranching, 
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Coronin 1A limits the nucleation of branched actin filaments at the leading edge of cells (Chan et al., 
2011). Mutations in CORO1A, the Coronin 1A encoding gene, have been described causing severe 
combined immunodeficiency in patients. Coronin 1A deficiency is characterised by severe peripheral 
T-cell deficiency, especially in naïve T cells, near complete absence of invariant NKT cells, and 
susceptibility to EBV-induced lymphoproliferation (Moshous et al., n.d.; Shiow et al., 2009, 2008). 
Studies in mice showed that Coronin 1A regulates actin dynamics in T cells and controls T cell 
homeostasis and trafficking. It has also been shown that Coronin 1A is essential for calcium signalling 
downstream of TCR and B-cell receptor activation and that the absence of the protein results in a 
reduction of cell proliferation and IL-2 production (Föger et al., 2006; Mueller et al., 2008). 
1.3.4 Immunodeficiencies due to mutations affecting actin and F-actin rearrangement 
Most of the mutations in actin regulators that have been described affect Arp2/3-dependent actin 
polymerisation. Below are described mutations in the β-actin gene and in the leukocyte specific 
protein 1, affecting actin interaction with regulators and actin filaments rearrangement, respectively. 
1.3.4.1 β-actin 
Actin is one of the most conserved proteins with as little as 20% of difference in the amino acid 
sequences between algae and humans. Consequently, it seems unlikely to identify non-lethal 
mutations in the β-actin gene. A patient presented with recurrent infection thrombocytopenia, 
intellectual impairment and short stature had a heterozygous mutation in the ACTB gene. The 
mutation resulted in an E346K substitution which is in a region of the protein that has been reported 
to interact with numerous cytoskeletal regulators (Nunoi et al., 1999). The patient immunodeficiency 
was the result of poor neutrophil chemotaxis and oxidative burst concomitant with impaired 
polarisation of the cytoskeleton in response to fMLP.  
1.3.4.2 Leukocyte specific protein 1 
Leukocyte specific protein 1 (LSP1) is a phosphoprotein that binds actin and is essentially expressed 
in neutrophils, macrophages, lymphocytes and endothelial cells (Jongstra-Bilen, Immunol Res 2006). 
It has been shown that LSP1 localises to the F-actin in lamellipodia and membranes ruffles where it 
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reorganises actin filaments into bundles (Jongstra-Bilen et al., 1992; Zhang et al., 2000). LSP1 was 
first identified as a 47 kDa protein overexpressed in patients suffering neutrophil actin dysfunction 
syndrome (NAD 47/89). Patient neutrophils displayed numerous projections, which are enriched with 
actin, and a higher expression of CD11b integrin. This phenotype was associated with recurrent 
bacterial infections and impaired neutrophil migration (Coates et al., 1991; Howard et al., 1994). 
These data suggested that LSP1 negatively regulated immune cell migration which was supported by 
experiments in LSP1 knock out mice, where neutrophils and macrophages display an increased 
migration towards the infection site and enhanced chemotaxis in response to fMLP (Jongstra-Bilen et 
al., 2000). The overexpression of LSP1 in the pro-monocytic U937 cell line to a similar level to 
patient neutrophils resulted in migration defect while cell expressing significantly less LSP1 displayed 
an improved migration compared to controls, indicating that the expression level of LSP1 regulates its 
function and the positive or negative influence on cell migration (Y. Li et al., 2000, p. 1). It has been 
shown that LSP1 negatively regulates the integrin CD11b/CD18 adhesion resulting in a more robust 
polarisation of F-actin at the leading edge and extended uropod in LSP1
-/-
 neutrophils let to adhere on 
fibrinogen or ICAM-1 only (Wang et al., 2002). However, the mechanism by which LSP1 regulates 
CD11b/CD18 activity via F-actin rearrangement is still not understood. 
 
1.4 Summary and aims 
Neutrophils are the first line of defence of the organism against pathogens. The destruction of 
pathogens relies on the ability of neutrophils to quickly migrate to the site of infection and 
phagocytose microorganisms. Cell shape changes, such as those involved in migration, phagocytosis 
and cell division, are dependent on actin cytoskeletal dynamics. The actin cytoskeleton is composed 
of filaments formed by polymerisation of actin monomers and is regulated by numerous proteins that 
can, for example, promote the polymerisation of actin monomers, regulate the formation of branched 
networks or sever actin filaments. The control of actin dynamics is complex and allows the quick 
reshaping of the actin cytoskeleton in response to stimuli. Mutations in genes that are involved in the 
regulation of actin dynamics in immune cells can lead to immunodeficiencies. While WAS is the most 
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well-known immunodeficiency caused by mutations in WASp, new mutations in this protein resulted 
in a constitutively active form of WASp that is associated with a severe neutropenia. The list of 
candidate proteins causing actin related immunodeficiencies keeps increasing with new mutations in 
actin regulatory genes being regularly described. The study of these new mutations increase our 
understanding of the role of actin regulators in immune response. Nevertheless open questions remain, 
such as, which actin dependent process(es) from cell division to cell migration is/are affected by 
mutations in actin regulators.  
The overall hypothesis of this work was that neutrophil migratory defects may be an important factor 
in immunodeficiencies in XLN patients and in patients with previously undescribed mutations in actin 
cytoskeleton regulators. 
To test this hypothesis, I first aimed at setting up a neutrophil migration assay that allows monitoring 
of neutrophil chemotaxis using primary neutrophils or a neutrophil-like cell line. My second aim was 
to investigate in vitro a potential neutrophil migratory impairment in immunodeficient patients with 
known or suspected actin cytoskeleton defect. As patient samples are scarce, my third aim was to 
genetically modify a neutrophil-like cell line to mimic mutations in actin regulators observed in 
patients and confirm their impact on neutrophil migration. Finally, my last aim was to assess the 
consequences of the studied mutations in actin cytoskeleton regulators on actin polymerisation and 
dynamics. 
  
63 
 
Chapter 2  Materials and Methods 
2.1 Reagents  
Sigma: Dimethyl sulfoxide (DMSO) (D2650), low melting temperature agarose gel (A9045), bovine 
serum albumin (A9418), recombinant Human Serum Albumin (A9731), fMLP (F3506), fibrinogen 
(F3879), rabbit anti human MKL1 antibody (HPA030782), Vinculin (V9131), Triton-X (X100), 
Igepal/NP-40 (I8896), LB broth (L3522), LB agar (L2897), Dextran from Leuconostoc mesenteroides 
(D1662).  
Thermo Fisher: 16% Formaldehyde solution, methanol-free (28906), ECL Western Blotting Substrate 
(32106). 
Hawksley: Dunn chambers (DCC100, Hawksley, UK). 
PeproTech EC Ltd: Recombinant human MIP-1α (300-08), GM-CSF (300-03) and IL-4 (200-04).  
Life Technologies: HBSS (14025050), Cell Trace CFSE Cell Proliferation Kit (C34554), Opti-MEM 
(31985062), RPMI (61870-044), DMEM (31966-047), skimmed milk powder (LP0031B), Prolong 
Gold antifade mountant (P10144). 
BD Bioscience: Fibronectin (354008). Antibodies: CD11b-PECy5 (555389), CD18-PE (555924), 
CD29-PE (555443), CD49d-PE (555503), PE-Cy5 Mouse IgG1, κ isotype (555750), PE Mouse IgG1, 
κ isotype (555749). 
Myltenyi Biotec: FPR1-APC antibody (130-100-812), REA-Isotype (130-104-614). 
Cell Signalling: protease/phosphatase inhibitor cocktail (5872), PMSF (8553), antiphospho-myosin 
light chain antibody (3671). 
GE Healthcare Life Sciences: Ficoll-Paque PLUS (17-1440-02). 
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2.2 General Buffers and Solutions 
Table 2-1: Buffers and solutions 
Name Composition Storage 
Phosphate buffered saline 
(PBS) 
11.9 mM phosphates,  
137 mM NaCl2, 2.7 mM KCl  
10X stock from Fisher 
Bioreagents; for cell culture 
1X PBS from Gibco was 
used; stored at RT 
Tris buffered saline–Tween 
(TBS-T)  
150 mM NaCl, 25 mM Tris-
HCl pH 7.6 + 0.1% Tween  
10X stock solution stored at 
RT; Tween added to 1X TBS 
prior to use 
BSA blocking buffer 5% BSA in TBS-T  Prepared prior to use 
Milk blocking buffer 5% skimmed milk in TBS-T Prepared prior to use 
Tris-Acetate EDTA (TAE)  40 mM Tris-acetate and 5 
mM EDTA 
10X stock solution stored at 
RT 
6x DNA loading buffer  10 mM Tris pH 7.5, 50 mM 
EDTA, 15% Ficol 400 and 
0.05% bromophenol blue 
Stored at RT 
Luria-Bertani (LB) broth  Sigma mix (10 g/L tryptone, 5 
g/L yeast extract, 5 g/L NaCl)  
autoclaved and stored at 4°C 
LB-agar  Sigma mix (LB + 15 g/L agar)  autoclaved, poured into Petri 
dishes (with antibiotic) and 
stored at 4°C 
Cell fixing buffer 
(adherent cells) 
 
4% PFA in PBS Made fresh from 16% 
methanol free PFA vials 
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Cell fixing buffer  
(suspension cells) 
2% PFA in PBS Made fresh from 16% 
methanolfree PFA vials 
Cell permeabilisation solution 0.1% Triton X-100 in PBS Diluted from 10% Triton X-
100 stock prior to use 
Cell lysis buffer 0.5% IGPAL or NP-40, 150 
mM NaCl, 50 mM Tris-HCl 
pH 8, Protease/Phosphatase 
Inhibitor Coktails 2x (Cell 
Signaling), PMSF 1 mM 
Stock at 4
o
C; inhibitors added 
prior to use 
Laemmli buffer 2x 10% -mercaptoethanol, 4 % 
sodium dodecyl sulfate, 125 
mM Tris pH 6.8, 0.2% 
Bromophenol Blue, 20% 
Glycerol 
 
5% Dextran 5% (weight/volume) Dextran 
from Leuconostoc 
mesenteroides (average 
molecular weight 35-45 kDa) 
in saline solution 
Autoclaved 
Saline 1x 0.9% (weight/volume) NaCl 
in distilled water 
Sterile (filtered using a 0.22 
µm filter) 
Saline 2x 1.8% (weight/volume) NaCl 
in distilled water 
Sterile (filtered using a 0.22 
µm filter) 
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2.3 Molecular Cloning 
2.3.1 Reagents 
The QIAprep Spin Miniprep and Maxiprep kits used for plasmid DNA isolation as well as the 
QIAquick PCR Purification and Gel Extraction kits were from Qiagen. The recombinant 
endonucleases enzymes, the Shrimp Alkaline Phosphatase, Pfu DNA polymerase, deoxynucleotides 
(dNTPs) and T4 DNA ligase were from Promega, New England Biolabs or Fermentas. The agarose 
and 1 kb+ DNA ladder were from Invitrogen. All nucleotides were synthesized by Invitrogen. dNTPs 
were from Promega and sequencing was performed by Source BioScience. 
2.3.2 shRNA 
Oligonucleotide MAL short hairpins were synthesized (Eurogentec) and inserted into a pBlue Script 
vector containing the human H1 promoter. H1-shRNA specific for MKL1 (shMKL1), or H1-SCR 
(scramble control sequence) cassettes were inserted into a lentiviral vector (pRRLsin-PGK-
eGFPWPRE, Genethon).  
shMKL1: 5’AGTAGCAGACAGCTCTTCCttcaagagaGGAAGAGCTGTCTGCTACT 3’ 
shSCR: 5'CGGCAGCTAGCGACGCCAT 3' 
2.3.3 mCherry-WASp lentiviruses 
As the expression of constitutively activated WASp protein is known to lead to an increase of 
apoptosis, the establishment of a cell line stably expressing CA-WASp was not possible. Therefore, 
CA-WASp was expressed by gene transfer before each experiment. Gene transfer was performed by 
lentivirus transduction, taking advantage of the availability of the lentiviral backbones containing the 
wild-type or the constitutively activated WASp tagged with green fluorescent protein (GFP). As most 
of the other proteins of interest owned in the laboratory were tagged with GFP, eGFP was replaced by 
the fluorescent protein mCherry to allow live imaging of WASp concomitantly with another protein. 
mCherry protein is excited at 575 nm and emits at 610 nm whereas GFP is excited at 488 nm and 
emits at 509 nm allowing the expression and detection in live imaging of two different proteins at the 
same time. eGFP was replaced with mCherry by cutting out the eGFP insert and cloning the mCherry 
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insert into two different lentiviral backbones, one under the CMV promoter and the other one under 
the SFFV promoter. SFFV promoter was used because it is less silenced than the CMV promoter in 
hematopoietic cell lineages resulting in a more stable expression.  
To visualise WASp transgene  in cells already expressing proteins tagged with GFP, the GFP tag was 
replaced with mCherry in the lentiviral vectors used to express GFP-WASp or the active WASp 
mutant GFP-I294T. The two lentivirus plasmids pHR'SINcppt\CEWW and pHR'SINcppt\SEWW, 
containing the transgenes eGFP-WASp and eGFP-I294T respectively, contained few unique 
restriction sites suitable for restriction enzyme digesting. The eGFP sequence in the 
pHR'SINcppt\CEWW vector had two suitable restriction sites: one for BamHI at the 5’ end of the 
transgene (position 8339) and BsrGI at the 3’ end of the eGFP sequence (position 9078). 
Unfortunately, in the pHR'SINcppt\SEWW, BsrGI has two restriction sites one at the positions 425 
and 8992 respectively, whereas BamHI’s unique restriction site was at the position 8253. Extraction 
of eGFP only from pHR'SINcppt\SEWW was achieved through partial digestion as follows: the 
plasmid was first fully digested with BamHI for 1 hour before the product of this digestion was 
partially digested with BsrGI for 30 minutes. The product of the partial digestion was then run on an 
agarose gel and visualized using a UVIdoc before  the band corresponding to the 
pHR'SINcppt\SEWW plasmid without eGFP was excised from the gel and purified using a gel 
extraction kit. The mCherry insert was produced by PCR using the mCherry tag of the 
LNTcmv\mCherry\alpha tubulin lentivirus plasmid as template. The two primers used for the PCR 
were: 5’ ATGGATCCAT GGTGAGCAAG GGCGAGG 3’ for the 5’ primer and 5’ GATGGAGATG 
CACTCACGCAC 3’ for the 3’ primer. The 5’ primer included the BamHI restriction site (GGATCC) 
that was added at the 5’ end of mCherry. The PCR product was purified using the PCR purification kit 
before being digested using BamHI and BsrGI. The mCherry insert was then ligated into the 
pHR'SINcppt\SEWW lentivirus backbone. 
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2.3.4  
2.3.5 PCR 
PCR were performed using 0.2 µg of DNA template together with the two primers (0.5 µM each), the 
dNTPs (at 200 µM each) and the Pfu DNA polymerase (2 µL) in Pfu DNA Polymerase 1X buffer 
with MgSO4. The PCR were carried out on the Eppendorf Mastercycler ep Gradient S using the 
following program: 96
o
C for 4 minutes, then 30 cycles of: denaturation at 96
o
C for 30 seconds; 
annealing at 62
o
C for 30 seconds; elongation at 75
o
C for 1 minute. Then a final step at 75
o
C for 7 
minutes was performed. 
2.3.6 Plasmid DNA production 
The Escherichia coli strain Stbl3 (Invitrogen) was used for all plasmid production and the bacteria 
were grown at 37°C on solid LB-agar Petri dishes for clone isolation or in liquid LB medium in an 
orbital shaker at 225 rpm for DNA production. Both the LB-agar and LB medium were supplemented 
with 100 μg.mL-1 of ampicillin to select the plasmid-transformed bacteria. Plasmid-transformed 
bacterial culture storage was done at -80°C in 20% glycerol in LB medium. 
Plasmid DNA was isolated using a Miniprep kit, for small-scale plasmid DNA isolation, or using the 
Maxiprep kit for large-scale plasmid DNA, both according to the manufacturer’s instructions. 
Minipreps were performed using 1.5 mL from a 5 mL overnight bacterial culture whereas Maxipreps 
were done using 250 mL overnight cultures. 
The concentration of DNA samples was determined by the measure of the absorbance at 260 nm on a 
NanoDrop ND-1000 spectrophotometer. DNA samples were stored at -20°C. 
2.3.7 Restriction digests 
The digestion of 1-2 μg of plasmid DNA by one or several restriction endonucleases was performed in 
1X supplied compatible buffer in a final volume of 10 or 50 μL for 1 hour at 37oC. The volume of 
enzyme was 5 to 10% of the total reaction volume. Sequential digests were performed using a PCR 
Purification kit according to the manufacturer’s instructions to remove the buffer salt between 
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successive digests or by isolating the digested DNA by agarose gel electrophoresis prior to subsequent 
digests. 
The 5’ DNA terminus of the backbone for a ligation reaction was dephosphorylated after digestion 
and before gel electrophoresis isolation with Shrimp Alkaline Phosphatase (1 unit/µg of DNA). The 
ligation reaction was performed for 15 minutes at 37
o
C using the provided buffer in a total reaction 
volume of 50 μL. The Shrimp Alkaline Phosphatase was inactivated by heating the reaction mix at 
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C for 15 minutes. 
2.3.8 Agarose gel electrophoresis and isolation of DNA fragments 
The DNA fragments were resolved in 1% agarose gel electrophoresis in TAE buffer at 100 V. 
Loading buffer was added to the samples before they were loaded in the agarose gel. The agarose gel 
was supplemented with Ethidium bromide at a concentration of 0.5 μg.mL-1 for subsequent DNA 
visualisation and a 1 Kb+ DNA Ladder was run alongside the samples. DNA visualisation was 
performed on a UVIdoc gel documentation system (UVItec). The DNA fragments of interest were 
excised from the agarose gel and purified using a Gel Extraction kit following the manufacturer’s 
instructions. 
2.3.9 Ligation and checking of ligated plasmids 
The ligation of the insert in the lentivirus plasmid was performed as follows: 100 ng of backbone was 
used for ligation with insert DNA in a 1:3 backbone to insert molar ratio using 0.5 μL T4 DNA Ligase 
in 1X T4 DNA Ligase buffer in a final volume of 10 μL. The ligation was carried out at 4°C overnight 
before the ligation products were transformed into competent bacteria. The transformed bacteria were 
then plated onto LB-agar plates and incubated overnight at 37
o
C. Colonies were picked up 
individually and transferred to LB medium in order to start small scale cultures overnight at 37
o
C. 
Plasmid DNA was then extracted and digested using the endonuclease PstI, which was selected 
because eGFP did not harbor a PstI restriction site whereas mCherry did. This allowed validation of 
the presence of the mCherry insert in the plasmid by visualisation of the pattern of the restriction 
fragments after digestion following agarose gel electrophoresis. All the ligations positively identified 
by PstI digestion were then confirmed by sequencing. 
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2.4 Cell culture 
2.4.1 Cell lines 
2.4.1.1 293T 
293T cells are derived from the Human Embryonic Kidney 293 (HEK293) cell line and express the 
SV40 large T-antigen allowing the episomal replication of transfected plasmids containing the SV40 
origin of replication. These adherent cells were expanded in 15 cm culture plates at 37°C under  a 
humid  atmosphere  of  5%  CO2  in  air  using  DMEM  medium  complemented  with GlutaMAX, 
10% fetal calf serum (FCS) and Penicillin/Streptromycin (Pen/Strep) at 1/100 (equivalent to a final 
concentration of 100 units/mL of Penicillin and 100 µg.mL
-1
 of Streptomycin).  Cells were maintained 
at viable cell density between 8x10
3
 and 8x10
4
 cells/cm
2
 by a twice-weekly split and were used before 
passage 10. For splitting, medium was removed and cells were washed with PBS to remove the 
remaining FCS. The cells were detached by incubation with trypsin/EDTA during 5 minutes at 37
o
C 
and were resuspended in fresh medium containing FCS in order to inactivate the trypsin. The cell 
suspension was then pelleted by centrifugation at 300 rcf during 5 minutes and resuspended in fresh 
culture medium. The cells were then counted using a hematocytometer and plated in new culture 
plates at the desired density. 
2.4.1.2 HeLa 
HeLa and HeLa expressing Actin-GFP (HeLa ActGFP) were cultured at 37°C under a humid 
atmosphere of 5% CO2 in air using DMEM medium complemented with GlutaMAX, 10% FCS and 
Pen/Strep.  Cells were maintained at viable cell density between 8x10
3
 and 8x10
4
 cells/cm
2
 by a 
twice-weekly split. Cells were used before passage 20. 
2.4.1.3 HL-60 
HL-60 cells were maintained in culture at a concentration between 0.1 and 1.5x10
6
 cells/mL in RPMI 
supplemented with GlutaMAX, 10% FCS, Pen/Strep and 25 mM HEPES. To differentiate HL-60 into 
neutrophil-like cells (dHL-60), 1x10
6
 cells were cultured for 5 days in medium supplemented with 
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1.3% of DMSO in a T25 flask. HL-60 cells were used before passage 20 as they become resistant to 
DMSO induced differentiation after too many passages. 
2.4.1.4 HT1080 
The Fibrosarcoma cell line HT-1080 was propagated at 37°C under an  atmosphere  of  5%  CO2  in  
air  using  DMEM  medium  complemented  with GlutaMAX, 10%  FCS and Pen/Strep. Cells were 
maintained at viable cell density between 10-80% confluence by a twice-weekly split and used before 
passage 20. 
2.4.1.5 THP1  
THP1 cells were cultured in suspension in RPMI supplemented with GlutaMAX, 10% FCS and 
Pen/Strep. Cells were maintained at 0.5-1x10
6 
cells/mL and used before passage 25. For dendritic cell 
differentiation, THP1 cells were cultured in the presence of 10 ng.mL
-1
 rhIL-4 (recombinant human 
interleukin-4) and 10 ng.mL
-1
 rhGM-CSF (granulocyte-macrophage colony stimulating factor) for 6 
days. Cells were split on days 2 and 5 with addition of fresh cytokines. Both adherent and suspension 
cells were harvested for use on day 6 or 7.  
2.4.1.6 U937 
Monocytic U937 cells were propagated at 37°C under an atmosphere of 5% CO2 in air using RPMI 
1640 medium complemented with GlutaMAX, 10% FCS and Pen/Strep. Cells were maintained at 
viable cell density between 2x10
5
 and 10
6
 cells/mL by a three time a week split and used before 
passage 25. 
2.4.2 Primary cells 
Patient and healthy donors’ samples were obtained with informed consent from the parents of the 
patient in accordance with the Declaration of Helsinki and with approval from local ethics committees 
(04/Q0501/119 and 06/Q0508/16). 
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2.4.2.1 Human neutrophil isolation  
Neutrophils were isolated from healthy donor or patient blood. To sediment erythrocytes, 2 mL of a 
5% dextran-saline solution was added to 10 mL of blood and gently mixed by inversion before let to 
sediment for 30 minutes. The plasma layer containing the granulocytes was collected and overlaid on 
an equal volume of Ficoll-Paque and centrifuged at 500 rcf for 10 minutes. After centrifugation, the 
neutrophils were pelleted at the bottom of the tube whereas the remaining PBMCs (monocytes and 
lymphocytes), basophils and platelets remained at the interface between the plasma layer and the 
Ficoll-Paque. It should be noted that during the collection of the plasma layer, erythrocytes may have 
inadvertently been collected at the same time, contaminating the neutrophil fraction. To ensure the 
absence of erythrocytes, an extra step was added in the protocol to lyse the potential remaining red 
blood cells: the neutrophil pellet was re-suspended in distilled water for 20 seconds to lyse the 
remaining red blood cells before addition of 2x saline solution to restore isotonocity. The neutrophils 
were then centrifuged at 250 rcf for 7 minutes and re-suspended in warm complete RPMI. When 
needed, the PBMC layer was taken before collection of the neutrophil pellet for CD14-positive cell 
selection. 
2.4.2.2 Primary fibroblast 
Skin fibroblasts from healthy donors were collected and provided by Dr Farhatullah Syed. The cells 
were cultured in RPMI 1640 medium supplemented with 10% FBS and Pen/Strep. Cells were 
maintained at viable cell density between 10-80% confluence by a twice-weekly split and used before 
passage 10. 
2.5 Lentiviral production, cell transduction and cell transfection 
Second generation lentivirus were produced by co-transfection of 293T cells with 1) the packaging 
plasmid pCMV 8.74, which contained the gag-pol, tat and rev genes, 2) the envelope plasmid 
pMD.G2 containing the insert for the VSVg envelope, and 3) the plasmid containing the gene of 
interest. 
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2.5.1 Lentiviral production 
293T cells were expanded in 15 cm culture plates. The day before transfection, 15 million cells were 
seeded in cell culture plates. On the day of transfection, a PEI solution was prepared by diluting the 
stock solution (10 mM) into Opti-MEM to reach a final concentration of 2 μM. A DNA solution was 
prepared to contain a mix of the packaging (pCMV 8.74 at 6 μg.mL-1), envelope (pMDG-2 at 2 
μg.mL-1) and gene of interest (8 μg.mL-1) plasmids. Both PEI and DNA solutions were filtered 
through 0.22 μm filter before being mixed in a 1:1 ratio and left at room temperature to let the PEI-
DNA complexes to form. Cell culture medium was removed and cells were gently washed with PBS, 
prior addition of 10 mL of the PEI-DNA solution. Alternatively, the PEI-DNA solution was directly 
added to the plates without removing the culture medium with no observed changes on the final viral 
titer. Cells were incubated with the PEI-DNA solution for 4 hours at 37°C and 5% CO2. Then the PEI-
DNA solution was removed and fresh culture medium was added to the plates. Viral supernatant was 
collected 48 hours after transfection and replaced with fresh culture medium, which was harvested 24 
hours later. Viral supernatant was filtered through a 0.22 μm filter to remove cell debris and then was 
concentrated by ultracentrifugation at 50,000 rcf for 2 hours at 4°C. Alternatively, viral particle 
concentration was performed by centrifugation at 4,000 rcf for 20 hours at 4°C. The viral pellet was 
resuspended in 100 μL of RPMI, incubated on ice for 30 minutes, and then centrifuged at 1,300 rcf for 
10 minutes to remove cell debris before being aliquoted and stored at -80
o
C. 
2.5.2 Lentivirus titration 
The titer of viral preparations was determined by measuring the transgene expression in 293T cells. 
293T cells were seeded at 5x10
4
 cells per well in 900 μL of culture medium in a 24 well plate. The 
day after, viral aliquots were thawed and 1:10
3
, 1:10
4
 and 1:10
5
 serial dilutions were prepared in 1 mL 
of complete medium. Then, 100 μL of diluted viral preparation was added to the cells to reach a final 
1:10
4
, 1:10
5
 and 1:10
6
 dilution factors. Cells were incubated at 37°C and 5% CO2 for 72 hours before 
the medium was removed, washed with PBS, and then incubated with 100 μL trypsin-EDTA for 5 
minutes at 37°C and 5% CO2. Cells were fixed and the transgene expression (tagged with a 
fluorescent protein such as GFP or mCherry) was determined by flow cytometry (see below). The 
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viral titration was calculated using the sample displaying 3 to 10% fluorescent positive cells and using 
the following formula:  
 𝑇𝑖𝑡𝑒𝑟 =  
(% fluorescent positive cells) x (number of cells seeded)
virus dilution
 
2.5.3 Cell transduction with lentiviruses 
The amount of viral particles added to the cells was defined by multiplicity of infection (MOI). This 
number indicates the amount of viruses per cell added to the culture medium. 
In order to transduce adherent cells, the cells were plated in a 12 wells plate at 1x10
5
 cells per well in 
1 mL of culture medium and incubated at 37
o
C and 5% CO2. The day after, the lentiviral aliquots 
were thawed and diluted into DMEM at a final volume of 200 μL before being added to the culture 
medium in the well. Cells were expanded before being used or enriched by fluorescence activated cell 
sorting (as specified in the text). 
The first protocol used to transduce HL-60 cells was to plate 5x10
5
 cells in a 12 well plate and mix 
lentiviral particles with the cells at a MOI of 10 before placing the plate in an incubator at 37°C and 
5% CO2. This protocol led to low transduction efficiency with less than 15% of transduced cells. 
Spin-induction was then used for transduction to increase interaction between cells and viral particles. 
The original protocol, which consists in spinning cells together with lentiviral particles at 2,000 rcf for 
several hours at room temperature (van Til and Wagemaker, 2014), was modified to avoid damaging 
the HL60 cells. 5x10
5
 cells were plated in a well of a 12 well plate and supplemented with viral 
particles at a MOI of 10 before being centrifuged at 950 rcf for 20 minutes at room temperature. The 
cells were then placed into an incubator at 37°C and 5% CO2. This protocol resulted in 75% positive 
HL-60 cells and was used for the transduction of the cells in suspension. Cells were expanded before 
being used or enriched by fluorescence activated cell sorting (as specified in the text). 
2.5.4 HT1080 transfection using Lipofectamine 2000 
The day before transfection, HT1080 cells were plated in a 24 well plate at 8x10
4
 cells per well in 0.5 
mL of their growth medium without antibiotics. For each well, two solutions were prepared: the DNA 
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solution consisting of 0.8 µg of DNA diluted in 50 µL of OPTI-MEM I without serum and the 
Lipofectamine solution (1.5 µL of Lipofectamine 2000 in 50 µL of OPTI-MEM I without serum). 
Both solutions were left to incubate 5 minutes at room temperature before being combined and left to 
incubate for a further 20 minutes at room temperature to allow the DNA-Lipofectamine complexes to 
form. Then, 100 µL of DNA-Lipofectamine complexes were added to each well containing the cells. 
After 24 hours of incubation, the expression of the transgene-tagged with a fluorescent protein was 
checked by epifluorescence microscopy.  
2.6 Gene expression analysis 
2.6.1 Real time quantitative PCR 
Total mRNA samples were prepared using the RNeasy Plus Mini Kit (Qiagen) accordingly to 
manufacturer instruction, using 1x10
6
 cells as starting material. Retro-transcription was performed 
using the cDNA Verso Kit (Thermo Scientific) accordingly to manufacturer’s instructions. 
Real time quantitative PCR was accomplished on an ABI PRIASM 7000 Sequence Detection System 
(Applied Biosystem). The reactions were performed using the following set of TaqMan probes and 
primers: Hs00159522_m1 (MYH9), Hs00252979_m1 (MKL1), Hs00364926_m1 (MYLK), 
Hs00697086_m1 (MYL9), Hs01060665_g1 (ACTB), Hs02758991_g1 (GAPDH) at a final 
concentration of 0.25 μM together with the Platinum Quantitative PCR SuperMix-UDG w/ROX (Life 
Technologies) and 30 ng of cDNA in a 25 μL reaction volume. Gene expression levels were 
normalised to the GAPDH gene and calculated using the ΔΔCt method. 
2.6.2 qPCR Arrays  
Retro transcription was performed accordingly to manufacturer instructions using the RT2 First 
Strand Kit (Qiagen, 330401) using 1 μg of total mRNA extracted from dHL-60 SCR or MKL1 cells. 
Then Real-time quantitative PCR was achieved on an ABI StepOnePlus Real Time PCR System 
(Applied Biosystem) using Human Cytoskeleton Regulators RT² Profile PCR Array and RT² SYBR 
Green ROX qPCR Mastermix (Qiagen, 330231 and 330520, respectively) accordingly to 
manufacturer’s instructions. Gene expression levels were analysed using the Web-based PCR Array 
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Data Analysis Software (www.SABiosciences.com/pcrarraydataanalysis.php). Gene expression levels 
were analysed using the ΔΔCt method and the GAPDH gene as control gene. The ΔΔCt method 
allows the analysis of the expression of target genes relative to reference genes such as GAPDH, β-
actin or other housekeeping genes. This method is based on the analysis of the measure of the 
amplification of the signal of each gene in the thermocycler. The Ct (cycle threshold) of a gene is the 
number of cycles needed for the signal of this gene to cross the threshold, i.e. to be discriminated from 
the background. The first step of the analysis is to calculate the relative gene expression (ΔCt) by 
subtracting the Ct of the reference gene from the Ct of the genes of interest. The relative gene 
expression was performed in the control sample (ΔCtref) and in the MKL1 knock-down sample 
(ΔCtMKL1). Then the relative expression of the genes of interest between samples (ΔΔCt) was 
calculated by subtracting relative expression of the control sample (ΔCtref) from the relative 
expression of the MKL1 sample (ΔCtMKL1). The fold change of the gene expression between samples 
was then calculated as follows: fold change = 2
-ΔΔCt
. 
2.6.3 RNA sequencing analysis 
RNA sequencing of the total mRNA isolated from control and MKL1 patient B lymphoblastoid cells 
was performed by S. Nejentsev’s laboratory. The data were pre-processed, giving for each gene a 
basic p-value, an adjusted p-value and the z-score (enrichment score) of the differentially expressed 
genes from the MKL1 sample compared to the control. Functional annotation clustering analysis was 
performed using the DAVID Bioinformatics resources 6.7 software (Huang et al., 2009). The analysis 
was carried out using lists of the significantly differentially expressed genes (p < 0.05) for all control 
vs. MKL1 cells. Clustering was performed using a high classification stringency and only clusters 
with an enrichment score higher than 1.3 were considered and reported. 
2.7 Protein expression analysis 
2.7.1 Western Blotting 
Cell lysates were obtained by incubating 1x10
6
 cells for 30 minutes at 4
o
C in 50 µL of NP-40 based 
buffer containing protease/phosphatase inhibitor cocktail (Cell Signalling Technology) and PMSF 
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(Cell Signalling Technology). During lysis, samples were vortex every 10 minutes. Samples were 
then centrifuged at 13,000 rcf at 4
o
C for 10 minutes to remove cells debris. Supernatant was then 
collected and mixed in a 1:1 ratio with Laemmli sample buffer and boiled at 95
o
C for 5 minutes. Cell 
lysates were separated on 12-14% NuPAGE Bis-Tris gels loaded with 30 μL of sample per well. 
Fermentas PageRuler Prestained Protein Ladder was included as a size marker.  Following transfer on 
a previously activated PVDF membrane, the membrane was then blocked with 5% milk/TBS-Tween 
0.1% (TBS-T) solution before being incubated with the antibody at 1/1000 in 5% milk /TBS-T 
overnight. After incubation with the appropriate secondary antibody conjugated with HRP, the 
membrane was then developed with PIERCE ECL Western Blotting substrate and the images 
acquired using UVIchemi imaging system. 
2.7.2 Western blot analysis by densitometry 
The Western blot images acquired with the chemiluminescence imaging system were analysed using 
the Gel analysis function of ImageJ/Fiji. First, each lane was selected using the rectangular selection 
tool encompassing the signal of the proteins (bands) and background. Then the selections were plotted 
to generate the profile of intensity of each lane. On each profile, the proteic signal generated a peak 
(due to the change in intensity) that could be distinguished from the background. The absence of 
signal saturation was confirmed prior to quantification. Using the straight line selection tool, the 
baselines were drawn on the lane profiles in order to close the peaks of interest and separate them 
from the background. Finally, using the wand tool, the intensities of the peaks of interest were 
measured. This process was performed on Western blots incubated with an antibody raised against the 
protein of interest and on Western blots incubated with the antibody detecting the house keeping 
protein GAPDH (used as loading control). The relative expression of the protein to the level of 
expression of GAPDH was calculated by dividing the value of the peak intensity of the protein of 
interest by the measure of the intensity of the GAPDH peak. 
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Table 2-2: Antibodies and fluorescent dyes 
Name Description Raised in Conjugate Manufacturer Reference Assay Dilution 
CD11b-PECy5 human CD11b mouse PE-Cy5 BD bioscience 555389 FC 10 µL/sample 
CD18-PE human CD18 mouse PE BD bioscience 555924 FC 10 µL/sample 
CD29-PE human CD29 mouse PE BD bioscience 555443 FC 10 µL/sample 
CD49d-PE human CD49d mouse PE BD bioscience 555503 FC 10 µL/sample 
PE-Cy5 Mouse 
IgG1 
isotype mouse PE-Cy5 BD bioscience 555750 FC 10 µL/sample 
PE Mouse IgG1 isotype mouse PE BD bioscience 555749 FC 10 µL/sample 
FPR1-APC human FPR1 REA169 APC Myltenyi Biotec 130-100-812 FC 10 µL/sample 
REA-isotype isotype REA293 APC Myltenyi Biotec 130-104-614 FC 10 µL/sample 
pMLC 
human phospho-
MLC 
rabbit none 
Cell Signaling 
Technologies 
3671 WB/IF 1:1000 / 1:50 
Vinculin human vinculin mouse none Sigma V9131 IF 1:100 
MKL1 human MKL1 rabbit none Sigma HPA030782 WB 1:250 
MKL1(sc) human MKL1 goat none Santa Cruz sc-21558 WB 1:500 
anti-goat HRP goat donkey HRP Santa Cruz sc-2033 WB 1:2000 
anti-mouse HRP mouse goat HRP ThermoFisher 31430 WB 1:2000 
anti-rabbit HRP rabbit goat HRP ThermoFisher 31460 WB 1:2000 
GAPDH human GAPDH mouse none Sigma G8795 WB 1:10,000 
anti-mouse AF568 mouse donkey AF568 Invitrogen A10037 IF 1:1000 
anti-rabbit AF568 rabbit donkey AF568 Invitrogen A10042 IF 1:1000 
AF488-phalloidin n.a. n.a. AF488 Molecular Probes A12379 IF/FC 1:200 
AF647-phalloidin n.a. n.a. AF647 Molecular Probes A22287 IF/FC 1:200 
DAPI n.a. n.a. n.a. Sigma D9542 IF 1:250 
PE: Phycoerythrine; APC: Allophycocyanin; Cy5: Cyanines5; AF: Alexa-fluor; HRP: Horseradish peroxidase; IF: immunofluorescence; FC: Flow cytometry; WB: Western blotting; n.a.: 
not applicable. 
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2.7.3 F/G actin ratio 
The F/G actin ratio was determined using the G-Actin/F-actin In Vivo Assay Biochem Kit 
(Cytoskeleton Inc., # BK037), following the manufacturer’s instructions. Ten million cells were 
lysed in Lysis and F-actin stabilisation buffer supplemented with 1 mM ATP and protease 
inhibitors. The samples were homogenised by pipetting and the lysates were then incubated at 
37
o
C for 10 minutes. Then 100 µL of each sample was centrifuged at 350 rcf for 5 minutes at 
room temperature. The supernatants were transferred into new tubes and centrifuged at 100,000 
rcf for 1 hour at 37
o
C. The ultracentrifugation resulted in the pelleting of the F-actin while 
leaving the G-actin in the supernatant. The supernatants were gently collected without 
disturbing the pellets and transferred to new tubes. Each pellet was resuspended in 100 µL of F-
actin depolymerisation buffer on ice for 1 hour. Then 25 µL of 5x SDS sample buffer was added 
to each supernatant and pellet samples and mix thoroughly. Finally 10 µL of each supernatant 
and pellet samples were run on a SDS-PAGE gel and analysed accordingly to the 
manufacturer’s instructions using the anti-actin rabbit polyclonal antibody supplied in the kit.  
2.7.4 Flow cytometry 
For flow cytometry, cells were washed in PBS, fixed with 4% PFA for 15 minutes and 
permeabilised with 0.1% Triton X-100 solution for 5 minutes. Antibodies or phalloidin were 
added in PBS-BSA (1%) for 45 minutes, then washed and analysed. For mixed population 
samples, cells were harvested and stained for 20 minutes with CFSE (5 μM in PBS) accordingly 
to the manufacturer’s instructions. Cells were then washed twice in serum free medium, mixed 
with the unlabeled population, fixed, permeabilised and stained as above.  For each antibody 
used, the corresponding isotype control was selected. Isotype controls are negative control 
antibodies that are designed to measure the level of the non-specific primary antibody binding 
that is responsible for the background signal. To correctly assess the non-specific binding of the 
primary antibody, the isotype control must match the host species, the type of immunoglobulin 
and fluorochrome conjugation of the primary antibody used in the study.  
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Figure 2-1: Flow cytometry gating strategy 
A) Using the forward scatter (FS Lin) / side scatter (SS Lin) plot, a gate R1 was drawn to select the cell 
population of interest. B) The R1 gate was applied on the eGFP / SS Lin plot in order to visualise both 
negative and positive eGFP/CFSE populations which were selected by creating two new gates R2 and R3. 
C) The two gates R2 and R3 were then used to measure the signal of interest, here PE, of the 
unstained/eGFP negative and eGFP/CFSE positive cells. 
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All flow cytometry analysis was carried out on the Cyan ADP Analyser using the Summit 4.3 
software (Beckman Coulter). For each experiment, unstained control, single stained samples 
and samples stained with isotype controls were prepared. The cells were gated using a forward 
scatter vs. side scatter plot (Figure 2-1 A). Before performing any analysis, the spectral overlap 
of the different dyes used in the experiments was corrected by using the compensation features 
of the Summit software. The compensation strategy was performed with all the dyes used in 
each experiment as follows (as an example, the compensation of GFP over PE is used): first an 
unstained control sample was run in order to establish the baseline signal. Then an unstained 
sample of cells expressing GFP was run. The PE signal of the GFP sample was then corrected to 
be similar to the unstained sample using the auto compensation feature of the software (the 
difference of the median of the PE signal between the unstained and GFP positive population 
must be < 1%). Once the compensation was setup, the analysis was performed as follows (as an 
example, the analysis of MKL1 vs. control undifferentiated HL-60 cells stained with an 
antibody conjugated with PE is used). The gate defined on the forward-scatter vs. side-scatter 
plot (Figure 2-1 A) was applied on the eGFP vs. side-scatter plot and the control (GFP negative) 
and the MKL1 KD (GFP positive) populations were gated (Figure 2-1 B). The two gates were 
applied on two PE histograms so the signal of the two populations could be measured (Figure 
2-1 C). 
2.8 Immunofluorescence 
2.8.1 Confocal microscopy 
For the staining of phosphorylated myosin light chain and actin cytoskeleton in neutrophil-like 
cells, dHL-60 cells were let to adhere on coverslips coated with fibronectin (100 µg.ml
-1
) for 20 
minutes. The coverslip was then gently washed to remove non-adherent cells. Cells were then 
uniformly stimulated with a solution of fMLP (final concentration 100 nM) for 2 minutes before 
fixation in 4% PFA for 20 minutes. The coverslips were washed with PBS, and the cells were 
then permeabilised with 0.1% Triton X-100 solution for 5 minutes. A 5% BSA solution was used 
to block the samples for 1 hour before incubation with the rabbit anti phosphorylated-MLC 
antibody (1/100) in 5% BSA for 1 hour. Coverslips were then washed three times with PBS 
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before incubation for 30 minutes with a solution containing the goat anti-rabbit secondary 
antibody conjugated with Alexa Fluor 647 (1/1000),Alexa 568-phalloidin (1/500) to stain F-actin 
and DAPI (4',6-diamidino-2-phenylindole) to stain the nucleus. 
For analysis of podosomes, coverslips were coated with fibronectin (10 µg.ml
-1
) for 1 hour 
at 37˚C or overnight at 4˚C. Coverslips were washed in PBS and primary DCs or THP1 cells 
were seeded for up to 2 hours at 37˚C. Once adhered, cells were fixed in 4% 
paraformaldehyde (PFA) for 30 minutes. Cell membranes were then permeabilised in 0.1% 
Triton X-100 for 5 minutes. Samples were blocked with 5% BSA in PBS for 20 minutes. Mouse 
anti-vinculin antibody was added at 1/100 dilution in PBS with 5% BSA for 1 hour at RT, 
followed by two 5 minutes washes. DAPI, Alexa Fluor 488-phalloidin and a secondary anti-
mouse-Alexa Fluor 568 antibody (1/200) were added for 45 minutes. Washing was repeated and 
coverslips were mounted on glass slides using AquaPolymount. Images were acquired at room 
temperature on a Zeiss LSM 710 inverted confocal microscope using 40x (C-Apochromat NA 
1.2, Water) or 63x (Plan-Apochromat NA 1.4, Oil) lens. Images were processed using FIJI (FIJI 
Is Just ImageJ) or Cell Profiler. 
Controls:  
When antibody staining were performed, secondary antibody staining alone were used as 
control to verify the specificity of the staining towards the protein of interest.  
If drugs that perturbed the actin-myosin cytoskeleton such as CK-666 or blebbistatin were used, 
the control condition was the cells treated with the same concentration of the vehicle used to 
deliver the drug, i.e. if the cells were treated with a drug in DMSO diluted at 1/1000 in cell 
medium then the vehicle control was DMSO only diluted at 1/1000 in cell medium. 
Image consistency: 
Unless stated otherwise, for each experiment a minimum of three fields of view containing ≥ 10 
cells each were acquired. Although image analysis was not performed in a blinded/double 
blinded condition, the images that were presented in figures for presentations or papers were 
chosen to be representative of the set of original images. To ensure objectivity, this was 
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confirmed by the visual inspection of the image presented and the original set of images by a 
colleague or supervisor.  
2.8.2 Quantitative fluorescence microscopy 
To quantify fluorescent signal from a confocal z-stack, a z-projection of the z-stack was created 
using the z-project (Addition) function and processed in Cell Profiler. For images containing a 
channel with nuclear staining such as DAPI, this channel was used to identify the nuclei as 
primary objects. The nuclei were then used as “seeds” to detect by propagation (either global or 
adaptive) the edges of the cells in the Actin channel (visualised by phalloidin staining). In the 
absence of nucleus channel, the Actin channel (phalloidin) was used to detect the cell edges 
using the Automatic threshold parameter. Regardless of the method used to detect the cell 
edges, all cells touching the boundaries of the image were automatically excluded from the 
analysis. Regions of interest for each cell were then created using the cells edges detected in the 
previous step. Then, the signal integrated intensity of the phalloidin or antibody staining was 
measured within the regions of interest. Background was not taken into account nor 
manipulated/subtracted during the analysis. 
2.8.3 Phenotypes quantitation 
Localisation of active myosin: 
To differentiate the cells showing a low mCherry signal to the one highly expressing CA-
WASp, the two populations were discriminated using the mCherry signal. All cells with a 
mCherry MFI higher than 3 times the value of the background were considered as high 
mCherry-CA-WASp expressing cells, while the cells with mCherry signal between 1 and 1.5 
times the background signal were considered as having a low mCherry signal. 
To study the activity of myosin in dHL-60 cells, the localisation of the signal of phosphorylated 
myosin (pMLC) staining was used. Using F-actin (phalloidin staining) confocal images, the 
lamellipodium and uropod of the cells were visually identified. The images of the F-actin and 
pMLC stainings, F-actin images were then used to visually score the pMLC cellular localisation 
as  
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Figure 2-2: Development of the migration assay 
A) Random migration of neutrophil-like cells (dHL-60 cells) on coverslips coated with solutions of i) 
fibrinogen at 1 mg.ml
-1
, ii) fibrinogen at 100 µg.mL
-1
, iii) 10% FCS and iv) 5% BSA. HL-60 cells were 
differentiated into dHL-60 cells by adding 1.3% DMSO in their culture medium for 5 days. Cells were 
then left to adhere 30 minutes before being stimulated with 200 nM of fMLP. B) Migration of dHL-60 
cells in the agarose Dunn chamber. The coverslips were coated with a 100 µg.mL
-1
 fibronectin solution 
before being passivated with a 0.2% HAS solution. A and B: The experiments were used for optimisation 
of experimental conditions therefore three independent experiments were not performed. Data 
representative of two experiments. Scale bar = 50 µm. 
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predominantly in the lamellapodia, uropod, in both or neither structure. No ROI was used for 
this quantification. Each population was manually counted using the cell counter plug-in of 
imageJ/Fiji. 
Uropod retraction and retraction fibres defects: 
To quantify the extended uropods in dHL-60 cells and the retraction fibres in THP-1 
macrophages, the F-actin confocal images of the cells were used. The dHL-60 cells with a thin 
uropod longer than the cell body were counted as “abnormally extended uropod”. In the THP-1 
macrophages cells, the cells with more and longer retraction fibres (“hairy” phenotype) were 
counted as positive for a retraction defect. Cells were counted using the Cell Counter plug-in in 
ImageJ/Fiji in non-blinded conditions.  
Cell mobility: 
The number of motile cells was quantified using time-lapse images of cells migrating in the 
Dunn chamber. Cells that were migrating more than twice their diameter over the duration of 
the experiment were counted as motile. The determination of the motility was made visually and 
the cells counted using the Cell Counter plug-in of ImageJ/Fiji. 
2.9 Cell Migration experiments: 
2.9.1 Dunn chamber 
Troubleshooting 
To establish the Dunn chamber assay, the migration of primary neutrophils was first assessed 
using the protocol developed by Dr Bouma, a postdoc in the laboratory. The protocol described 
the coating of the coverslip using a solution of 10 mg.mL
-1
 of fibrinogen and the different steps 
of the assembling of the Dunn chamber. HL-60 cells differentiated into neutrophil-like cells 
(dHL-60) were used as a model to study neutrophil migration. Using this protocol, the dHl-60 
cells were not able to chemotax correctly:  
 most of the cells were very active but unable to migrate, suggesting an adhesion too 
strong to allow the detachment of the cells. 
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 the few cells that were able to migrate did not migrate in the direction of the 
chemoattractant but showed a random migration pattern also known as chemokinesis 
indicating a possible failure in the establishment of the chemokine gradient. 
 
To determine the conditions to allow the cells to adhere enough without impeding the migration, 
the dHL-60 cells were left to adhere on different adhesion molecules and then uniformly 
stimulated with fMLP at a final concentration of 200 nM. The cell chemokinesis was imaged at 
37
o
C for 1 hour at 1 image/minute using Axiovert 135 microscope, equipped with a Achroplan 
10x/0.25 objective, an environmental chamber and a motorised stage. First lower concentration 
of fibrinogen of 1 mg.mL
-1
 (Figure 2-2 A i) and 100 µg.mL
-1
 (Figure 2-2 A ii) were used to coat 
the coverslip by immerging the coverslip in the fibrinogen solution for 1 hour at 37
o
C before 
being washed three times with PBS. The cells were left to adhere 30 minutes and then imaged 
as described above. For both coating with 1 mg.mL
-1
 and 100 µg.mL
-1
 of fibrinogen, the cells 
adhered, spread but were unable to migrate suggesting an impaired detachment due to a strong 
adhesion. Then, the coverslips were coated with a solution of 10% FCS in RPMI medium using 
the same protocol as for fibrinogen (Figure 2-2 A iii). Numerous cells adhered but few cells 
spread and among them, less than 50% migrated. To reduce the cell adhesion strength, the 
coverslips were coated with a solution of 5% BSA in PBS (Figure 2-2 A iv). After 30 minutes 
of adhesion, a low number of cells adhered to the coverslip but most of them were able to 
migrate after stimulation with fMLP. A solution of 100 µg.mL
-1
 of fibronectin was then used to 
coat the coverslips before using a solution of 0.2% HSA to passivate the fibronectin coating 
(Figure 2-2 B). This method to coat the coverslip allowed a high number of cells to adhere with 
most of the cells migrating. The fibronectin coating passivated with 0.2% HSA gave satisfactory 
results and was then used to study dHL-60 cell migration. 
The failure of the dHL-60 cells to migrate in the direction of the source of chemokine suggested 
a difficulty in the establishment of the chemokine gradient in the Dunn chamber. To assess the 
establishment of the gradient in the Dunn chamber, the outer well was either filled with a 
solution of 1 µg.mL
-1
 fluorescein or dextran-rhodamine in PBS or with an agarose gel 
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containing 1 µg.mL
-1
 of fluorescein whereas the inner well was filled with PBS only. The 
chamber was assembled and placed on an Axiovert 135 microscope, equipped with an 
Achroplan 10x/0.25 objective and a motorised stage. The imaging started 15 minutes after 
assembling the chamber due to the distance between the laboratory and the microscopy room, 
and one image of both the phase contrast channel and the FITC/TRITC channel were taken 
every 5 minutes during one hour or overnight. To analyse the gradient evolution over time, 
images recorded on the microscope were analysed using FIJI/ImageJ. Using the rectangular 
selection tool, a selection of 50 pixels wide and 350 pixels long was draw across the bridge 
(from the outer well towards the inner well) of the Dunn chamber on the phase contrast image. 
This selection was then duplicated on the FITC/TRITC image and the intensity of the 
fluorescence signal along the selection was plotted generating the profile of the fluorescein 
gradient over the bridge. The fluorescence profile across the bridge was plotted for different 
time points to determine the evolution of the gradient. As described in chapter 3, the use of 
FITC in the Dunn chamber showed the failure of the establishment of a gradient from the outer 
well to the inner well. To improve the establishment of the gradient, agarose was added to the 
outer well to act as reservoir and to allow the slow diffusion of the FITC over the bridge. 
Agarose was added to the outer well as follows: a 2x FITC solution (2 µg.mL-1) was mixed 
with a 2% agarose solution. After melting at a temperature > 90
o
C, the agarose was left to cool 
to 37°C. This temperature was used to prevent the denaturation of the potential chemokines of 
interest for the experiments (here represented by FITC). Agarose was quickly mixed with FITC 
at 37°C and pipetted into the outer well of the chamber before gelation occurred at 36°C. To 
improve the process by allowing gelation at lower temperature, the molecular biology agarose 
was replaced with a low gelling temperature agarose that melted at temperatures > 65
o
C and 
gelled between 26 and 30
o
C. The low gelling temperature agarose was certified for cell culture 
to reduce the possible effect of impurities contained in the agarose on the cell migration. This 
low melting agarose together with the fibronectin coating of the coverslips allowed the 
development of the protocol described below. 
Cell preparation:  
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dHL-60 cells were washed three times in a warm HBSS/2% HSA/100 mM HEPES solution. 
THP1 cells were washed three times in warm RPMI/1% FBS. 
In some experiments, the two populations of interest (control and mutated) were mixed in a 
ratio 1:1 before being used in the Dunn chamber. This ensured that the cells were exposed to the 
same experimental conditions (extracellular matrix protein coating, chemoattractant gradient 
and chamber assembly). To distinguish the two populations, one of them was either expressing 
a GFP or mCherry tagged protein or stained with CFSE prior to the combination of the two 
populations as described in the flow cytometry section of this chapter. When CFSE was used, 
the staining was performed alternatively on the two populations: in one experiment, the control 
population was stained while in the other experiment, the population of interest was stained and 
the control left unstained. 
Coverslips coating:  
Depending on the cells used for the experiment, coverslips were coated with a solution of 
fibrinogen at 25 mg.mL
-1
 (primary neutrophils), or with a solution of fibronectin at 100 μg.mL-1 
(dHL-60) or 10 μg.mL-1 (THP1) for one hour at 37oC. The coverslips were washed twice with 
PBS before being used. Different extracellular matrix proteins for primary neutrophils and dHL-
60 cells were used to obtain the appropriate adhesion of the cells on the coverslips. Protocols 
using fibrinogen to make primary neutrophils adhere on coverslips had previously been 
established (by Dr. Bouma and Dr. Burns from the laboratory), while following the evaluation 
of the suitability of various adhesion molecules described above, fibronectin was chosen to coat 
the coverslips in dHL60 migration experiments (Millius and Weiner, 2009). The need to use 
different extracellular matrix protein depending on the cells studied might be due to  differences 
between primary neutrophils and neutrophil-like dHL-60 cells in their profile of integrin 
expression (Carrigan et al., 2005). 
Cell adhesion:  
1x10
5
 neutrophils or dHL-60 cells were left to adhere on coated coverslip for 20 to 30 minutes. 
The coverslip was washed once with the medium used for the migration without chemokine to 
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remove non-adherent cells. 2x10
4
 THP1 cells were left to adhere for at least 2 hours in cell 
culture medium containing 1% of FBS, and the coverslip was washed with the same medium 
before use. 
Chemokines:  
A 100 nM fMLP solution was used for neutrophil/dHL-60 experiments. MIP-1α at 10 nM was 
used for THP1 migration. 
Initial chamber assembly: 
To setup the chamber, initially both wells were filled with control medium. Then the coverslip 
on which the cells had adhered was gently laid on the well ensuring that a narrow filling slit was 
left on the outer well. The coverslip was held on the chamber and excess medium was removed 
before sealing all coverslip edges with hot wax except for the filling slit. The outer well was 
then drained with a syringe and a needle before being refilled with the chemoattractant solution 
to create the chemoattractant gradient over the bridge. After removing the excess of solution on 
the glass slide, the filling slit was sealed with hot wax. The Dunn chamber was then placed on 
an environmentally-controlled microscope stage and was left idle for 15 minutes to allow 
gradient formation and temperature equilibration. Then cell migration was imaged over the 
bridge for one hour capturing one image per minute. 
Chamber assembly in the agarose Dunn chamber set-up: 
In order to stabilise the gradient in the Dunn chamber, 80 μL of a 1% agarose gel containing the 
chemokine was poured into the outer well of the chamber and let to polymerise for 2 minutes. 
The inner well was filled with 50 μL of the medium without chemokine, and the chamber was 
assembled by laying down the coverslip on which the cells were adhering. The chamber was 
then sealed with wax. Cells were the imaged at 37
o
C on an Axiovert 135 microscope, equipped 
with an Achroplan 10x/0.25 objective and a motorised stage, by capturing one image per minute 
during one hour for the neutrophil/dHL-60 or one image every 5 minutes for 4 hours for THP1 
experiments, respectively. 
Cell tracking: 
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To track the migrating dHL-60 cells on the movies created from the time-lapse imaging of the 
Dunn chamber, the Manual Tracking plug-in from ImageJ/Fiji was used. The following imaging 
parameters were entered in the plug-in: time interval: 1 minute, x/y calibration: 1.03093 µm, z 
calibration: 0.0 µm, search square size for centering: 5.0, dot size: 5.0, line width: 2.5, font size: 
18. The cells were then tracked by clicking on each cell on each image of the movie following 
one cell at a time over the successive frames. The results were saved in an Excel file that was 
then processed as described below. 
Analysis: 
The cell tracking results were collected as a single text file containing all tracks one after each 
other with one measure per column: Track number, slice number, position X of the cell, position 
Y of the cell, distance, velocity, and pixel value. X and Y positions, distance and velocity are 
the four parameters required to do a minimal characterisation of the migration of each cell since 
they allow to calculate migration direction and speed. A Matlab routine was developed to 
automatically extract each track from the file and separately copy it into a database to allow 
easy and fast data processing (Figure 2-3-A). From the four initial parameters measured by the 
Manual tracking plug-in, several other parameters were calculated using the MatLab routine 
(Figure 2-3-B and C): 
 A cell track is composed of n positions (𝑝1, … , 𝑝𝑛), with each position pi defined by its 
coordinates (𝑥𝑖, 𝑦𝑖) where x is the coordinate along the horizontal axis (or x axis) of the 
image, y the coordinate along the vertical axis (or y axis) of the image and i the index of 
the position with 1 ≤ 𝑖 ≤ 𝑛. 
 The instantaneous velocity: this parameter is calculated by the ImageJ/Fiji plug-in 
Manual tracking. The instantaneous velocity is defined as the distance between two 
successive positions divided by the time interval between the two successive positions, 
𝑣𝑖 = 𝑑(𝑝𝑖 , 𝑝𝑖+1) ∆𝑡⁄ . 
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 The mean velocity: the mean velocity of each cell was calculated by averaging the 
instantaneous velocities of the cell, ?̅? =  (1 𝑛) ∑ 𝑣𝑖
𝑛
𝑖=1⁄ .  
 The total distance that each cell travelled was computed by adding all the distances 
between the successive positions during the migration: 𝑑𝑡𝑜𝑡 =  ∑ 𝑑(𝑝𝑖 , 𝑝𝑖+1)
𝑛−1
𝑖=1   
 The net distance, was defined as the direct distance between the starting and the ending 
point of the cell path, 𝑑𝑡𝑜𝑡 =  𝑑(𝑝𝑖, 𝑝𝑛). 
 The Chemotactic Index: this parameter was determined from the net distance to total 
distance ratio: 𝐶𝐼 = 𝑑𝑛𝑒𝑡 𝑑𝑡𝑜𝑡⁄ . This parameter represents the directionality of the 
migration with a value of one indicating a migration in a straight line and a value close 
to zero indicating a random migration. Because it does not integrate any reference point, 
the chemotactic index does not indicate the ability of cells to specifically respond to the 
chemoattractant source.  
 The instantaneous angle: for each time point the instantaneous angle between the 
gradient and the direction of the cell, 𝛼𝑖 =  tan
−1(𝑦𝑖+1 − 𝑦𝑖 𝑥𝑖+1 − 𝑥𝑖⁄ ) was calculated 
to ensure that the directionality of the cell migration is in the direction of the 
chemoattractant. By plotting the frequency distribution of instantaneous angles, a 
deviation of the cells from the chemoattractant could be determined.  
 The angle variation: this parameter is defined as the difference between two angles, 
𝛾𝑖 = 𝛼𝑖+1 − 𝛼𝑖 and shows the angular variation between two successive migration 
positions. This allows to evaluate the persistence of cell migration: an angular variation 
of zero indicates that the cell does not change direction from the previous time point. 
 The mean angle is the mean of the instantaneous angle values for each cell to simplify 
the graphical representation of the instantaneous angles and is calculated as follows,  
?̅? =  tan−1(∑ sin 𝛼𝑖
𝑛
𝑖=1 ∑ cos 𝛼𝑖
𝑛
𝑖=1⁄ ). Indeed, when the frequency distribution of the 
instantaneous angles of a high number of cells is plotted, a high number of values in one 
direction can dominate over rare behaviours from other cells (Figure 2-3-C). 
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Figure 2-3: Data processing and migration parameters  
A) The manual tracking of the cells using the ImageJ plugin generates a unique result file containing the 
position of each cell at each time point. All these results are sequentially ordered within the file with no 
separation between the results from different cells. The MatLab routine then reads the result file from the 
tracking and organises the results in a set of tables with each table containing the data from only one cell. 
B and C). The MatLab routine then processes the data and for each track calculates the mean speed, the 
chemotactic index, the instantaneous angle, the angle variation, the total and the net distances and the 
mean angle. 
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2.9.2 Transwell migration: 
To study dHL-60 migration in Transwell inserts, 24 well inserts with a pore size of 3 µm (BD 
Falcon #: 353096) were used. The inserts were first placed in the wells of the Companion plate 
(BD Falcon #: 353504) and were then coated with a fibronectin solution (100 μg.mL-1) for 1 
hour at 37
o
C before being washed three times with HBSS. Then, 1.2 mL of the chemoattractant 
solution (100 nM fMLP in HBSS/2% HSA/100 mM HEPES) was pipetted in the wells without 
removing the insert in order to avoid the formation of bubbles underneath the insert membrane. 
The dHL-60 cells were counted, washed twice with HBSS and resuspended in HBSS/2% 
HSA/100 mM HEPES at a concentration of 1x10
6
 cells/mL and then 4x10
5
 cells were seeded in 
the insert. The lids were placed on the plates and the plates were incubated at 37
o
C for the 
indicated time. Then, in order to detach the cells loosely adherent to the insert membrane or to 
the well plastic, 15 μL of a 0.5 M EDTA solution was added in each well and the plates were 
incubated at 4
o
C for 15 minutes. The inserts were then carefully removed and the cells in the 
well gently resuspended by pipetting and then counted using a haemocytometer. Each condition 
studied was run in triplicate on the plate. 
2.9.3 Fibroblast migration 
Fibroblast migration was monitored using the Oris cell migration assay  
(Platypus Technologies, CMA1.101). After sealing the Oris Cell Seeding Stoppers in each well, 
40,000 cells were seeded in each well and left to adhere for 24 hours. The cell seeding stoppers 
were then gently removed, the cells were washed twice with PBS, and fresh medium was added. 
Cell migration was then monitored at 37°C for 18 hours with an Achroplan 10x/0.25 objective 
mounted on an Axiovert 135 time-lapse microscope equipped with a motorized stage. One 
image was captured every 15 minutes. Migration was quantified by measuring the area invaded 
by the cells using the ImageJ/Fiji software. 
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2.10 Fluorescence Time-Lapse Imaging of eGFP-CENPA HT1080 cells 
2.10.1 Generation of HT1080 cells stably expressing eGFP-CENPA 
The peGFP-N1 vector containing the eGFP-CENPA insert under CMV promoter and a 
neomycin/kanamycin resistance gene was provided by Dr Guillaume Charras. HT1080 cells 
were transfected using Lipofectamine 2000 as described in the 2.5.4  section of the chapter. 
Briefly, 0.8 µg of EGFP-CENPA vector were diluted together with 1.5 µL of Lipofectamine 
2000 in OPTI-MEM I medium without serum. The solution containing the vector DNA 
complexed with the Lipofectamine was added on 8x10
4
 HT1080 cells for 24 hours before being 
replaced with fresh culture medium containing 1 mg.mL
-1
 of G418/Geneticin. The cells were 
kept in culture with medium containing 1 mg.mL
-1
 of G418 for two weeks before being sorted 
by FACS on a MoFlo XDP cell sorter (Beckman Coulter). Only the cells displaying a high 
eGFP signal were single cells sorted in 96 well plates containing conditioned medium (50% 
fresh culture medium and 50% medium from HT1080 cells cultivated for 3 days) supplemented 
with 1 mg.mL
-1
 of G418/Geneticin. After the sort, the cells were kept in culture for 10 days 
before the 24 brightest clones were visually selected and transferred in a 48 well plate. The 
selected clones were left to grow in conditioned medium with G418 for 24 hours before the 
medium was changed for fresh culture medium containing G418. After a week, the 5 brightest 
clones were visually selected and transferred in a 6 well plate. After a week, each of the clones 
was transferred in several 10 cm petri dishes to expand the cells and freeze several aliquots. 
Cells from each clones were plated on coverslips, fixed and mounted using ProLong Gold 
mounting medium before being imaged by confocal microscopy using the 488 nm laser at the 
same intensity for all clones. 
2.10.2 Imaging of kinetochore oscillations 
To image kinetochore oscillations, HT1080 cells expressing eGFP-CENP-A were transduced 
using lentiviruses to express mCherry, mCherry-WASp wild type and mCherry-CA-WASp. The 
expression of the three different transgenes was driven by the CMV promoter. Five different 
conditions were imaged in this experiment: untransduced HT1080 and HT1080 expressing 
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mCherry alone as controls; HT1080 cells expressing mCherry WASp wild-type, or mCherry-
CA-WASp treated or not with the ARP2/3 inhibitor CK666. 
First, 2x10
5
 cells were seeded in glass-bottom dishes (FluoroDish, WPI) in 2 mL of DMEM 
supplemented with 10% FCS and Pen/Strep. Then, six hours after seeding, the attachment of the 
cells to the dishes was visually confirmed by microscopy and the medium was replaced with 
imaging medium (D-MEM medium without red phenol complemented with GlutaMAX, 10% 
FCS and 25 mM HEPES). Twenty-four hours after seeding, the cells were imaged using a 
100×/1.4 NA oil objective lens on a Olympus IX81 microscope fitted with a 37°C 
environmental chamber and equipped with Andor iXon3 DU 897-BV camera and with an 
Andor Spinning Disk confocal microscopy system. Cells in metaphase with the chromosomes 
aligned on the equatorial plan were captured using a z-stack composed of 20 z sections (0.5 μm 
apart) every 7.5 s for 5 min.  
2.10.3 Analysis of the oscillations of kinetochores (Kymograph) 
The movements of the kinetochores were analysed using imageJ/Fiji. The z-stack produced by 
the imaging of the kinetochores was open in ImageJ/Fiji. Then, using the rectangular selection 
tool, a selection containing a pair of kinetochores was created. Using the Duplicate function, 3 z 
planes containing the selection were duplicated resulting in a new z-stack of 3 z planes 
restricted to the selection containing the pair of kinetochores of interest. A z-projection of the 
new z-stack was created using the z-project (Maximum Intensity) function. Using the Montage 
function, each image of the new z-stack was put one after each other as one column creating a 
kymograph (a x-t scan). The oscillation of the kinetochore pair was then visible on the 
kymograph and the amplitude, period and speed of the kinetochore oscillation could be 
analysed. 
2.11 Statistical analysis 
Unless otherwise stated, the statistical power of the experiments presented in this thesis was 
assessed by unpaired t-test with two-tailed p-value. The normality of the distribution of the 
values was tested using the D’agostino and Pearson normality test. 
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A one-way ANOVA was used to test the statistical power of three or more conditions with only 
one parameter measured. The ANOVA test was used together with a Tukey post-test in order to 
compare all the conditions to each other and determine the significance of the variation between 
each condition. 
The F-test was used to analyse the variance of the distribution of the angles between the 
gradient of fMLP and the migrating cell path of the dHL-60 control and CA-WASp cells. The 
distribution of the angles between the chemoattractant and the migrating control cells seemed to 
be more dispersed than the distribution obtained for the CA-WASp cells. Therefore, the 
variance of the distributions between the two populations was compared using the F-test. The 
null hypothesis of the test is that the variances of the two populations are equal. As the test 
evaluates the ratio of the variances of the two populations, if the variances are equal, then the 
ratio = 1. The F-test was performed using the vartest2 function in Matlab. 
 
All statistical analyses, with the exception of the F-test, were performed using GraphPad Prism 
5.0. Presentation of significance in figures was as follows: * = p-value < 0.05, ** = p-value < 
0.01, *** = p-value < 0.001. Unless stated otherwise, data are represented as the mean +/- 
standard deviation. The number of measurements and independent experiments are stated in the 
figure legends.  
97 
 
Chapter 3  Cell migration in the Dunn chamber 
3.1 Introduction 
Cell migration is fundamental process needed for the development of multi cellular organism 
and its maintenance. Cells migrate in a specific direction in response to a specific chemical or 
mechanical stimulus in order to complete a define task. Some well-studied examples of 
processes relying on migration include the movement of cells throughout the embryo during 
development, the migration of metastatic cells towards a growth factor source or the migration 
of neutrophils towards the infection site in order to clear it from pathogens. Dysfunction in the 
chain of events that regulates the process of migration can lead to several pathologies such as 
metastatic cancer or primary immunodeficiency. To study migration, several tools exist and the 
correct one will be chosen depending on the question asked. Two types of experimental setups 
exist: those which do not allow direct visualisation of the cell nor the chemoattractant gradient 
called indirect assays, and those which allow direct visualisation of the cells and the gradient 
using a microscope that are defined as direct assays. 
The Boyden/Transwell chamber is maybe the most common indirect assay. It consists of two 
chambers separated by a porous membrane. One of the chambers contains the cells and the other 
one the solution of chemoattractant. The chemoattractant will diffuse through the pores of the 
membrane into the chamber containing the cells, establishing a gradient of molecules that cells 
will follow. After a specific and usually long time, between 1 to 4 hours, the number of cells 
that successfully migrated through the pores of the membrane will be counted and the 
chemotaxis in response to the chemoattractant will be calculated. This assay is very useful to 
study several conditions in the same time and so is well suited for screening chemoattractants or 
migration inhibitors. However, because it is an indirect assay, it only allows an estimation of the 
chemotaxis and does not allow direct observation of cell migration. As cells migrate through the 
membrane pores, they obstruct these pores modifying the local gradient of chemoattractant 
which can further be dependent on unknown flow conditions making difficult to know the 
nature and concentration of the gradient. The Boyden/Transwell assay is a convenient and 
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sensitive tool to study cell migration but to study the chemotactic response to a gradient of 
chemoattractant, the direct visualisation of the cells is required. 
The first tool available for direct visualisation of cell chemotaxis was the Zigmond chamber 
(Figure 3-1-A) and was used to study neutrophil migration in a shallow gradient. The chamber 
consists of a plexiglass slide in which two wells separated by a bridge have been cut. A 
coverslip on which the cell adhered is maintained on the slide using springs and the wells are 
filled with a control solution and a chemoattractant solution. The small space between the 
surface of the bridge and the coverslip allows the chemoattractant to diffuse towards the well 
that contains the control solution. Cells sense this gradient and migrate in the direction of the 
well filled with chemoattractant. Migration is observed and recorded on a microscope allowing 
a direct visualisation of cell chemotaxis. This setup is very good to study cell chemotaxis but the 
variation of the gap over the bridge and the deformation of the chamber due to the use of springs 
that are thermosensitive are responsible for variations in the gradient. 
The Dunn chamber was first described to study the migration of fibroblasts and neutrophils 
(Zicha et al., 1991). This system revealed that fibroblasts display a very low velocity of around 
1 µm.min
-1 
whereas the leukocytes have previously been shown to migrate at a speed of up to 30 
µm.min
-1
. The chamber consists of a standard glass slide of 1 mm thickness in which two 
concentric ring-shaped wells were drilled (Figure 3-1-A). The bridge between the inner and 
outer wells was polished so the surface of the bridge laid 20 μm below the surface of the slide 
(Figure 3-1-B). Therefore, when the wells are covered with the coverslip, on which the cells 
adhere, there is a gap of 20 µm between the coverslip and the bridge surface. The inner well is 
filled with control medium and the outer well with a solution containing the chemoattractant. 
The gap over the bridge allows the diffusion of chemoattractant from the outer well to the inner 
well so that a linear gradient is established and maintained during several hours (Figure 3-1-B). 
To get around the gradient variation in the chamber, the authors designed the chamber so no 
string or other metallic part are used and they used thick #3 (0.25 – 0.35 mm) coverslips to 
reduce its sensibility to change of temperature that would result in variations in the  
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gap over the bridge. The Dunn chamber was designed to establish very stable gradient that 
fibroblasts, due to their low speed, necessitate to establish a good chemotactic response. Zicha 
et al. showed that this allowed the formation of a gradient that was stable over a period of 96 
hours (Zicha et al., 1991). 
The Insall chamber is a new chamber derived from the Dunn chamber. It consists of a square 
inner well surrounded by the outer well. On two faces of the inner well, two coverslip supports 
stand to avoid any deformation of the coverslip that could crush the cells or modify the gradient. 
Two bridges of different widths close the inner well: one 0.5 mm and one 1 mm width bridges 
which provide different gradient steepnesses (Figure 3-1-A). The chamber also includes two 
loading wells to easily change the medium in the outer well. This new chamber has a promising 
design that is well suited to study cell chemotaxis (Muinonen-Martin et al., 2010) and has 
recently been used in several studies (Phillips and Gomer, 2012; Roberts et al., 2015; Sapey et 
al., 2014, 2011).  
I chose to use the Dunn chamber to study neutrophil migration because it has been shown to 
allow the establishment of chemoattractant gradient and neutrophils have been shown to 
chemotax in this chamber. Furthermore, the Dunn chamber is a well-known setup to study cell 
migration and is re-usable since it is made of glass.  
To investigate neutrophil migration, I used the human promyelocytic leukemia HL-60 cell line 
that can be differentiated into neutrophil-like cells, called dHL-60 (Figure 3-2-A and B). The 
differentiation was achieved by culturing the cells for 5-6 days in their culture medium 
complemented  with 1.3% DMSO  (Millius and Weiner, 2010). When compared to primary 
human neutrophils, the dHL-60 cells displayed a similar migrating response towards the 
chemotactic peptide fNLPNTL, an fMLP analogue, but a very poor response to IL-8 (Hauert et 
al., 2002), making the dHL-60 a good model to study neutrophil migration when formyl 
peptides such as fMLP are used as chemoattractant. 
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Figure 3-1: Chambers for direct visualisation of chemotaxis 
A) Schematic representation of the Zigmond, Dunn and Insall chambers. The Zigmond chamber 
is composed of two wells separated by a bridge, one well is filled with medium while the other 
well is filled with medium containing the chemoattractant. The coverslip on which the cells 
adhere will be laid on top of the chamber, creating a small gap between the bridge and the 
coverslip that will allow the formation of a gradient of chemoattractant. The Dunn chamber was 
built by drilling two concentric rings separated by a bridge. The inner well is filled with medium 
and the outer well is filled with medium containing chemoattractant. The diffusion of the 
chemoattractant over the bridge from the outer well to the inner well creates a gradient of 
chemoattractant that will be followed by the cells. The Insall chamber is composed of an inner 
well surrounded by a bridge and an outer well. The bridge has two different widths to allow the 
creation of chemoattractant gradients with different steepnesses. B) Profile view of the Dunn 
chamber. C) Inset of the view over the bridge delimited by the dotted square in B). 
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3.2 Results 
To investigate neutrophil migration, I decided to use the Dunn chamber as it allows a direct 
visualisation of the cells during migration and this assay is commonly used to study migration. I 
first defined the conditions adapted for the migration of primary neutrophils and dHL-60. Both 
cell types respond well to 100 nM of fMLP and only differ in the extra-cellular matrix protein 
used to coat the coverslip: I used fibrinogen for the primary neutrophils and fibronectin for the 
dHL-60 cells. In these conditions, I was able to observe that the cells randomly migrated in all 
directions but not towards the fMLP gradient suggesting a failure of chemotaxis (Figure 3-2-C). 
The presence of random migration indicated that the migration conditions allowed cells to move 
without adhesion problems but the absence of chemotaxis suggested a problem in sensing the 
gradient. To evaluate if the gradient was well established and maintained in our imaging 
conditions, I firstly identified the gradient characteristics using 70 kDa rhodamine-dextran This 
experiment showed a quick establishment of the gradient as described in the original Dunn 
chamber paper. Nevertheless, since fMLP is a small molecule (437 Da), I also tested the 
establishment of the gradient with a solution of FITC (360 Da). Surprisingly, there was no 
establishment of a FITC gradient with a steep slope over the bridge. Instead, a gradient was 
observed only in the first 20 µm adjacent to the outer well, followed by a uniform distribution 
over the rest of the bridge (Figure 3-2-D), explaining the absence of chemotaxis during dHL-60 
migration. The difference in gradient formation between the rhodamine-dextran (70 kDa) and 
the FITC (360 Da) might be due to the important difference of size of the two molecules. 
Indeed, the diffusion coefficient is higher for molecules of small size resulting in a faster 
diffusion of FITC over the bridge and therefore a faster uniformisation of the concentration 
between the two wells and the absence of gradient.  
To allow the establishment of a gradient of small-sized molecules such as fMLP and FITC in 
the Dunn chamber, I decided to slow down the quick molecule diffusion from the outer well 
over the bridge. To do so, I decided to pour an agarose-gel containing FITC into the outer well 
to slow down the diffusion in the outer well (Figure 3-3-A). 
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Figure 3-2: Cell migration in the Dunn chamber 
A and B) Cytospin of HL-60 cells and dHL-60 cells  respectively. HL-60 cells were differentiated by 
adding 1.3% DMSO in their culture medium for 5 days. Cells were stained using the Diff-Quick staining. 
C) Tracks of 12 dHL-60 cells migrating during 60 minutes in the Dunn chamber, imaged at 37
o
C at 1 
image/minute using an Axiovert 135 microscope, equipped with an Achroplan 10x/0.25 objective, an 
environmental chamber and a motorised stage.  Cells were tracked using the ImageJ manual tracking 
plug-in and plotted in Excel. D) FITC gradient stability in the Dunn chamber over 60 minutes. FITC (1 
µg.mL
-1
) was loaded into the outer well of the Dunn chamber and the Dunn chamber was imaged at 37
o
C 
at 1 image/minute using an Axiovert 135 microscope, equipped with an Achroplan 10x/0.25 objective and 
an environmental chamber. The FITC signal was quantified using ImagejJ using a rectangular selection of 
50 pixels of width that stretched from the inner well to the outer well. A-D: The experiments were used 
for optimisation of experimental conditions therefore three independent experiments were not performed 
Data representative of two independent experiments, one replicate per experiment. 
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The use of the agarose gel in the outer well did not allow us to setup the Dunn chamber as it has 
been described before so I defined a new protocol to setup the chamber. 
I first melted the 2% low gelling-temperature agarose gel at 75
o
C for 45 min and then let it cool 
down at 37
o
C. I mix, in a 1:1 ratio, the agarose gel with a solution of FITC previously warmed 
at 37
o
C, resulting in a FITC-loaded 1% agarose gel solution. I immediately poured 80 µL of this 
agarose gel in the outer well of the Dunn chamber taking care of not spilling gel on the bridge or 
within the inner well. I let the gel to set for 2 minutes and then filled the inner well with 60 µL 
of control medium. I then closed the chamber with the coverslip, which allows control medium 
to flood the gap over the bridge, and I sealed the chamber by applying wax on the coverslip four 
edges (Figure 3-3-A). Then, I imaged the formation of the FITC gradient over the bridge using 
the same microscope setup and imaging conditions as previously described. Using this modified 
system, I could observe the formation of a gradient from the outer well to the inner well within 
15 minutes: At this time point, the FITC concentration at the inner-well edge was between 30 to 
50 % of the concentration at the outer-well edge (Figure 3-3-B). I could observe very little 
change in the gradient over one hour after the setup of the chamber. I tested the stability of the 
gradient over longer periods of time and I could observe that, within a 100 µm distance from the 
inner well, FITC concentration remained stable for 6 hours with 40-50 % of the maximum 
concentration and then increased to 50-60%. The middle region of the bridge displayed a low 
but noticeable increase in FITC concentration over time and the 100 µm-wide zone adjacent to 
the outer well showed virtually no change in concentration (Figure 3-3-C). The use of FITC-
loaded agarose gel in the outer well of the Dunn chamber allowed the formation of a gradient 
between the outer well and the inner well and appeared suitable to reliably monitor neutrophil 
migration towards a gradient of fMLP. 
Then, I tested if neutrophils migrating in the agarose Dunn chamber showed a chemotactic 
response. The outer well was filled with a solution of melted agarose at a concentration of 1% 
and fMLP at a final concentration of 100 nM. 
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Figure 3-3: Agarose Dunn chamber and impact on chemoattractant gradient 
A) Schematic of the Agarose Dunn chamber. B and C) Stability of a FITC gradient in the Agarose Dunn 
chamber over B) one hour and C) 10 hours. A FITC-loaded 1% agarose gel solution (1 µg FITC per mL) 
was loaded to the outer well of the Dunn chamber and the agarose Dunn chamber was imaged at 37
o
C at 
1 image/minute using an Axiovert 135 microscope, equipped with an Achroplan 10x/0.25 objective, an 
environmental chamber. The FITC signal was quantified using ImageJ using a rectangular selection of 50 
pixels of width that stretched from the inner well to the outer well. B-C: The experiments were used for 
optimisation of experimental conditions therefore three independent experiments were not performed. 
Data representative of two independent experiments, one replicate per experiment.  
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The Dunn chamber was assembled and setup on the microscope as described in the Materials 
and Method section. Cells were imaged for one hour and one image was captured every minute 
and migrating cells were manually tracked using the Manual Tracking plug-in in Fiji/ImageJ. 
When I used neutrophils that I plated on fibrinogen, I could observe directed migration of most 
of the cells towards the outer well (Figure 3-4-A, upper line, Figure 3-4-C). Neutrophils 
displayed a good mobility in the agarose Dunn chamber with 74% of mobile cells. Within the 
mobile population, 73% of cells showed directed migration towards the outer well indicating the 
ability of the cells to do chemotaxis in this setup (Figure 3-4-B). I also tested the ability of HL-
60 cells to do chemotaxis in the agarose Dunn chamber. Most of the dHL-60 cells migrated in 
the direction of the outer well (Figure 3-4-A, bottom line, Figure 3-4-E) and displayed a good 
chemotaxis with 95% of mobile cells and 88% of directed migration. This showed that the use 
of agarose gel to cage fMLP and slowly release it into the bridge gap not only resulted in the 
establishment of a gradient of chemoattractant but also allowed cells to do chemotaxis in 
response to the chemoattractant gradient. This setup appeared well-adapted to study neutrophil 
or dHL-60 migration. 
Using the MatLab routine I developed, I analysed the migration of neutrophils and dHL-60 
described above. Neutrophils displayed an average velocity of 8.6 µm.min
-1
 (+/- 2.8 µm.min
-1
), 
with some cells migrating up to a speed of 15 µm.min
-1
 (Figure 3-5-A). dHL-60 cells overall 
migrated at a faster velocity with an average velocity of 14.9 µm.min
-1
 (+/- 2.8 µm.min
-1
) and a 
maximum speed of 21.5 µm.min
-1
 (Figure 3-5-C). In this experiment, neutrophils showed a 
better directionality than dHL-60 cells with a chemotactic index of 0.69 and 0.55, respectively 
(Figure 3-5-B and D). The weak directionality of dHL-60 cells was confirmed by analysing 
instantaneous angle distributions where I could see a more spread distribution of the values in 
comparison to the neutrophil instantaneous angle distribution (Figure 3-5-E and H). The angle 
variation analysis of the dHL-60 population showed that these cells deviated much more than 
primary neutrophils with mainly a turning angle up to 60
o
 and even some values up to 180
o
 
indicating a temporary migration in the opposite way of the gradient (Figure 3-5-F and I). 
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Figure 3-4: Migration of primary neutrophils and dHL-60 in the agarose Dunn chamber 
A) Magnification of part of the bridge shows several neutrophil and dHL-60 cell migration in the 
direction of the chemoattractant, 100nM of fMLP, during 60 minutes. Scale bar: 100 μm. B and D) 
Mobile and directed migration fractions of the whole population of migrating primary neutrophils and 
dHL-60, respectively. C and E) Tracks of C) 33 neutrophils or E) 19 dHL-60 cells migrating from their 
initial position in the agarose Dunn chamber. The outer well, source of the chemoattractant, is located at 
the top of the graphs. The cells were imaged at 37
o
C at 1 image/minute using an Axiovert 135 
microscope, equipped with an Achroplan 10x/0.25 objective, an environmental chamber and a motorised 
stage. Cells were tracked using the ImageJ manual tracking plug-in and tracks were processed in Matlab 
using a custom-written routine. A-E: The experiments were used for optimisation of experimental 
conditions therefore three independent experiments were not performed. Data representative of two 
independent experiments, one replicate per experiment. 
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Nevertheless, mean angle analysis confirmed that most of the population of neutrophils and 
dHL-60 were migrating in the chemoattractant direction with few values deviating from the 30
o
 
arc from the chemoattractant (Figure 3-5-H and J). 
3.2.1 Assay reliability 
In order to use the modified Dunn chamber as routine assay to detect neutrophil migration 
defect, I analysed the reliability of this method. To reduce the possible influence of the variation 
from different healthy donors, I used dHL-60 as a standard. The advantage of using this cell line 
as a model for neutrophil migration is that the cell characteristics should remain similar from 
one experiment to another, reducing variations in the results obtained. To analyse the inter-
experiment variability of the dHL-60 chemotactic response, I used the control cells of 9 
experiments where cells displayed a chemotactic response to fMLP which allowed me to 
determine the average speed, standard deviation and coefficient of variation of dHL-60 
chemotaxis in the agarose Dunn chamber. Experiments in which neutrophils from healthy 
volunteers showed no directionality in their migration (possibly due to a failure to establish an 
fMLP gradient) where excluded from the analysis of chemotaxis. The coefficient of variation 
(CV) is a standardised measure of the dispersion of a probability distribution and is defined as 
the ratio of the standard deviation to the mean. Measure of the CV is often used as quality 
control for intra- or inter-assays in laboratory (Hanneman et al., 2011) and reflects the 
performance of the assay in the hand of the user.  In my studies, neutrophil-like dHL-60 
migrated on average at a speed of 14.5 μm.min-1 (+/- 2 μm.min-1) and showed a variation of 
14% from one experiment to another (Figure 3-6-A and C). Compared to dHL-60, primary 
neutrophils displayed a slower average speed of 12.6 μm.min-1 (+/- 2.6 μm.min-1) and a CV of 
20.7% (Figure 3-6-A and B). These data were obtained from 6 independent experiments, using 
different donors. The higher standard deviation and CV of primary neutrophils probably reflect 
the variation between patient genetic backgrounds which could represent up to 38% of the cause 
of variation (Kabbur et al., 1997) but also the additional steps of cell manipulation necessary to 
isolate primary cells.  
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Figure 3-5: Migration parameters 
A) Velocity frequency distribution of migrating primary neutrophils. B) Chemotactic index of primary 
neutrophils during migration. C) Velocity frequency distribution and D) chemotactic index of migrating 
dHL-60. E and H) Instantaneous angle (α), F and I) angle variation (γ) and,  G and J) mean angle (?̅?) of 
migrating primary neutrophils and dHL-60, respectively. Cells migration was followed during 60 minutes 
in the agarose Dunn chamber in response to 100nM of fMLP. The migration parameters were calculated 
using a custom-written Matlab routine from cell tracks obtained by manually tracking cells using the 
manual tracking plug-in of ImageJ. The graphs E to J were generated using the Matlab routine while the 
graphs A to D were done in GraphPad Prism. A-H: The experiments were used for optimisation of 
experimental conditions therefore three independent experiments were not performed. Data representative 
of two independent experiments, one replicate per experiment.  
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To estimate the reliability of the measures obtained from neutrophils migrating in the agarose 
Dunn chamber, I evaluated the number of tracked cells needed within each experiment to have 
the average velocity within the 95% confidence interval of all experiments combined. In both 
primary neutrophils and dHL-60 experiments, the tracking of 10 cells was enough to reach 60% 
of the average velocity of the different experiments within the 95% confidence interval.  
Increasing the number of cells tracked to 15 or 20 did not seem to increase the number of values 
within the 95% confidence interval but allowed to identify the outliers neighbouring the 95% 
confidence interval. 
3.3 Discussion 
The Dunn chamber is a well-established direct visualisation chamber for cell migration and has 
been used numerous times to study immune cells migration. I chose to use this setup because it 
has been shown to allow the establishment of a stable gradient of chemoattractant and also it is 
reusable since made of glass. Accordingly to the literature, I determined the conditions for 
neutrophils and dHL-60 cells to adhere and migrate on fibrinogen and fibronectin coated 
coverslips, respectively. When I first tried to make cells migrate in the Dunn chamber, I was 
surprised to observe only random migration. Since I used the same cells, the same fMLP 
concentration, and the same coverslip coating with fibronectin as members of Dr. Charras’ 
group who achieved successful dHL-60 chemotaxis towards fMLP delivered through 
micropipettes, I concluded that the random migration was not the consequence of a defect in cell 
differentiation or an issue with the concentration of chemoattractant or with the extra-cellular 
matrix protein used to coat the coverslip but more probably due to a failure in the formation of 
the chemoattractant gradient. To confirm that the gradient formation did not occur correctly, I 
filled the outer well with fluorescent dyes to visualise the gradient formation over the bridge and 
its maintenance over long durations. First I used 70 kDa dextran-rhodamine and could observe 
the establishment of a steep and stable gradient. Because diffusion is correlated to the molecule 
size, I decided to use a molecule which size is closer to the one of fMLP in order to have a 
better characterisation of the fMLP gradient formation. I used FITC to do so and I could only 
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Figure 3-6: Evaluation of the Dunn chamber assay variability 
Cells migration was followed during 60 minutes in the agarose Dunn chamber in response to 100nM of 
fMLP. The cells were imaged at 37
o
C at 1 image/minute using Axiovert 135 microscope, equipped with a 
Achroplan 10x/0.25 objective, an environmental chamber and a motorised stage. A) Variation between 
successive assays was evaluated using the coefficient of variation defined as CV = SD/average. B and C) 
Evolution of the average velocity in function of the number of cells tracked during the migration in the 
agarose Dunn chamber for B) primary neutrophils and C) dHL-60 respectively. B: Results were obtained 
from 5 independent experiments. C: results from 9 independent experiments. 
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observe a gradient close to the outer well but not on the rest of the bridge. Several hypotheses 
could explain this result. The first one is the distance between the cell culture room where the 
Dunn chambers were setup and the time-lapse microscope room where I carried-out the 
observations. When patient samples were processed, we isolated PBMCs from the blood 
samples and therefore, we needed to do the cell isolation under sterile conditions. Therefore, all 
the material for the Dunn chamber was set in the cell culture room. Assembling the Dunn 
chamber in the cell culture room also prevented the cells from being exposed to bacterial 
products. Indeed, the main lab was primarily used for molecular biology experiments with 
bacterial cultures processed on a weekly basis, generating aerosols that could have contaminated 
and stimulated the cells. Unfortunately, it was not possible to use a room closer to the 
microscope to assemble the chamber. The time-lapse microscope used was located in a different 
wing of the building and the route to reach it included stairs and a lift. In theory, once the Dunn 
chamber is setup, liquid inside is assumed to be incompressible and so should not be much 
influenced by movement of the slide due to the user. Nevertheless, it is always recommended to 
be gentle when carrying the chamber but when one has to go down stairs before taking a lift 
even being very careful, it can be challenging to avoid vibrations. These vibrations may be 
enough to perturb the gradient of small molecules over the bridge. It is important to notice that 
usually scientific articles describing direct visualisation chambers such as the Dunn chamber do 
not mention how the handling of the chamber can influence the gradient. It would have been 
interesting to image the FITC gradient before going out of the room where the chamber was 
assembled and after the travel to the room where the microscope was located to evaluate how 
much the travel between the two rooms may have perturbed the gradient. The second hypothesis 
is that the use of #1.5 coverslips modifies the gradient. The Dunn chamber was originally 
designed to be used with a thick #3 coverslip to prevent any deformation of the coverslip due to 
change of temperature that could induce a variation of the height of the gap between the bridge 
and the coverslip and thus perturb the gradient.  It was originally decided to use both low 
magnification lenses to be able to record the behaviour of a whole population and high 
magnification lenses to image specific cell structures such as the lamellipodium during 
migration. Low magnification lenses are usually air lenses with a long working distance and 
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both thin (#1.5 coverslips) and thick (#3 coverslips) coverslips can be used. On the other hand, 
high magnification lenses are oil immersion objectives with short working distances and 
therefore one must use #1.5 coverslips. To be able to use the Dunn chamber with either air and 
oil microscope lens, I decided to use #1.5 coverslips. Because of its thinness, this coverslip 
model is highly sensible to change in temperature and can expand and contract easily. It is 
possible that during the period the Dunn chamber reaches the temperature of 37°C in the 
microscope environmental chamber, the coverslip expands resulting in a variation of height of 
the gap over the bridge altering correct gradient establishment. Unfortunately, due to technical 
issues with the microscope, I could not use the high magnification lenses and eventually did not 
record high-resolution migration of neutrophil or dHL-60 cells in the Dunn chamber. A third 
hypothesis is that because fMLP is a small molecule, it diffuses too fast from the outer well over 
the bridge to enable the formation of a stable gradient. It would have been interesting to use a 
chemoattractant of higher molecular weight such as IL-8 that would diffuse more slowly and 
maybe easily allow the formation of a gradient. Because of the very poor response of dHL-60 to 
IL-8, fMLP was chosen. These hypotheses combined with the difficulty to setup the chamber as 
described in the original paper may explain why I was not able to create a gradient of FITC and 
fMLP. 
To be able to establish a gradient in the Dunn chamber, I modified the protocol and filled the 
outer well with an agarose gel containing FITC. I was able to observe the formation of a steep 
gradient as early as 15 minutes after assembling the chamber. The gradient revealed itself to be 
stable over 10 hours indicating the robustness of this new protocol. The agarose gel decreases 
the diffusion coefficient of FITC in the outer well, restoring the role of reservoir of the outer 
well. By pouring agarose gel only in the outer well and not over the bridge, only the release of 
FITC from the outer well to the bridge should be slowed whereas the conditions for the 
diffusion of FITC over the bridge should be comparable between the initial and new Dunn 
chamber setups allowing the formation of the gradient of FITC similar to that described by 
Zicha et al.. The use of agarose showed two advantages: firstly by acting as a reservoir, it may 
reduce the sensitivity of the Dunn chamber to vibration during transport from the cell culture 
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room to the microscope. Secondly, during the time required for the chamber to reach 37°C prior 
to image acquisition, the FITC-containing agarose may be less sensible to possible coverslip 
expansion reducing or buffering the perturbations produced during gradient establishment. 
Using agarose with fMLP in the outer well, I was able to observe directional migration towards 
the chemoattractant of primary neutrophils and dHL-60 which I was unable to do using the 
original setup. The use of agarose in the Dunn chamber raised the question of possible 
contamination of the agarose with lipopolysaccharides (LPS) secreted by bacteria which can 
alter neutrophil migration. It has been shown that LPS induces cell polarisation and actin 
rearrangement in neutrophils leading to an increase of cell stiffness together with neutrophil 
retention in lung capillaries or polycarbonate filters due to the impaired deformability of 
neutrophils activated with LPS (Erzurum et al., 1992). Activation of neutrophils by LPS also 
directly inhibits chemotaxis in response to IL-8 (Bignold et al., 1991) but it is still not clear if 
LPS directly alters chemotaxis in response to fMLP since contradictory results have been 
described in different studies (Bignold et al., 1991; Kharazmi et al., 1991).  In order to limit the 
possible contamination of the agarose used in the Dunn chamber with LPS, I used an agarose 
that was certified for cell culture. Because LPS could alter the actin polymerisation and the 
migration of neutrophils or dHL-60 it would be important to test the possible contamination of 
the agarose used in the Dunn chamber with LPS using assays used by the industry to test LPS 
contamination such as the Limulus Amoebocyte Lysate (LAL) assay or the Factor C ELISA. 
Analysing the reliability of this assay showed that there was an important inter-assay variation 
(up to 20%). These analyses demonstrated that, in most of the cases, tracking 20 cells per 
sample is necessary to have a reliable average velocity value. The situation of the outliers which 
even after the tracking of 20 cells were still outside of the 95% confidence interval showed the 
necessity to repeat the experiments in order to confirm the results and rule out the possible 
effect of the patient condition on the day the blood sample is taken (fatigue, physical activity, 
seasonal disease) that could affect neutrophil response. The study of the response of neutrophils 
from numerous healthy donors would allow the determination of a standard response facilitating 
the analysis of results from patient cells. A deep study of the parameters that could influence the 
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success of the assay should be performed in order to enhance its reliability. In the meantime, the 
use of intracellular dyes such as CFSE (carboxyfluorescein succinimidyl ester) is a simple way 
to improve the assay reliability. Indeed, staining one of the populations (e.g. control) with CFSE 
and mixing it with the unstained population (e.g. patient) guarantees that, when monitored in the 
same chamber, both patient and control cells are subjected to the same conditions. In order to 
use this dye, we would first need to assess that it does not influence cell migration. This could 
be tested by labelling control cells with CFSE and mixing labelled and unlabelled control cells 
to monitor their respective migration in the same Dunn chamber. If the CFSE does not display 
any interference with cell migration, it would help to quickly identify chemotaxis failure, 
adhesion impairment or migration defect of one of the samples.  
The association of the agarose Dunn chamber with the semi-automatic tracking/processing 
routine I developed is a robust tool to study neutrophil migration. Using this new setup, I could 
study the consequences of the expression of CA-WASp on dHL-60 migration (Chapter 4) and 
the impact of MKL1 deficiency on primary neutrophils and dHL-60 cells (Chapter 5).  
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Chapter 4  The constitutively activate Wiskott-
Aldrich protein alters neutrophil migration and 
the spindle assembly checkpoint. 
4.1 Introduction 
The actin cytoskeleton is attached to the cell membrane and is a key element in the regulation of 
cell shape. The components of actin are dynamically regulated and undergo a rapid turnover 
allowing the quick reorganisation of the cytoskeleton in response to stimuli. Cortical actin has 
recently attracted increasing attention and its regulation in cellular processes such as 
cytokinesis, cell migration, and embryogenesis has been thoroughly investigated. These changes 
in cell shape are fundamental for the immune cells to perform numerous tasks from cell division 
to migration and phagocytosis making the actin cytoskeleton one of the main structures to 
achieve correct protection of the organism.  
One of the regulators of actin turnover is the Wiskott-Aldrich Syndrome protein and is 
expressed in the hematopoietic cell lineages driving actin rearrangement through spatial and 
temporal activation of the Arp2/3 complex, which triggers the nucleation of new branched actin 
filaments. Mutations in the CBD domain of WASp have been described and result in the loss of 
the auto-inhibited conformation of the protein producing a constitutively activated form of 
WASp (Ancliff et al., 2006; Devriendt et al., 2001). So far three mutations have been described 
in patients, L270P, S272P and I294T; they result in similar phenotypes and are considered as 
equivalent. The constitutively activated forms of WASp are responsible for an unregulated and 
mislocalised actin polymerisation which results in the alteration of actin structures involved in 
cell migration (Ancliff et al., 2006) and leads to an excess of F-actin throughout the cell 
(Moulding et al., 2007). In patients, these mutations are responsible for severe neutropenia and 
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monocytopenia causing recurrent bacterial infections. Patients with these mutations also present 
cellular division defects indicating chromosomal instability or myeloid malignancy (Ancliff et 
al., 2006; Beel et al., 2009; Moulding et al., 2007).  
In most of the patients, bone marrow examination showed an arrest of the neutrophil 
development at the promyelocyte/myelocyte stage (Ancliff et al., 2006; Devriendt et al., 2001)). 
This myelopoeisis arrest went along with a dramatic increase of apoptosis during in vitro 
neutrophil production from CD34+ cells isolated from patient bone marrow (Ancliff et al., 
2006). From these results it was hypothesised that a defect during cell division might be 
responsible for the neutrophil maturation arrest and increase of apoptosis. A study of the 
underlying mechanism of the impact of CA-WASp (I294T) by gene transfer on cell division and 
apoptosis, performed by Moulding et al., showed that during mitosis, the excess of F-actin 
surrounded the spindle and chromosomes all the time from their alignment to their separation 
and was accumulated at the cleavage furrow around the middle of the spindle. Live cell imaging 
experiments revealed a delay in mitosis from metaphase to anaphase and an increase of 
cytokinesis failure. It was shown that the cytokinesis failure was responsible for the rise of 
multinucleated cells and that the expression of WASp I294T was responsible for a decreased 
proliferation and an increase of apoptosis. Because WASp has no known role in cell division, it 
was hypothesised that the excess of F-actin throughout the cell altered the mechanical properties 
of the cell leading to the impairment of mitosis. When I started this project, preliminary data 
from Dale Moulding et al. (since published as (Moulding et al., 2012) showed that the 
expression of the constitutively active WASp induced a two fold increase of the cytoplasmic 
viscosity and elasticity resulting in a diminution of chromosomal movement by around 20%. 
This was less than what it was expected given the two fold increase in viscosity, thus suggesting 
an upregulation of the motive forces applied on chromosomes. From these preliminary results, it 
was hypothesised that since chromosome motility was perturbed at anaphase, then chromosome 
movements during the spindle assembly checkpoint should also be altered. The spindle 
assembly checkpoint ensures the correct segregation towards each pole of the two sister 
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chromatids of the chromosomes and delays mitosis until correct attachment of the chromosomes 
to the spindle.  
When entry to mitosis is imminent, the chromosomes are replicated and condensed to facilitate 
their movement through the cell. To be able to be pulled by the microtubules of the spindle, 
chromosomes build a structure called kinetochore that allows their attachment to microtubules. 
Kinetochores are divided in three regions: the inner kinetochore, which constitutes the interface 
between chromatin and other kinetochore regions; the outer kinetochore which contains the 
attachment sites to microtubules, also called kinetochore microtubules (kMT); and the central 
kinetochore between the inner and outer kinetochore regions (reviewed in (Cheeseman and 
Desai, 2008)). One particularly important protein of the inner kinetochore is CENP-A, a variant 
of the histone H3, which is the first protein assembled in the kinetochore and is essential to the 
incorporation of other CENP proteins involved in the kinetochore assembly. Once the 
kinetochore structure is complete, it acts as an interface where kMTs can be attached in order to 
pull each sister chromatid towards the opposite poles of the dividing cell. In order to ensure 
correct distribution of genomic material to each pole, the correct attachment, known as 
amphitelic attachment, of paired sister kinetochores to opposite poles is checked by successive 
cycles of pulling forces from the opposites poles (reviewed in Watanabe, 2012). The amphitelic 
attachment generates tensions that are generated by the pulling forces by the kMTs, from the 
opposite poles, attached to each sister kinetochore and this tension has an important role in 
stabilising the attachment. As a matter of fact, the mono-polar attachment due to this lack of 
tension is very unstable and allows a new cycle of capture of the kinetochores by the kMT until 
the correct attachment is achieved. This cycle of trial and error is mainly regulated by the 
protein kinase Aurora B which is located between the two sister kinetochores. The tension 
generated in the case of amphitelic attachment stretches the kinetochore increasing the distance 
between the kinetochore and Aurora B, whereas in the case of mono-polar attachment Aurora B 
is located close to the kinetochores. The Aurora B-kinetochore proximity allows Aurora B to 
destabilise the microtubule attachment sites by phosphorylating proteins of the kinetochores 
whereas the remoteness due to amphitelic attachment prevents kinetochore phosphorylation thus 
stabilising the microtubule attachment (Watanabe, 2012). Overall, incorrect kinetochore 
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attachment to kMTs blocks, through the spindle assembly checkpoint, the progression of the cell 
cycle. Once all the chromosomes are correctly attached to the spindle, the checkpoint allows 
chromosome segregation and cell division progress. Considering the importance of the tension 
generated during the spindle assembly checkpoint, alteration of cytoplasmic mechanical 
properties may perturb the checking of the correct attachment of the chromosomes to the kMTs 
and delay or prevent mitosis completion. 
We hypothesised that the lack of circulating neutrophils and monocytes in the blood may be the 
result of combinatory defects in migration and mitosis caused by the modification of the cellular 
mechanical properties due to the dramatic alteration of the actin cytoskeleton regulation.  
The group had been investigating the role of CA-WASp using the mutation in the CBD domain 
replacing the isoleucine by a threonine at the position 294 (I294T) as a model for CA-WASp 
and had generated published and preliminary data. Here, I used the same mutation to study how 
the constitutively activated WASp (CA-WASp) altered neutrophil migration and cellular 
division during the spindle assembly checkpoint.  
4.2 Results 
4.2.1 The loss of the auto-inhibited conformation of WASp alters neutrophil migration 
To express CA-WASp in the cells of interest, I used two different backbones: one under the 
CMV promoter and the other one under the SFFV promoter. As the CMV promoter is strongly 
silenced in hematopoietic cell lineages, the SFFV promoter allows a more stable expression of 
the transgene. I removed the eGFP tag from the backbones and replaced it with mCherry 
(Figure 4-1-B).  
To validate that the new vectors I made were resulting in the correct phenotype, I transduced the 
HT-1080 fibrosarcoma cell line with CMV-mCherry–WASp and CMV-mCherry-CA-WASp 
lentiviruses. As expected, mCherry-CA-WASp expression resulted in an excess of F-actin 
mislocalised through the cytoplasm (Figure 4-1-C, iii and iv) whereas WT-WASp expression 
(Figure 4-1-C, ii and v) resulted in a similar phenotype as control cells (Figure 4-1-C, i and iv). I 
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then determined by Western blot the expression pattern of CA-WASp in HL-60 cells transduced 
with sffv-mCherry-CA-WASp lentiviruses (Figure 4-1-D). In the transduced cells, we could 
clearly observe the endogenous WASp as well as the mCherry-WASp which had a higher 
molecular weight due to the mCherry tag. Expression levels of CA-WASp were in the same 
order of magnitude as the endogenous WASp, which was consistent with results obtained from 
previous studies in the group using CA-WASp lentiviruses on hematopoietic cell lines 
(Moulding et al., 2007). Such levels of expression had been shown to be sufficient to induce 
unregulated and mislocalised actin polymerisation (Moulding et al., 2007). 
To evaluate the possible impact of CA-WASp on neutrophil migration, I transduced HL-60 cells 
with SFFV-mCherry- CA-WASp lentiviruses and the day after, I added 1.3% DMSO into the 
cell medium to induce the differentiation into neutrophil-like cells (dHL-60 CA-WASp). 
Untransduced cells were used as control (dHL-60). As shown in Chapter 2, the protocol used to 
monitor the migration in the agarose Dunn chamber displayed a high inter-assay variability. 
Therefore, to make sure that both control and transduced cells were subjected to the same 
experimental conditions, Dunn chamber experiments were performed by mixing both 
populations together in a 1:1 ratio and by monitoring control and transduced cells in the same 
Dunn chamber. Both control and CA-WASp dHL-60 were able to migrate towards the source of 
fMLP in the agarose Dunn chamber (Figure 4-2-A, VideoS4-1). The dHL-60 expressing the 
mutant WASp exhibited reduced average velocity with an average value of 11.3 µm.min
-1
 (+/- 
0.48 µm.min
-1
), which is significantly different (p < 0.001) than the control cell average velocity 
of 14.2 µm.min
-1
 (+/- 0.40 µm.min
-1
) (Figure 4-2-B). Cell velocity alteration by CA-WASp was 
not accompanied by a modification of the cell directionality since no significant difference was 
detected between the chemotactic index of control and CA-WASp cells (Figure 4-2-C). The 
chemotaxis of both populations was confirmed by analysis of the average angle between the 
gradient of fMLP and the cell path during the migration (Figure 4-2-D and E). The distribution 
of the average angle of cells expressing the mutant WASp was more compact (-5.7 +/- 12.1 
degrees) than the distribution in control cells (-2.5 +/- 19.8 degrees), indicating less variation 
between the gradient of fMLP and the cell path during migration. The significant difference in  
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Figure 4-1: Mutations in the CBD domain resulted in a constitutively active WASp 
A) Mutations in the CBD domain of WASp have been described (bottom), resulting in a loss of the auto-
inhibited conformation of WASp (top) and opening the protein in its active form (middle). B) 
Replacement of the eGFP insert in the WASp and CA-WASp (I294T) vectors by the mCherry fluorescent 
protein. These vectors are under CMV and SFFV promoters. C) Expression of CA-WASp in the HT1080 
fibrosarcoma cell line using the CMV-mCherry-WT-WASp and CMV-mCherry-CA-WASp vectors. Two 
days after transduction, the HT1080s were plated onto coverslips and left to adhere overnight at 37
o
C 
with 5% CO2 before being fixed. The cells were then permeabilised and stained with phalloidin 
conjugated with Alexa647.  Expression of CA-WASp resulted in an excessive and mislocalised F-actin 
content compared to control and WT WASp expressing cells. The cells were imaged using a Zeiss 
LSM710 confocal microscope using a 40x/1.0 water objective. D) Expression of WASp and CA-WASp 
in HL-60 cells wild-type (untransduced) or transduced with lentivirus carrying WASp-I294T. HL-60 cells 
were transduced with SFFV-mCherry-CA-WASp before being lysed using RIPA buffer three days after 
transduction. 20µL of samples were loaded in each lane. C and D: The experiments were used for 
optimisation of experimental conditions therefore three independent experiments were not performed. 
Results representative of two independent experiments. One replicate per experiment.  
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the variance of the two populations, 6.88 and 2.54 for control and CA-WASp cells, respectively, 
was confirmed by a positive F-test result indicating less variation in the distribution angle 
between the gradient of fMLP and the migrating cell path. This could be interpreted as the cells 
expressing the mutant WASp were more directional than the control cells but this interpretation 
is in contradiction with the result of the chemotactic index. 
To determine if the defect in migration of the dHL-60 expressing the mutant WASp observed in 
2D, as in the Dunn chamber, would be similarly seen in 3D, I studied the migration of control 
and CA-WASp dHL-60 in Transwell inserts (Figure 4-3-A). The membrane of the insert is 
about 10 µm thick and the pores 3 µm in diameter forcing cells to change shape and migrate in 
confined space. Cells were seeded into the upper well whereas the lower well contained a 
solution of fMLP. Cells were left to migrate for 1 or 2 hours at 37
o
C and 5% CO2 in an 
incubator. After 1 or 2 hours, cells in the lower well were counted: up to 25% of the cell input 
had migrated through the insert membrane and fell into the lower well. No significant difference 
was found between the two populations at the 1 hour and 2 hour time points (Figure 4-3-B). 
This result was surprising since it was hypothesised that excess of F-actin due to CA-WASp 
would alter the dynamics of the change in cell shape that is required for the cells to migrate 
through the insert. I verified by confocal fluorescence imaging if any alteration of cell shape 
was observable during migration through the membrane pores (Figure 4-3- C and D). I could 
clearly observe an increase of F-actin signal into cells expressing WASp mutant (Figure 4-3-D) 
but no abnormal cell shape in comparison to control cells (Figure 4-3-C). In both populations, I 
could observe cells on both sides of the membrane validating their correct migration. 
Then, I investigated the hypothesis that the migratory defect observed in the agarose Dunn 
chamber may be due to an alteration of actin dynamics. Control and CA-WASp cells were 
mixed in a single tube before being stimulated with fMLP for different time points. Actin 
polymerisation was stopped by addition of a concentrated solution of PFA fixing cells 
instantaneously. Cells were then stained for F-actin using phalloidin-Alexa647 and analysed by 
flow cytometry. The experiments were performed at two different temperatures, 22
o
C and 37
o
C, 
because actin polymerisation is a temperature sensitive process. While performing the  
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Figure 4-2: Expression of CA-WASp in dHL-60 cells altered migration towards fMLP 
A) Snapshot of time-lapse video of control and CA-WASp expressing dHL-60 migrating in the agarose Dunn 
chamber towards the outer well which contained 100 nM of fMLP. To ensure that both populations were subjected to 
the same experimental conditions, control and CA-WASp cells were mixed before being plated on the coverslip. 
Control (top row) and CA-WASp (bottom row). The cells were imaged at 37oC at 1 image/minute for 1 hour using an 
Axiovert 135 microscope, equipped with an Achroplan 10x/0.25 objective, an environmental chamber and a 
motorised stage. Scale bar = 20 μm. Cells were tracked using the ImageJ manual tracking plug-in and tracks were 
processed in Matlab using an in-house routine. B) Average velocity of control and CA-WASp cells. C) Cells 
expressing the mutant WASp did not display any significant change in the chemotactic index. D and E) Frequency 
distribution of the average angle between the chemoattractant gradient and the cell path during migration of D) 
control cells or E) cells expressing CA-WASP. A: Data representative of three independent experiments. B-E: Data 
pooled from three independent experiments. One replicate per experiment. Data analysed by t-test. In B: **: p <0.01.  
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experiment at 37
o
C is more representative of physiological conditions, using a lower 
temperature (22
o
C) was expected to decrease the actin polymerisation kinetics and, as a 
consequence, to facilitate the visualisation of possible defects in actin dynamics in CA-WASp 
cells. In all experiments, cells expressing CA-WASp had a stronger signal than the control cells 
at baseline level and during the stimulation with fMLP. This suggested a higher content of F- 
actin in the cells expressing the mutant WASp although no significant difference was found 
when compared to the control cells (Figure 4-4-A and B). Interestingly, the difference between 
the mutant and control cells was not altered significantly during the stimulation with fMLP, 
suggesting that the actin polymerisation dynamics was similar between the two populations. 
These results indicated there was no major defect of the actin polymerisation machinery in the 
cells expressing the mutant WASP. To confirm this, I studied the possible effect of CA-WASp 
on the Arp2/3 complex, which is activated by WASp to nucleate new branched actin filaments, 
by examining the expression and localisation in dHL-60 cells of Arp2/3 complex subunit p34. 
Two populations were determined using the mCherry signal: cells with a mCherry signal equal 
to 1 to 1.5 time the background signal were considered to have a low expression of mCherry-
CA-WASp while the cells with a mCherry signal higher than three time the background were 
considered to have a high expression of CA-WASp. The impact of CA-WASp on the cells was 
then evaluated in these two populations. Confocal images revealed a trend in cells highly 
expressing CA-WASp showing a small increase of their p34 signal suggesting a possible 
upregulation of this protein (Figure 4-4-C and E). This was associated with a higher content in 
F-actin in CA-WASp cells (Figure 4-4-F). The trend showing an increased expression of p34 in 
the cells expressing the mutant WASp was not confirmed by Western blot since no difference in 
the p34 content was observed in CA-WASp cells in comparison with controls (Figure 4-4-D). I 
finally analysed if the mutant WASp had any impact on the cell area indicating difficulties or 
ease for the cells to spread. I could not observe from the confocal images any difference in the 
area of the two populations suggesting that CA-WASp had no impact on it (Figure 4-4-G). 
Taken together, these results indicated that CA-WASp did not affect actin polymerisation 
dynamics nor the expression and localisation of Arp2/3 complex. 
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Figure 4-3: CA-WASp did not alter cell migration through 3D environment 
A) Schematic representation of the Transwell insert system used to assess the migration of dHL-60 cells. 
B) Cells expressing CA-WASp did not show significant alteration of their migration in response to 100 
nM of fMLP after migrating for 1 hour or 2 hours through the Transwell insert. After the cells were left to 
migrate for 1 or 2 hours, EDTA was added to each well and the plate placed at 4
o
C for 15 minutes in 
order to enhance the detachment of the cells that migrated through the membrane but were still attached 
to it. Then the medium in the well was resuspended before 20 µL was taken out and mixed in a 1:1 ratio 
with trypan blue and the cells were counted using a haemocytometer. C and D) 3D and orthogonal views 
of C) control and D) CA-WASp dHL-60 migrating through the pores of a Transwell membrane, 1 hour 
after the cells were seeded in the insert. The lower chamber contained 100nM of fMLP. The cells were 
imaged using a Zeiss LSM710 confocal microscope using an oil immersion 63x/1.4 N.A. objective. 
Green: F-actin, Red: mCherry-CA-WASp, Blue: Dapi and Grey: fibronectin. Close arrow head: cell of 
interest; open arrow head: cell that already migrated through the membrane. B: Exploratory experiments 
that were not investigated further, therefore three independent experiments were not performed. Data 
from two independent experiments. Three replicates per experiments. C and D: Data representative of two 
independent experiments. 
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It has been shown that the expression of CA-WASp induces, through the excess of mislocalised 
F-actin, an increase of the cytoplasm viscosity (Moulding, 2013). This change of the cell 
physical properties could alter the forces generated by myosin IIa to ensure the contractility 
needed to ensure cell migration. Therefore, I studied if myosin activity was altered by CA- 
WASp expression. Uniformly stimulated dHL-60 expressing or not the mutant WASp were 
fixed and stained for F-actin and phospho-MLC, which is the active form of the regulatory light 
chain of myosin (Figure 4-5-A). As previously described, two populations were determined 
using the mCherry-CA-WASp signal: low mCherry (signal equal to 1 to 1.5 time the 
background) and high mCherry (signal  higher than three time the background). The impact of 
CA-WASp on the cells was then evaluated in these two populations. Preliminary results 
suggested that cells expressing CA-WASp may display a modification of pMLC signal with a 
possible increase of the number of cells that exhibited pMLC localised only at either the 
lamellipodium or the uropod (Figure 4-5-B), while the number of cells showing a pMLC signal 
at both lamellipodium and uropod appeared to decrease. These preliminary observations of the 
cells expressing the mutant WASp further suggested a small increase of the total signal of 
pMLC per cell (Figure 4-5-C) correlated with an increase of F-actin (Figure 4-5-D). The trend 
showing the possible increase of pMLC signal was similarly observed by Western blot in two 
independent experiments (Figure 4-5-E and F). Additional independent experiments would be 
required to confirm these data. Next, I investigated the possibility to rescue CA-WASp 
phenotype. As CA-WASp activates Arp2/3 complex to trigger the nucleation of new branched 
actin filament, I used Arp2/3 inhibitor CK-666 to try and clear the excess of F-actin due to the 
mutant WASp. I first decided to determine the concentration of CK-666 needed to clear the 
excess of filamentous actin in the cytoplasm without altering the cortical actin cytoskeleton. To 
do so, I measured F-actin content in CA-WASp dHL-60 cells, stimulated or not with fMLP and 
treated with increasing CK-666 concentrations, and compared it with the values obtained for 
untreated wild-type dHL-60 cells (Figure 4-6-A and B). Using CKK-666 concentrations up to 
100 µM was determined as suitable, as it has previously been reported that even at such high 
concentration, CK-666 did not alter the morphology of Arp2/3 depleted fibroblasts (Wu et al., 
2012). This suggested that, despite the low potency of the compound, CK-666 does not seem to  
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Figure 4-4: CA-WASp did not alter actin polymerisation kinetics and p34 expression 
A and B) Actin polymerisation kinetics of control and CA-WASp cells measured at A) 22°C and B) 
37°C. Both populations were mixed into the same tube before being stimulated for the indicated time with 
100nM of fMLP, fixed using a solution of 4% paraformaldehyde, permeabilised using a 0.2% Triton-X 
solution and stained with phalloidin-Alexa647. F-actin content was then measured by flow cytometry. C) 
Confocal images of dHL60 control (top row) or highly expressing mCherry-CA-WASp (bottom row). 
The cells were stimulated with 100nM of fMLP before being fixed, permeabilised and stained. The cells 
were stained for F-actin (middle column) and the Arp2/3 subunit p34 (right column). The cells were 
imaged using a Zeiss LSM710 confocal microscope using an oil immersion 63x/1.4 objective. Scale bar = 
10μm. Signals of interest were measured from z-stack projection using CellProfiler. The F-actin signal 
was used to detect the cell edges and to define ROI in which the p34 and F-actin signals were measured. 
The ROIs were also used to measure the area of the cells. D) Expression of p34 in control and CA-WASp 
cells was evaluated by Western blot. E) p34 intracellular signal, F) F-actin content and, G) cell area were 
measured from the image showed in C) using Cell profiler software (>= 30 cells measured). A-G: 
Exploratory experiments that were not investigated further, therefore three independent experiments were 
not performed. Results from two independent experiments, one replicate per experiment. 
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have off-target effects at concentrations up to 100 µM. Therefore, it was decided to test CK-666 
at 10, 20, 40 and 80 µM. In unstimulated conditions, the CA-WASp cells displayed a two fold 
increase of their F-actin content in comparison to control cells. Treatment with 10 µM of CK-
666 for 5 min resulted in a strong decrease of total filamentous actin in cells expressing the 
mutant WASp. The use of higher concentrations of CK-666 (20, 40 and 80 µM) showed a 
content of F- actin in CA-WASp cells similar as the one in wild-type cells (Figure 4-6-A). 
When cells were treated with CK-666 and stimulated with fMLP, only the 10 µM concentration 
of Arp2/3 inhibitor showed a reduction of the total F-actin but with still a signal still above the 
wild-type cell baseline. Higher CK-666 concentrations produced a signal below wild-type cell 
baseline suggesting a complete inhibition of actin polymerisation in response to fMLP 
stimulation (Figure 4-6-B). From the results of the two experiments described above, I decided 
to use a concentration of 10 µM of CK-666 since it was the only concentration allowing to clear 
some of the F-actin due to CA- WASp without preventing actin polymerisation in response to 
fMLP stimulation. When I tested the effects of CK-666 on cell migration, I could observe that 
CA-WASp cells treated with the inhibitor had an average velocity of 10.74 µm.min
-1
 (+/- 0.65 
µm.min
-1
) that was lower than untreated CA-WASp (12.46 +/- 0.89 µm.min
-1
) or control (14.35 
+/- 0.99 µm.min
-1
) cells (Figure 4-6-C). The fact that addition of CK-666 seemed to decrease 
the migration speed of dHL-60 cells expressing CA-WASp revealed that this Arp2/3 inhibitor 
might not be suitable to rescue the phenotype resulting from the mutant WASp. 
4.2.2 CA-WASp impairs cell division through mechanical alteration of the spindle 
assembly checkpoint 
In order to monitor kinetochore oscillations during the spindle assembly checkpoint, I stably 
expressed the CENP-A protein tagged with GFP in the HT1080 fibroblast cell line. Cells that 
have been selected to express eGFP-CENP-A, following Neomycin selection treatment for 14 
days, were single sorted by Fluorescence-Activated Cell Sorting (FACS) and cultured under 
Neomycin pressure for 14 additional days. The eGFP-CENPA expression is restricted to the 
nuclei during interphase with a weak diffuse background and bright dots (Figure 4-7-A). From 
nuclear envelope breakdown until the end of mitosis, the eGFP-CENPA protein would be  
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Figure 4-5: Expression of the mutant WASP altered the activity of myosin IIa 
A) Confocal images of dHL-60 displaying low or high expression of CA-WASp (top and bottom row, 
respectively). The cells were stimulated with 100nM of fMLP before being fixed, permeabilised and 
stained. Cells were stained for F-actin and phospho-MLC, the active form of the myosin. Cells were 
imaged using a Zeiss LSM710 confocal microscope using an oil 63x/1.4 objective. Scale = 10 μm. B) 
Localisation of the pMLC signal in control cells and cells expressing the mutant WASp. Signals of 
interest were measured from z-stack projection using CellProfiler: using the F-actin signal, the cell edges 
were detected and used to define ROI in which the pMLC and F-actin signals were measured. C) Total 
intracellular pMLC signal measurement in cells showing a low and high expression of the mutant WASp. 
D) F-actin content in cells showing a low and high expression of CA-WASp. E) Activity of MLC was 
assessed by Western blot in control and CA-WASp cells. Band intensity of the Western blot shown in D) 
was evaluated using ImageJ F). A-F: Exploratory experiments that were not investigated further, therefore 
three independent experiments were not performed. A-D: data from a single experiment. E) and F) are 
representative of two independent experiments. One replicate per experiment. 
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localised to the kinetochores allowing me to track their movement during the spindle assembly 
checkpoint. The five brightest clones were visually selected (Figure 4-7-B) in order to be able to 
setup live imaging conditions in which the lowest laser possible would be used to avoid 
damaging the cells. I measured the five clones’ respective signal/noise ratio in order to select the 
best clone for our experiments by measuring the lowest, corresponding to the background, and 
brightest, which would be similar to the signal observed when the kinetochores would be 
assembled, fluorescence signal in a defined region of interest through each slide of the stack 
(Figure 4-7-C). Of the five clones, three had a signal/noise ratio under 500 and were eliminated. 
Clones 2 and 3 had a signal/noise ratio of 946 and 810, respectively (Figure 4-7-D). Only clone 
2 allowed me to reach the imaging conditions required: an exposure time of 30 ms, low laser 
power and no delay in mitosis. As a result, clone 2 was used for all following experiments. I 
monitored kinetochore oscillations in metaphase cells over 5 minutes with one time point every 
7.5 seconds imaging a stack of 21 slices through a height of 10 µm to acquire most of the 
nucleus volume (Jaqaman et al., 2010).  
During the spindle assembly checkpoint, I could observe the pairs of kinetochore oscillating 
(Figure 4-8-A, VideoS4-2 and4-3) confirming the correct localisation of the eGFP-CENP-A 
constructs during mitosis. A kymograph of a selected kinetochore pair was then prepared and 
used to measure the amplitude and period of the kinetochore’s oscillations (Figure 4-8-B). In 
control cells, the average period was 96.5 seconds (+/-21.9 sec) (Figure 4-8-C). When wild-type 
WASp tagged with mCherry or the control vector is expressed carrying mCherry alone, the 
average period is 98.25 sec (+/- 21.9 sec) and 102.3 sec (+/- 16.3 sec), respectively, with no 
significant difference from the control. When CA-WASp was expressed, the mean period 
increased to 118.25 seconds (+/- 18.1 sec) and was significantly different form the control 
conditions (p<0.001). To rescue CA-WASp phenotype, I used the Arp2/3 inhibitor, CK666 at a 
concentration of 40 µM to clear unregulated polymerisation of actin in the cytoplasm due to 
CA-WASp. The use of this inhibitor significantly decreased the viscosity of cells expressing 
CA-WASp, reaching a value close to the one of control cells (Moulding, 2013). When cells 
expressing CA-WASp were treated with the Arp2/3 inhibitor CK666, the period decreased to  
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Figure 4-6: Inhibition of Arp2/3 did not rescue of the phenotype caused by CA-WASp 
A and B) Assessment of the CK-666 concentration needed to clear the excess of F-actin due to CA-
WASp in order to have a similar F-actin content as control cells in unstimulated and fMLP stimulated 
conditions, respectively. In both unstimulated and stimulated conditions, the cells were processed as 
follows: in all conditions, control cells were left untreated while the CA-WASp cells were independently 
treated with CK-666 or DMSO alone (DMSO at a final concentration of 0.2%. This is equivalent to the 
concentration of DMSO when CK-666 was used at 80µM). Then, control and CA-WASp cells were fixed 
separately before being mixed together at a 1:1 ratio resulting in a mixed population containing untreated 
control cells and CA-WASp cells, treated or not. In the stimulated condition B), both control and CA-
WASp cells were stimulated with 100 nM of fMLP. The cells were then processed to be stained with 
phalloidin-Alexa647 in order to measure their F-actin content by flow cytometry. Results from each 
condition was normalised to the F-actin content of the control cells of that condition. C) Average velocity 
of control cells, CA-WASp cells and CA-WASp cells treated with CK-666 in the agarose Dunn chamber. 
A-B: Exploratory experiments that were not investigated further, therefore three independent experiments 
were not performed. Results from a single experiment, three replicates per condition. C: Results from a 
single experiment, one replicate per condition. 
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103.7 seconds (+/- 19.6 sec) with no significant differences from the control conditions but 
significantly different from the cell expressing CA-WASp (p<0.05).  
The amplitude of oscillations was 3.12 µm (+/- 0.65 µm), 2.86 µm (+/- 0.45 µm) and 3.42 µm 
(+/- 0.59 µm) in control cells, cells expressing WT-WASp and cells expressing CA-WASp, 
respectively (Figure 4-8-D). No significant difference was found between the various 
conditions. To calculate the oscillation speed, the speed was defined as the following: 
𝑆 =  𝐴 𝑃⁄  
 
Where S is the speed (in µm.s
-1
), A is the amplitude (in µm) and P is the period (in seconds) of 
the oscillations. The speed of control cells was 34.3 nm.s
-1
 (+/- 8.2 nm.s
-1
) whereas in WT-
WASp or CA-WASp cells, the oscillation speed was 29 nm.s
-1
 (+/- 5.2 nm.s
-1
) and 27 nm.s
-1
  
(+/- 4.3 nm.s
-1
) respectively. The speed difference between CA-WASp expressing cells and 
control cells was significant (Figure 4-8-E). 
4.3 Discussion 
4.3.1 The loss of the auto-inhibited conformation of WASp alters neutrophil migration 
To investigate the consequences of constitutively activated WASp expression on neutrophil 
migration, I used HL-60 cell line differentiated into neutrophil-like cells and expressed in these 
cells the mutant protein by transduction with lentiviruses.  
Expression of CA-WASp in HL-60 cells using lentiviruses resulted in expression levels of the 
mutant WASp in the same order of magnitude than the endogenous WASp. This result was 
expected as a previous study in the lab (Moulding et al., 2007) showed the difficulty to express 
CA-WASp at high levels. This might be due to the open conformation of CA-WASp that might 
enhance its degradation. Nevertheless, such expression pattern of CA-WASp as the one 
observed in HL-60 were previously shown to be sufficient to induce an excess of F-actin in the 
cytoplasm causing mitotic defects in other hematopoietic cells (Moulding et al., 2007). This 
suggested that such expression levels of CA-WASp in HL-60 cells would lead to unregulated  
132 
 
 
Figure 4-7: Expression of eGFP-CENP-A construct in HT-1080  
A) Expression of eGFP-CENP-A in the HT-1080 fibroblast cell line observed using an epifluorescence 
microscope equipped with a 20x/0.2 air objective. Phase contrast image is shown on the left panel, while 
on the right the cells expressing the eGFP construct can be seen in the FITC channel. We can observe that 
eGFP-CENP-A expression is restricted to the cell nucleus. B) Z-projection of confocal images of the 5 
brightest clones shows different levels of eGFP-CENP-A expression. The cells were left to adhere for 24 
hours on coverslips before being fixed and mounted using prolong gold mounting medium. Then the cells 
were imaged using a LSM710 confocal microscope equipped with a 40x/1.0 water objective. C) 
Representative measurement of the signal/noise ratio. Using ImageJ/Fiji, a ROI was drawn in the nucleus 
of each cell (white circle). Within the ROI, the lowest (noise) and highest (eGFP-CENP-A structures) 
fluorescent signals were measured in each slice of the z-stack to calculate the signal/noise ratio. Here a 
cell from the clone A2 was used as example. For clarity, only the slices 4, 8, 12, 16 and 20 are shown 
here. D) Signal/noise ratio calculated using the method showed in C).  A-D: The experiments were used 
for optimisation of experimental conditions therefore three independent experiments were not performed. 
Data from two independent experiments. One replicate per experiment.  
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and mislocalised actin polymerisation and might affect cell mechanical properties. Our 
subsequent results (Figure 4-4-A) confirmed an increase of actin content in CA-WASp cells of 
about 40-50% when compared to untransduced control cells, suggesting a similar phenotype as 
the one of U937 cells transduced with CA-WASp lentiviruses (Moulding et al., 2007).  
The use of lentiviruses to transiently express the mutant WASp in cell lines was chosen over the 
constitutive expression of CA-WASp as it was known in the group that the latter resulted in cell 
death after 5-7 days of expression due to mitosis defects. Considering that HL-60 cells required 
a 5 day-treatment with DMSO in order for them to differentiate into dHL-60, we could argue 
that the expression of CA-WASp in these cells would result in a high number of dead cells due 
to apoptosis, and as such may introduce a bias in the results obtained. However, during HL-60 
differentiation into neutrophil-like cells, the HL-60 stop dividing after 1-2 days in the presence 
of DMSO in the culture medium (Sun and Wang, 1995). In the current study, the cells were 
transduced only 24 hours before treatment with DMSO to differentiate them, and would as a 
consequence stop dividing quickly after the transduction, probably limiting the effect of the 
expression of CA-WASp on cell division and death. Nevertheless, it would be interesting to 
confirm this by studying apoptosis and necrosis of HL-60 expressing the mutant WASp during 
differentiation. The dHL-60 cells expressing CA-WASp showed an alteration of their ability to 
migrate characterised by a decrease of their velocity. Their directionality during migration was 
not altered and their chemotactic capacity was similar to that of control cells. The average angle 
distribution suggested that cells expressing the mutant protein were less likely to change 
direction from the fMLP gradient; but this tendency was not reflected in the chemotactic index, 
which was nearly identical between CA-WASp and control cells. Surprisingly, the migratory 
defect was not observed in confined environment through the pores of a Transwell insert when 
the cells were left to migrate for 2 hours (Figure 4-3). On the contrary, when the cells were 
allowed to migrate for only one hour the CA-WASp cells seemed to display a better, although 
not significant, migratory response compared to control. This was unexpected as this does not 
correlate with the Dunn chamber results and would then need to be confirmed. The possible 
small difference between control and CA-WASp cells could be investigated further by repeating  
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Figure 4-8: F-actin excess due to CA-WASp altered kinetochore dynamics 
A) Time lapse of kinetochore pair oscillations during the spindle checkpoint image using a100×/1.4 NA 
oil objective lens on a Olympus IX81 microscope fitted with Andor Spinning Disk confocal system and   
a 37°C environmental chamber. A z-stack composed of 20 z sections (0.5 μm apart) was taken every 7.5 s 
for 5 minutes. One pair of kinetochore was highlighted (dashed circle). Z-projection of 5 successive slices 
of the whole stack was visualised here. Scale bar = 8 μm. B) Kymograph of a kinetochore pair oscillating 
over time and graphical representation of the oscillation. C) Period of the kinetochore oscillation in 
control cells (control and mCherry) and in cells expressing wild-type WASp, CA-WASp, and CA-WAp 
in presence of the Arp2/3 inhibitor CK-666. The mCherry, mCherry-WASp wild type and mCherry-CA-
WASp transgenes were expressed in the cells using lentiviruses carrying the transgene under CMV 
promoter. D and E) Amplitude and speed of the kinetochore oscillation in control, WT WASp and CA-
WASp cells. A: Images representative of three independent experiments. C-E: Data from three 
independent experiments. Data analysed by ANOVA; C and E: *: p <0.05. C: **: p <0.01, ***: p <0.001. 
  
135 
 
the experiment at a shorter time point, such as 30 minutes, as the CA-WASp cells might have an 
advantage at short time point but not at longer time points such as 2 hours. Nevertheless, it 
remains challenging to directly compare results from the Transwell system and the Dunn 
chamber. The cells do not migrate in the same environment, 2D in the Dunn chamber and the 
confined environment of the pore of the membrane of the Transwell insert, suggesting that 
different mechanisms could be involved. The defect observed in CA-WASp cells in the Dunn 
chamber could be explained by two different hypotheses: a) the constitutively activated WASp 
mutant altered actin polymerisation by sequestering components of the actin polymerisation 
machinery such as Arp2/3 complex or b) the excess of F-actin would change cell properties, 
impairing the physical abilities of cells to migrate. I investigated both hypotheses and tried to 
rescue the phenotype using the Arp2/3 inhibitor CK-666.  
Firstly, the misclocalisation of the filamentous actin excess through the cytoplasm was 
hypothesised to alter the spatio-temporal regulation of the actin polymerisation in CA-WASp 
cells by hijacking the molecular components that are responsible for actin filament nucleation, 
such as Arp2/3. However, I could show that actin polymerisation did not seem to be defective in 
the cells expressing CA-WASp (Figure 4-4). Nevertheless, despite similar kinetics between 
control and CA-WASp cells during the stimulation with fMLP, the initial response of the two 
populations to the chemoattractant might be different. The slope of the initial response of 
control cells to fMLP seemed slightly steeper than the slope of the CA-WASp cells. This 
suggested that the mutant cells might have a lower initial polymerisation rate before reaching a 
plateau at 30 seconds of stimulation. It would be very interesting to confirm this result and 
investigate the possible mechanism. The absence of strong defect in actin polymerisation was 
supported by results showing that Arp 2/3 complex expression was not modified and was still 
strongly located in the lamellipodium. This could be the result of a too low expression of the 
mutant WASp to completely hijack the Arp2/3 machinery. Indeed, it has been shown that 
Arp2/3 concentration in neutrophils was about 10 µM, a concentration far above the limiting 
Arp2/3 concentration to nucleate actin filament (Higgs et al., 1999). Higgs et al. also showed 
that in vitro, in presence of a low concentration of G-actin (4 µM) and of Arp2/3 (50 nM), actin 
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nucleation reached a plateau in presence of 1 µM of WASp VCA domain. This suggested that, 
to prevent spatio-temporal regulation of Arp2/3 resulting in the alteration of actin structure in 
the cells, CA-WASp should have been expressed at very high level which was not possible in 
these cells.  
The fact that the mutant WASp did not alter Arp2/3 localisation in the lamellipodium could 
explain why I could not observe any strong modification of the cell directionality. Indeed, it has 
been shown that Arp2/3 was required for lamellipodium establishment and for directional 
migration of fibroblasts (Suraneni et al., 2012). The high concentration of Arp2/3 in neutrophils 
preventing its depletion in the lamellipodium due to the actin polymerisation in the cytoplasm 
may have avoided directionality alteration of CA-WASp dHL-60 cells in the agarose Dunn 
chamber. I observed that the variation of the average angle distribution of cells expressing the 
mutant WASp was reduced indicating a more directional migration than that of control cells; 
but I could not identify the same effect from the chemotactic index calculation. These two 
results showed that both measures had their limits: the chemotactic index may not be sensitive 
enough to detect small changes, whereas the F-test used to determine the significance of the 
variance difference between the two conditions is highly sensible to bias introduced by the 
possible non-normal distribution of the results (Fisher et al., 1995). This shows that 
interpretation of directionality measurement need to be carefully performed. 
The second hypothesis was that excess of F-actin due to CA-WASp would alter cell properties 
and lead to migratory defects. It has been shown that F-actin excess in the cytoplasm modified 
cell physical properties by increasing cytoplasm viscosity by two fold when compared to control 
cells (Moulding et al., 2012). Because contractility of the acto-myosin cortex is required for cell 
migration, it was hypothesised that the change in physical properties would influence myosin II 
activity. It has been shown that myosin II activity is necessary to break cell symmetry (Yam et 
al., 2007) to allow the formation of protrusions, is involved in actin retrograde flow regulation 
in the lamellipodium (Cai et al., 2006; Yang et al., 2012) and drives the retraction of the rear of 
the cells (Eddy et al., 2000, p. 200). We could think that the increase of cytoplasm viscosity 
may prevent the correct retraction of the rear and may necessitate an increase of myosin activity 
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in the uropod to generate enough forces to allow the correct retraction of the cell rear. 
Preliminary results are in line with this hypothesis: a possible increase of MLC activity in CA-
WASp cells was observed by immunofluorescence and Western blot (Figure 4-5). This increase 
in pMLC signal seemed to be accompanied by a change in pMLC localisation pattern with a 
preferential accumulation of signal in the lamellipodium. If new evidences support these 
findings, we could hypothesise that MLC activity would compensate the change in cell physical 
properties, which may explain why no uropod retraction defect was observed in cells expressing 
CA-WASp. Also, as myosin is involved in the regulation of the actin retrograde flow in the 
lamellipodium, an increase of pMLC signal in the lamellipodium could be a consequence of the 
alteration of actin dynamics in the lamellipodium (Ponti et al., 2004; Vicente-Manzanares et al., 
2007). 
To demonstrate that the excess of cytoplasmic F-actin was responsible for the observed 
migratory defect and for the increased myosin light chain activity, I tried to rescue the 
phenotype by clearing cytoplasmic actin using the Arp2/3 inhibitor CK-666. Preliminary results 
showed that at a low concentration of 10 µM, CK-666 seemed to partially clear F-actin excess 
without altering actin polymerisation in response of fMLP stimulation. When I used the Arp2/3 
inhibitor on migrating cells expressing the mutant WASp, preliminary results showed a decrease 
of cell velocity when compared to untreated CA-WASp expressing cells. The interpretation of 
this result was delicate as a control condition with the vehicle (here DMSO) would have been 
more suitable. Nevertheless, it seemed that the inhibitor might not only have been clearing the 
cytoplasmic actin in excess due to the mutant WASp but probably also altering normal actin 
migratory structures in the cells. This result together with published evidences that CK-666 lead 
to a switch from lamellipodium to bleb based migration (Bergert et al., 2012) prevented the use 
of CK-666 to rescue the phenotype resulting from the constitutively activated WASp. 
It should be noted that the results presented here were obtained from cells transduced with 
lentiviruses driving the expression of CA-WASp under the SFFV promoter and these were 
compared to untransduced cells. It would have been of great importance to use cell transduced 
with lentiviruses driving the expression of the tag protein mCherry alone similarly to the control 
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used in the kinetochore experiments. However, for reasons that were not identified, the titre of 
the production of lentiviruses driving the expression of mCherry alone under the promoter 
SFFV was repetitively too low to be used hence preventing the use of these lentiviruses as 
control. Using such control would strengthen the results and allow to discard any possible 
alteration of the cells by the transduction process. 
To conclude this first section, it was hypothesised that the unregulated actin polymerisation due 
to the mutant WASp would alter the actin structures or the mechanical properties of neutrophils 
and would lead to a migratory defect.  Surprisingly, the mutant WASp did not seem to 
dramatically alter neutrophil actin migratory structures as it has been described in patient 
macrophages (Ancliff et al., 2006). This suggested that only the modification of the cytoplasmic 
viscosity might be responsible for the migratory defects observed in CA-WASp dHL-60. As 
migration is heavily based on rearrangement of the actin cytoskeleton and that it has been very 
challenging to discriminate the actin structures independent of the mutant, like the 
lamellipodium, from the excess of F-actin resulting from the WASp mutant, it has been difficult 
to study in-depth this mutant role in neutrophil migration and to understand the molecular 
mechanism responsible for the migratory defect.  
However, it would have been interesting to study the effect of CA-WASp on other regulators of 
the actin cytoskeleton. It has been shown that the actin cytoskeleton depending of formins are 
competing for G-actin with the actin cytoskeleton depending of Arp2/3 (Burke et al., 2014). 
Since it has been shown that the formin mDia1 is required for polarisation and migration of 
neutrophils (Shi et al., 2009b), it would have been interesting to investigate the effects of CA-
WASp on the localisation, expression and activity of mDia1. Another interesting candidate 
would have been the cofilin protein, which is involved in actin filament depolymerisation. It has 
been shown that cofilin is necessary for the chemotaxis of dHL-60 cells (Hirayama et al., 2007). 
It would also be interesting to investigate how expression of cofilin was affected by the 
expression of CA-WASp in order to maintain correct actin filament depolymerisation. 
The expression of CA-WASp mildly altered neutrophil migration suggesting the neutropenia 
and recurrent bacterial infection affecting XLN patients may not be primarily caused by a 
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migratory defect. This would indicate that a cell division defect would be the main factor 
responsible of the neutropenia and the subsequent bacterial infections. 
4.3.2 CA-WASp impairs cell division through mechanical alteration of the spindle 
assembly checkpoint 
The expression of CA-WASp resulted in a mislocalised excess of F-actin through the whole cell 
and has been shown to result in a two fold increase of the cytoplasmic viscosity (Moulding et 
al., 2012). The mitosis defects with the reduction in chromosome speed during their segregation 
suggested they were due to the increase in cytoplasm viscosity. Therefore, I looked at the 
chromosome oscillation during the spindle assembly checkpoint, hypothesising that the excess 
of F-actin could alter the sensing of the correct attachment of the microtubules to the 
kinetochores.  
I studied the oscillation of kinetochores by time-lapse imaging and could observe that the 
kinetochore oscillation period was increased in cells expressing CA-WASp and this phenotype 
could be rescued by inhibiting Arp2/3 actin polymerisation using the CK-666 inhibitor. The 
increase of the kinetochore oscillation period in CA-WASp cells could be due to either a 
decrease of speed or an increase of amplitude. The measurement of these parameters 
demonstrated that the speed but not the amplitude was affected by the excess of F-actin. As it 
has been shown that the excess of F-actin due to CA-WASp caused an increase of cytoplasmic 
viscosity (Moulding et al., 2012), we hypothesised that the increased cytoplasmic viscosity only 
affected the speed of the chromosome movement. This was supported by previous results from 
the group showing a decrease of chromosome speed during their segregation (Moulding et al., 
2012) in cells expressing CA-WASp. Surprisingly, the decrease of speed was less than what 
was expected. Indeed, because cytoplasm can be defined as a viscous fluid (Darling et al., 
2006), the relationship between velocity, viscosity and force applied on the kinetochores to 
generate the movement is defined by: 𝐹 ~ 𝜇𝑉 where F is the force applied, µ the viscosity and 
V the velocity. Thus, for a two fold increase of viscosity, we should have expected a decrease of 
50% of the speed of the chromosome movement. Here, we observed a reduction of speed of 
22%, far from what was envisioned suggesting a possible compensation mechanism. We 
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subsequently showed that an increase in quantity of kMT compensated the increased viscosity 
(Moulding et al., 2012).  
Cell division is a process that mechanically segregates the genomic content of one cell into two 
identical daughter cells. This process relies on the physical properties of the cell in division and, 
if the alterations of these properties exceed the resistance of the cell, it leads to the impairment 
of the cell division completion. The results presented here and the one published by Moulding et 
al. (Moulding et al., 2012, 2007) showed that the mechanical alteration of cell properties due to 
the excess of filamentous actin as a result of constitutively active WASp is responsible for 
inducing cell division defects. This was consistent with our knowledge that WASp has no role, 
by itself, in cell division. Nevertheless, the tight regulation of actin cytoskeleton during 
cytokinesis is critical to ensure that the physical properties of the cleavage furrow do not 
prevent cell division completion. It would be of interest to investigate if the excess of F-actin 
due to CA-WASp could lead to a mislocalisation and/or to the alteration of expression of 
regulators of the acto-myosin cytoskeleton.  
We could think for example of cofilin which regulates actin filament disassembly and when its 
activity was inhibited led to an increase in F-actin content in the cells resulting in delay in 
mitosis, and increased the number of cells with nuclear abnormalities (Gohla et al., 2005). 
Another candidate could be the actin interacting protein 1 that is involved in the regulation of 
actin filament disassembly by cofilin and, when AIP1 expression was knocked down, it resulted 
in F-actin excess in the contractile ring during cytokinesis, which further led to an increase of 
multinucleated cells (Kato et al., 2008). 
Another important player of cell mechanics is the non-muscular myosin II. It has been shown 
that myosin II activity was important for the position of the cytokinetic furrow (Sedzinski et al., 
2011) and for actin localisation and dynamics at the contractile ring (Murthy and Wadsworth, 
2005). It has also been shown that inhibition of myosin II at the contractile ring prevented the 
achievement of the cytokinesis (Guha et al., 2005; Murthy and Wadsworth, 2005). We could 
speculate that concomitantly to the partial clearance of F-actin by cofilin, an increase of myosin 
II activity could be increased in order to compensate the alteration of the cell physical properties 
and allow cytokinesis completion. 
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As the expression of CA-WASp results in an excess of F-actin in the cytoplasm that is 
responsible for an increase of cytoplasmic viscosity (Moulding et al., 2012), it would be 
interesting to investigate if CA-WASp could be used as a model to study mechanical dependent 
mechansims.   
For example, it is known that Aurora B plays an important role in sensing the amphitelic 
attachment tension and that during the oscillation of the spindle assembly checkpoint, the 
distance between the inner and outer kinetochores was modified depending if the kinetochore 
was pulled or pushed away from the cell pole (Dumont et al., 2012). Thus, we could use the 
expression of the mutant WASp to alter the cytoplasm properties and perturb the kinetochore 
stretching in order to study Aurora B activity on the different kinetochore structures. This would 
allow us to get a better understanding of the mechanisms of the spindle checkpoint. 
In conclusion, we showed that CA-WASp expression resulting in excess of F-actin impaired 
both the spindle assembly checkpoint and neutrophil migration. The defect in the spindle 
assembly checkpoint could be responsible for the neutropenia observed in the patients, while the 
migratory alteration could prevent the few circulating neutrophils to reach the infection site. 
This highlights the importance of the mechanical properties of the cytoplasm in the correct 
achievement of processes that rely on cell shape changes. The mutant WASp perturbs processes 
in which it has no known role and could be used as a model to perturb cell mechanics in other 
cellular functions such as cell spreading, apoptosis and mechanosensing. 
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Chapter 5  Role of MKL1 in neutrophil 
migration 
 
5.1 Introduction 
MKL1 and its homolog MKL2 are members of the myocardin-related transcription factor 
(MRTF) protein family and shuttle between the cytoplasm and the nucleus to regulate the 
transcriptional activity of the Serum Response Factor (SRF) (reviewed in (Olson and Nordheim, 
2010). MKL1 has the ability to bind G-actin through its RPEL domains. In the cytoplasm, G-
actin binding to MKL1 prevents the import of MKL1 into the nucleus, inhibiting the 
transcription of MKL1/SRF-dependent genes. In the nucleus, the binding of G-actin to MKL1 
promotes the export of MKL1 into the cytoplasm, inhibiting its transcriptional activity. It has 
been shown that, when globular actin is incorporated into actin filament due to the stimulation 
of the actin polymerisation machinery, the subsequent decrease of available G-actin in the 
cytoplasm releases MKL1 that can shuttle into the nucleus to activate the transcription of SRF 
dependent genes (Figure 5-1:). Therefore, MKL1 activity depends on the G-actin levels in the 
cytoplasm and nucleus and reflects the dynamics of actin filament polymerisation. The actin-
MKL1-SRF circuit modulates the transcription of genes in correlation with the dynamics of 
polymerisation and depolymerisation of the actin cytoskeleton. SRF targets genes that encode 
proteins involved in the regulation of the actin cytoskeleton as well as the actin protein itself 
(Miralles et al., 2003; Vartiainen et al., 2007) creating a feedback regulation of all cellular 
activities dependent on the actin cytoskeleton. MKL1 and MKL2 are widely expressed and have 
been shown to regulate muscle tissue, contractile, actin cytoskeleton and cell motility genes 
(Gilles et al., 2009; Olson and Nordheim, 2010). Recently, MKL1 and MKL2 have been shown 
to be involved in megakaryocyte maturation (Cheng et al., 2009; Smith et al., 2013, 2012) and 
several studies 
  
144 
 
  
Figure 5-1: MKL1 domains 
MKL1 binds to G-actin via its RPEL domains. When not bound to G-actin, the basic nuclear localisation 
sequences B2-3 in the RPEL domains is free to interact with importin α/β leading to the accumulation of MKL1 
in the nucleus. Once in the nucleus, MKL1 binds to the Serum Factor Response (SRF) and drives the 
transcription of numerous genes, including actin cytoskeleton related genes, via its transactivation domain. 
RPEL:actin-binding domain; B1-3: basic nuclear localisation sequence; Gln-rich: glutamine rich sequence; 
SAP: DNA-binding domain; LZ: Leu Zipper coiled-coil region; Pro-rich: Proline-rich domain; TAD: Trans-
Activating Domain; MKL1: Megakaryocytic Leukemia 1 protein 
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emphasise the importance of MKL1 in the maturation and migration of megakaryocytes (Cheng 
et al., 2009; Gilles et al., 2009). Despite these evidences, the role of MKL1 in immune cells has 
not been reported. The work presented here describes for the first time a patient with a 
deficiency of MKL1 resulting in a severe immunodeficiency syndrome. The absence of MKL1 
is responsible for low levels of polymerised actin in neutrophil, myeloid and lymphoid cells and 
results in impaired migration of neutrophils.  
Disclaimer: Part of this work has been done in collaboration. Figure 5-2 A and B have been 
done in Kimberley Gilmour’s Lab. Figure 5-3A, B, C, and Figure 5-5 A has been done by Dessi 
Malinova. Figure 5-7D was done by Karolin Nowak. Primary fibroblasts from healthy donors 
were kindly provided by Dr Syed. 
5.2 Results 
A young patient was treated for Pseudomonas septic shock associated with meningitis, 
malignant otitis externa, and more than thirty cutaneous and subcutaneous abscesses. The 
patient responded slowly to the antibiotic therapy and after initial investigation, a neutrophil 
deficiency was suspected.  
Neutrophil phagocytosis was tested and showed a dramatic decrease of patient neutrophils to 
phagocyte pre-opsonised E. Coli over time (Figure 5-2-A and B). To test the possibility that not 
only phagocytosis was deficient, indicating a possible cytoskeletal defect, the ability of patient 
neutrophils to migrate was tested using the agarose Dunn chamber setup. Patient cells displayed 
severe migratory defects with more than 90% of cells unable to migrate, compared to healthy 
donor cells where only 35% failed to migrate (Figure 5-2-C and E, Video S5-1 and5-2). The 
few patient neutrophils that were able to migrate did so with a reduced velocity of 6.3 μm.min-1 
(+/- 0.6 μm.min-1) compared with 12.4 μm.min-1 (+/-0.4 μm.min-1) for control cells (Figure 5-2-
E). Nevertheless, these rare migrating cells followed the direction of the fMLP gradient, 
suggesting a correct signal transduction in response to fMLP (Figure 5-2-F and G). 
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Figure 5-2: Patient neutrophils displayed phagocytosis and migration defects. 
A) Bacteria uptake measured by flow cytometry at 5 and 10 minutes after mixing the blood sample with 
the opsonised FITC E.coli (4x10
7
 bacteria per 100µl of whole blood). B) Quantification of the bacterial 
uptake as seen in A) at 5, 7 and 10 minutes. C) Snapshots from the video of migrating neutrophils from 
patient and control samples in the agarose Dunn chamber in the direction of 100nM of fMLP. The cells 
were imaged at 37
o
C at 1 image/minute for 1 hour using an Axiovert 135 microscope, equipped with an 
Achroplan 10x/0.25 objective, an environmental chamber and a motorised stage. Cells were tracked using 
the ImageJ manual tracking plug-in and tracks were processed in Matlab using an in-house routine. D) 
Chemotactic index calculated from the migration experiment. E) Frequency distribution of the average 
velocity of the individual cells during the migration of control and patient neutrophils in the agarose Dunn 
chamber. F and G) Frequency distribution of the average angle between the chemoattractant gradient and 
the cell migration path of F) control and G) patient neutrophils. A-G: The data were collected from a 
single experiment, one replicate. 
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Patient neutrophils also showed a higher mean chemotactic index compared to control (Figure 
5-2-D). These results need to be considered carefully due to the low percentage of patient cells 
migrating (<10%). This set of results showed that both phagocytosis and migration were 
impaired suggesting an alteration of the actin cytoskeleton, myosin regulation or integrin 
function. Supporting the hypothesis of an actin cytoskeletal defect, low levels of polymerised 
actin were found in lymphoid (Figure 5-3-A and B) and myeloid (Figure 5-3-A and C) cells. 
The patient’s clinical results suggested an unidentified disorder and since the patient was born 
to second cousin consanguineous parents, we hypothesised a recessive mutation was responsible 
for the defects observed. Using whole exome sequencing, a nonsense variant K723X in the 
MKL1 gene was identified, predicting a truncated MKL1 protein. The presence of the mutation 
was confirmed by Sanger sequencing (Figure 5-3-D) and Western blot of patient peripheral 
blood mononuclear cells (PBMC) and EBV-transformed lymphoblastoid cell line (LCL) 
showed the absence of full length MKL1 protein (Figure 5-3-E and F respectively). 
To confirm that the disruption of MKL1 in neutrophils was responsible for the observed 
phenotype, MKL1 expression in the HL-60 cell line was knocked-downed using lentiviral 
vectors carrying shRNA against MKL1 (HL-60 MKL1). Protein expression levels were 
analysed by Western blot and showed that HL-60 MKL1 and neutrophil-like differentiated HL-
60 MKL1 (dHL-60 MKL1) expressed only 10-20% of the protein compared to the HL-60 SCR 
and dHL-60 SCR cells carrying the scrambled shRNA (Figure 5-4-A-C). The dHL-60 MKL1 
cells displayed low levels of F-actin compared to dHL-60 SCR cells as in patient cells (Figure 
5-4-D). Since MKL1 controls the expression of numerous genes involved in the actin 
cytoskeleton regulation, I tested the ability of the differentiated cells to polymerise actin in 
response to fMLP. dHL60 cells showed an almost 2 fold increase in polymerized F-actin when 
treated with fMLP, as did cells expressing the scrambled shRNA (Figure 5-4-E). MKL1 shRNA 
cells displayed a lower level of F-actin representing 70% of the F-actin level of dHL-60 WT 
(Figure 5-4-F). Stimulation of dHL-60 MKL1 with fMLP triggered actin polymerization 
resulting in an increase of the F-actin content representing 50 % of the F-actin content of 
stimulated dHL-60 WT (Figure 5-4-F). These results show that cells lacking normal  
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Figure 5-3: Patient cells displayed low level of F-actin correlated to the lack of normal MKL1 
expression 
A) In order to reduce the variation between samples and obtain an accurate measure of F-actin levels in 
both populations, patient cells were stained with CFSE. Then the two populations were mixed before 
fixation and staining with phalloidin-Alexa 647. B and C) Phalloidin signal was collected by flow 
cytometry in B) lymphoid and C) myeloid cells. D) Whole genome sequencing indicated a non-sense 
mutation of the MKL1 gene carried by the patient. This mutation was confirmed by Sanger sequencing. E 
and F) MKL1 expression detected in E) PBMC and F) B LCLs from healthy donors and the patient. A-E: 
data were collected from a single experiment, one replicate and F: data from two independent 
experiments, one replicate per experiment. 
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expression of MKL1 are still able to polymerise actin in response to a stimulus; however this 
response is weaker than in control cells.  
Then, I tested if the severe reduction of MKL1 expression in dHL-60 mimicked the patient 
phenotype and altered cell migration. Migration of dHL-60 MKL1 cells was impaired with 21% 
of immobile cells whereas only 2% of control cells were immobile (Figure 5-4-G, Video S5-3 
and 5-4). Cell velocity was also altered with an average velocity of 11.9 μm.min-1 (+/- 0.4 
μm.min-1) and 15.1 μm.min-1 (+/- 0.6 μm.min-1) for the dHL-60 MKL1 and dHL-60 SCR, 
respectively (Figure 5-4-G). The dHL-60 MKL1 cells, as control cells, showed a good 
chemotactic response (Figure 5-4-I and J) but also displayed a better persistence during 
migration than the control cells as shown by a chemotactic index of 0.64 (+/- 0.02) and 0.51 (+/- 
0.02), respectively (Figure 5-4-H). Taken together, these results show that the knock-down of 
MKL1 in the differentiated HL-60 cells mimics the patient phenotype. The striking reduction of 
F-actin content in dHL-60 MKL1 cells suggested that actin polymerization machinery could be 
impaired. When the F-actin and G-actin contents were determined by Western blot, dHL-60 
MKL1 cells displayed a strongly reduced F- and G-actin contents but a similar F/G-actin ratio 
compared to dHL-60 SCR cells (Figure 5-5-A). To confirm this result, I expressed G-actin-
mCherry in HL-60 MKL1 cells and differentiated these cells into neutrophil-like phenotype. I 
then measured the F-actin content and could observe that expression of the G-actin-mCherry 
construct reduced the difference of F-actin content between dHL-60 MKL1 cells and dHL-60 
WT cells (Figure 5-5-B and C), although this difference remained statistically significant. I also 
evaluated if actin regulator expression was altered by the knock down of MKL1 in dHL-60 cells 
by using RT-qPCR arrays with primers for actin and microtubules genes. I could observe that, 
in the set of genes with differential expression, most of the actin regulators were upregulated in 
absence of MKL1 with only ACTB, CDC42BPA, FNBP1L and CTTN that were downregulated 
(Figure 5-5-D). 
When uniformly stimulated with fMLP, 43% (+/- 5%) of MKL1-silenced dHL-60 cells 
displayed an elongated uropod, compared with 15% (+/- 1.5%) of control cells (Figure 5-6-A 
and B), suggesting an uropod retraction impairment. 
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Figure 5-4: Silencing of MKL1 in differentiated HL-60 mimicked the patient phenotype 
A) MKL1 expression in undifferentiated HL-60 cells and differentiated dHL-60 cells expressing shRNA against 
MKL1 or scrambled shRNA assessed by Western blot. B and C) Semi-quantitation by densitometry of MKL1 
expression levels in B) HL-60 and C) dHL-60 cells. D-F) Quantification of F-actin by flow cytometry. Both dHL-60 
WT and dHL-60 MKL1 or SCR were mixed together before being fixed, permeabilised and stained for F-actin using 
phalloidin-A647. D) Flow cytometry plot showing F-actin in dHL-60 MKL1 and SCR cells. E) F-actin levels in dHL-
60 WT and SCR. F) F-actin levels in dHL-60 WT and MKL1. G-J) Migration of dHL-60 SCR and MKL1 in the 
agarose Dunn chamber in the direction of 100 nM fMLP was imaged at 37oC for 1 hour at 1 image/minute using 
Axiovert 135 microscope, equipped with a Achroplan 10x/0.25 objective, an environmental chamber and a motorised 
stage. Cells were tracked using the ImageJ manual tracking plug-in and tracks were processed in Matlab using an in-
house routine.  G) Frequency distribution of the average velocity of migrating dHL-60 SCR and MKL1. H) 
Chemotactic index of MKL1 and SCR cells. I and J) Frequency distribution of the average angle between the 
chemotactic gradient and the cell migration path of I) dHL-60 SCR and J) MKL1. D-F: Both dHL-60 WT and dHL-
60 MKL1 or SCR were mixed together before being fixed, permeabilised and stained for F-actin using phalloidin-
A647. A-C:  Measures were from 9 (A and B) and 4 (C) experiments. and G-J: data were collected from three 
independent experiments, A-C and G-J) One replicate per experiment. D-F: data were collected from three 
independent experiments, three replicates per experiment. Data analysed by t-test. F: *  p < 0.05, F and H: **  p< 0.01  
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To understand if this phenotype could be observed in other myeloid cells, I also used the 
monocytic cells THP-1 differentiated into macrophage-like cells to investigate the effect of 
MKL1 knock down on macrophage migration. In THP-1 macrophages, I observed an increase 
in the number of cells with elongated retraction fibres, suggesting an impairment of the 
detachment of the cell rear (Figure 5-6-C and D). As uropod retraction is regulated by the 
Myosin IIa complex and MKL1 has been shown to regulate expression of the light chain of this 
complex, I investigated if the elongated uropod was a result of a modification of the Myosin IIa 
complex due to the silencing of MKL1. The inhibition of the interaction of Myosin IIa with F-
actin in dHL-60 WT cells, by treatment with blebbistatin, resulted in a similar phenotype with 
elongated uropod (Figure 5-7-A). Moreover, I found that mRNA and protein expression of the 
myosin regulatory light chain (MYL9) component of myosin IIa complex was severely reduced 
in MKL1 deficient HL-60 (Figure 5-7-B, D). There was also a moderate reduction in β-actin 
mRNA but no changes in myosin regulatory heavy chain (MYH9) expression were observed in 
HL-60 MKL1 cells (Figure 5-7-B). The same changes in MYL9, ACTB and MYH9 expression 
have been observed in EBV-transformed lymphoblastoid cell line (LCL) of the patient 
compared to healthy donor LCL (Figure 5-7-C). Taken together with previously published work 
(Gilles et al., 2009), these findings show that myosin regulatory light chain expression is 
regulated by MKL1 and may be responsible for the impairment of the migration of MKL1 
deficient neutrophils due to the uropod retraction defect. 
The migration impairment observed in the dHL-60 MKL1 cells could also be due to a defect of 
the cell maturation in absence of MKL1. Therefore, I verified that the differentiation of HL-60 
expressing MKL1 shRNA was similar to control cells. I could observe in both dHL-60 SCR and 
MKL1 cells the presence of multi-lobed nuclei, one of the main characteristic of mature 
neutrophils, suggesting a correct maturation of the cells (Figure 5-8-A). The maturation of HL-
60 into neutrophil-like cells is characterised by the upregulation of CD11b expression and 
downregulation of CD49d at the cell surface. As expected, CD11b was upregulated in dHL-60 
MKL1 cells but at a higher level than in control cells. Also, CD29/CD49d was downregulated in 
the MKL1 deficient cells at a similar level than the SCR cells (Figure 5-8-C). 
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Figure 5-5: MKL1 deficiency altered actin expression 
A) Amounts of F-actin and G-actin in dHL-60 SCR and dHL-60 MKL1 cells were determined using the 
G-Actin/F-actin In Vivo Assay Biochem Kit. The F- and G- actin fraction were then run on a SDS-PAGE 
gel and analysed by Western blot. Quantification of the F/G actin ratio was performed using Gel analysis 
function of ImageJ/Fiji. B) and C) Measurement of the F-actin content by flow cytometry in dHL-60 
WT (white bars) and MKL1 (striped bar) and in MKL1 expressing G-actin-mCherry (grey bar). Both WT 
and MKL1, +/- mCherry-actin, cells were mixed together before being fixed, permeabilised and stained 
for actin using phalloin-Alexa647. D) Fold change of actin regulators mRNA expression levels quantified 
by RT-qPCR arrays in dHL-60 MKL1 cells compared to dHL-60 SCR cells. Only significantly 
differentially expressed genes (p < 0.05) were reported. A-D: results from three independent experiments, 
one replicate per experiment. Data analysed by ANOVA with Tukey post-test. C: **  p < 0.01, ***  p < 
0.001  
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The expression of FPR1, the receptor for fMLP, was similar on both SCR and MKL1 dHL-60 
cells indicating that the migration impairment was not due to a signalling defect at the cell 
surface (Figure 5-8-B). One of the clinical features of MKL1 deficiency was that the patient 
presented numerous scars due to subcutaneous abscesses. Therefore it was hypothesised that the 
absence of MKL1 could alter the healing process. Since fibroblast migration is an essential step 
in the process of wound healing, I knocked down MKL1 in fibroblasts and monitored their 
migration in a scratch-wound assay. I could observe that MKL1 fibroblasts were slower than 
SCR fibroblasts (Figure 5-9-A and B) and also that their morphology was altered. Strong 
differences could be observed between SCR and MKL1 fibroblasts: on the one hand, SCR 
fibroblasts spread well and displayed well defined cortical actin filaments together with 
numerous stress fibres; on the other hand, stress fibres could not be observed in MKL1 
fibroblasts which did not spread and displayed a spindle like shape (Figure 5-9-C). 
To understand which set of genes involved in actin cytoskeleton and cell migration were 
regulated by MKL1, I analysed data from a RNA-seq experiment performed on the patient B 
LCLs in Sergey Nejentsev’s team. As expected, the regulation of the actin cytoskeleton is an 
important target of MKL1, as observed by the down regulation of 17 unique actin-related genes 
and 2 redundant genes in patient cells. Software analysis of functional clustering identified 
cytoskeletal organisation, migration and adhesion as the major groups (Figure 5-10-A). Among 
the downregulated genes involved in actin cytoskeleton and cell migration, 5 genes are known 
to be expressed in immune cells and directly involved in cell migration: ACTN1, ITGB1, PLS1, 
UTRN and ZYX. ACTN1 encodes the actinin alpha 1 protein that is involved in bundling actin 
filaments and has been shown to regulate neutrophil and T lymphocyte migration (Yuruker and 
Niggli, 1992). ITGB1 gene encodes the CD29 receptor that binds fibronectin and regulates cell 
adhesion (Elloumi-Hannachi et al., 2015). L-plastin 1 (PLS1) is, as ACTN1, involved in actin 
filament bundle regulation and has been shown to regulate neutrophil and T lymphocyte 
migration (Morley, 2012). Utrophin (UTRN) is expressed in B lymphocytes, B LCLs and  
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Figure 5-6: MKL1 deficient cells displayed retraction defect of the rear of the cell 
A) dHL-60 SCR and MKL1 were plated on fibronectin-coated coverslips for 20 minutes before being uniformly 
stimulated with a solution of fMLP at a final concentration of 1x10-7 M. Control cells displayed well defined 
lamellipodia at the leading edge of the cell while MKL1 deficient cells did not (open arrow head). A high proportion 
of the cells lacking MKL1 presented abnormally extended uropod (closed arrow head). For easier visualisation, an 
inset has been added on the top left corner of the image showing a MKL1 dHL-60 cell with an extended uropod 
(originally in the dashed square). The image intensity of the inset has been increased 500% compared to the original 
image. B) Quantification of the extended uropod in the SCR and MKL1 deficient populations seen in A. C) THP-1 
cells differentiated into macrophage-like cells were plated on fibronectin-coated coverslips and let to adhere for 4 
hours. The cells were stained for actin and vinculin. Both populations displayed podosomes composed of an actin 
core surrounded by a vinculin ring (closed arrow head). MKL-1 cells also displayed a high number of retraction 
fibres (open arrow head). Image intensity of the MKL-1 population was increased by 500%. D) Quantification of the 
proportion of THP-1 macrophage like cells presenting retraction fibres. B and D) Quantification was performed using 
the Cell Counter plug-in in InageJ. A and C: cells were images using a Zeiss LSM710 confocal microscope using an 
oil immersion 63x/1.4 objective. A-D: data from three independent experiments, one replicate per experiment. Data 
analysed by t-test. B: ***  p < 0.001, D: **  p < 0.01. 
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neutrophils where it regulates cell chemotaxis (Cerecedo et al., 2010). ZYX gene encodes the 
zyxin protein which interacts with α-actinin and is involved in signal transduction during cell 
adhesion (Reinhard et al., 1999). In addition to the cytoskeletal regulatory genes identified in 
the screen, the other major functional cluster identified was regulators of transcription. 
Surprisingly, MYL9 was not among the genes downregulated in the patient B LCL. Although it 
has been detected as downregulated in the RNA-seq, its p-value was too high to be considered 
as significant (downregulated by 3.15 p-value = 0.065). The ACTB gene was also 
downregulated (by 2.46) but also failed to reach significance (for which the p-value was 0.3). 
The absence of normal MKL1 expression also resulted in the upregulation of numerous genes 
including 6 genes involved in cell migration (Figure 5-10-B). The myosin 1f belongs to this 
cluster of genes and has been shown to be involved in neutrophil adhesion, migration and 
maintenance of correct cortical actin cytoskeleton. This preliminary analysis of the RNA-seq 
experiment surprisingly showed that the genes expected to be downregulated were not in this set 
of genes and that these data, at this stage, do not support the results obtained by qRT-PCR. The 
RNA-seq and qRT-PCR taken together raise questions about the genes targeted by MKL1 and 
stress the need of a deeper analysis of these experiments. 
5.3 Discussion 
MKL1 is a ubiquitously expressed transcription co-factor that regulates the expression of 
numerous genes related to the β-actin cytoskeleton including the β-actin gene itself but it had no 
known role in the immune system. So far, few murine models have been developed to 
investigate the role of MKL1, MKL2 (which is the homologue of MKL1), and SRF. It has been 
shown that MKL1 knockout in mice displayed partial embryonic lethality due necrosis of 
myocardial cells. Yet MKL1
-/-
 mice that develop to birth have normal life spans although they 
show abnormal mammary gland function and low platelet count in peripheral blood (Sun et al. 
2006; Cheng et al. 2009). MKL1 is needed for the maturation and migration of megakaryocytes 
(Cheng et al. 2009; Gilles et al. 2009). However, in mice, MKL2 can partially compensate for 
MKL1 loss in megakaryocytes. Indeed, the KO of MKL1 together with the conditional KO of 
MKL2 resulted in a more severe phenotype than KO of MKL1 alone (Smith et al. 2012). MKL1  
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Figure 5-7: The uropod retraction defect of MKL-1 deficient cells was due to the MYL9 
downregulation 
A) Wild-type dHL-60 cells were pre-incubated or not with the myosin II activity inhibitor blebbistatin 
before being plated on fibronectin-coated coverslips for 20 minutes in medium containing blebbistatin 
(100 µM, cells were incubated for 30 minutes with the inhibitor) or not (vehicle: DMSO). Cells treated 
with blebbistatin (middle lane) displayed abnormally extended uropods (open arrow head) as it was 
possible to observe in dHL-60 MKL1 silenced cells (bottom lane). Cells were images using a Zeiss 
LSM710 confocal microscope using an oil immersion 63x/1.4 objective. Scale bar = 10 µm. B) The RNA 
expression in dHL-60 SCR and MKL1 cells was quantified by qRT-PCR. We could observe a 
downregulation of the expression of ACTB and MKL1 genes but also a dramatic decrease of expression of 
the MYL9 gene encoding the regulatory light chain of myosin IIa. C) Transcript expression of B LCLs 
from the patient and a healthy donor showed the same profile as the transcript expression in HL-60 cells 
showed in B. D) Western blot expression of pMLC in dHL-60 MKL1 cells. A: data from three 
independent experiments, one replicate per experiment. B and C: data from three independent 
experiments, three replicates per experiment. D: Due to time restriction, only two experiments could be 
performed. Data from two independent experiments, one replicate per experiment. Data analysed by 
ANOVA with Tukey post-test. B and C: ***  p < 0.001. 
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KO partial embryonic lethality is in line with results from MKL2 knockout and SRF conditional 
knockout that displayed embryonic lethality due to a spectrum of cardiovascular defects (Oh, 
Richardson, and Olson 2005; Miano et al. 2004) while SRF null mice were shown to die at a 
very early stage of embryogenesis (Arsenian et al. 1998). These results suggested that MKL1 
partial embryonic lethality was possibly due to a compensatory mechanism by MKL2 or 
myocardins that are expressed in the same tissues as MKL1. So far none of the murine models 
has revealed a critical role of MKL1 in regulating the immune actin cytoskeleton and immune 
function. In this chapter, we showed that the severe immunodeficiency syndrome of the patient 
was correlated with the absence of normal expression of the protein MKL1 due to a non-sense 
mutation in the protein. The patient carried a mutation in MKL1 replacing the Lysine in position 
723 by a stop codon. This truncated protein would have all the RPEL domains binding the G-
actin and also be able to dimerise through its Leu zipper domain. The SAP domain, which 
activates a specific subset of SRF-dependent genes in muscles, would also be present in the 
mutant protein. The activity of the SAP domain in MKL1 is controversial since the deletion of 
this domain has no effect on the ability of MKL1 to interact with SRF (Miralles et al., 2003). 
However, the K723X MKL1 mutant would lose its C-terminal region containing the potent 
transcriptional activity domain needed for the stimulation of the SRF activity. It has previously 
been shown that a MKL1 mutant called C723 with its C-terminal region deleted from the 723 
position completely lost its activity and could be used as a weak dominant negative mutant (Cen 
et al., 2003). In our study, the truncated MKL1 has been predicted to have a molecular weight of 
77 kDa and in theory should be detected by Western blot using antibodies raised against an 
amino acid sequence included in the 1-723 first amino acids. The antibody I used for the 
detection of MKL1 by Western blot was raised against the amino acid sequence 556-680 of 
MKL1 and as such was expected to be able to detect the mutated protein. As shown in Figure 
5-3-E and F, I could detect a faint band of protein with a lower molecular weight (~80-85 kDa) 
than the original band (~110 kDa) corresponding to MKL1. This lower band could be the 
truncated protein, and the low intensity of the band would suggest that the mutant protein is 
poorly expressed or quickly degraded. Taken together, these results suggested that there is no  
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Figure 5-8: MKL1 deficiency did not alter HL-60 maturation into neutrophil-like cells 
A) Using a cytospin centrifuge, dHL-60 SCR and MKL1 cells were concentrated and spread on 
microscope slides. The cells were then stained using the Diff-quick staining. B) Evaluation by flow 
cytometry of FPR1 expression at the cell surface of dHL-60 SCR and MKL1. C) Expression of CD11b, 
CD18, CD29 and CD49d at the surface of undifferentiated and differentiated HL-60 MKL1 and SCR 
cells was assessed by flow cytometry. D) Quantification of the flow cytometry histograms seen in C. A-
D: data from three independent experiments, one replicate per experiment. Data analysed by t-test. D:  * : 
p < 0.05. 
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activity of MKL1 in the cells of the patient. The patient neutrophils displayed phagocytosis and 
migration impairments. Both processes are dependent on the fast rearrangement of the cell 
cytoskeleton suggesting an actin cytoskeleton defect which is consistent with the lack of correct 
MKL1 expression. 
The actin cytoskeleton defect was confirmed by the dramatic reduction of the F-actin level in 
myeloid and lymphoid cells from the patient. Despite the low level of F-actin in lymphoid cells, 
the patient did not display abnormalities in lymphoid phenotype nor function with the exception 
of a defective T-cell proliferation in response to anti-CD3 antibody and patient’s B LCL 
impaired migration toward MIP3α. This suggested a possible impairment of signal transduction 
in the T cell receptor pathway and defective migration of the cells from the lymphoid lineage. 
Phagocytosis is the process by which immune cells engulf and destroy pathogens they 
encounter. This process is actin dependent (reviewed in (Rougerie et al., 2013)) and is divided 
in four steps: 1) the initiation of the phagocytic cup which recruits the molecular element for the 
polymerization of actin, 2) the extension of the initial pseudopod along the pathogen, 3) the 
elongation of the pseudopod and 4) the closure of the phagocytic cup into the nascent 
phagosome. The three first steps are highly dependent on actin polymerization and the lack of 
F-actin in patient cells could explain the phagocytosis defect observed in the patient neutrophils. 
The three last steps of the phagocytosis are also dependent on the cellular contractile activity in 
the pseudopod. These contractions are due to myosin II activity during the primary extension of 
the pseudopod (Araki et al., 2003; Olazabal et al., 2002) and to the activity of other non-
conventional myosin during the elongation of the pseudopod and the closure of the phagocytic 
cup. Our results show that myosin IIa expression was dramatically reduced and correlate 
previous results showing that myosin IIa expression was regulated by MKL1 (Gilles et al., 
2009; Medjkane et al., 2009) suggesting that in addition to the lack of correct actin 
polymerisation, an alteration of the myosin II activity could decrease the ability of MKL1 
deficient neutrophils to phagocyte pathogens.  
Using the neutrophil-like differentiated HL-60 cells, I further showed that the silencing of 
MKL1 was responsible for the migration impairment and also for the reduced levels of F-actin.   
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Figure 5-9: MKL1 deficiency altered fibroblast shape and migration 
A) Migration of fibroblasts expressing SCR or MKL1 shRNA over 18 hours in a wound scratch assay 
using the Oris cell migration assay. Cell migration was imaged at 37°C by taking one image every 15 
minutes for 18 hours with an Achroplan 10x/0.25 objective mounted on an Axiovert 135 time-lapse 
microscope equipped with a motorized stage. B) Measure of the areas of migration observed in A). 
Analysis was performed in ImageJ/Fiji by detecting and measuring the cell free area using the threshold 
and measure particles functions. C) Fibroblasts expressing SCR and MKL1 shRNA were fixed and 
stained for actin using phalloidin Alexa647. Cells were images using a Zeiss LSM710 confocal 
microscope using an oil immersion 40x/1.0 objective. Arrow heads indicate stress fibres that are present 
in SCR fibroblasts but absent in MKL1 KD fibroblasts. MKL1 KD fibroblasts image intensity was 
increased 5 times. A-C: data from three independent experiments, one replicate. Data analysed by 
ANOVA with Tukey post-test. B: *  p < 0.05. 
 
  
161 
 
We hypothesised that the migration defect observed in MKL-1 deficient primary neutrophils 
and dHL-60 neutrophil-like cells could be explained by three different but probably 
complementary causes: 1) the lack of G-actin available in the cells, 2) the nearly complete 
absence of myosin light chain activity and 3) the possible overexpression of integrines or 
alteration of their cycling.  
1) dHL-60 MKL1 deficient cells responded to fMLP stimulation by increasing their F-actin 
content but to a much lower level than the non-silenced cells, suggesting that the low levels of 
F-actin were mainly due to the low level of G-actin available. We confirmed by Western blot 
that F- and G-actin levels were low in MKL1 deficient cells. The decrease of F-actin in the 
dHL-60 MKL1 cells is consistent with results from SRF
-/-
 neutrophils studied by Taylor et al.. 
By knocking-out SRF in the hematopoietic cell lineages, they could analyse the G- and F-actin 
content in SRF
-/-
 neutrophils by labelling the cells with DNaseI and phalloidin, respectively. 
While phalloidin binds with high affinity to F-actin, DNaseI binds with high affinity to G-actin 
(Mannherz et al., 1980). When DNaseI is labelled with a fluorophore, it can be used to 
determine G-actin content in fixed cells using flow cytometry or microscopy (Cramer et al., 
2002). In Taylor et al., the phalloidin staining showed the SRF
-/-
 cells had a strong decrease in 
F-actin content while the DNAseI staining did not show any alteration of the G-actin content 
(Taylor et al., 2014). This result was surprising as SRF drives the expression of β-actin (Miano 
et al., 2007). A decrease of actin levels would have been expected, with consequences on both 
F- and G-actin contents in the SRF
-/-
 neutrophils. It would be interesting to confirm their result 
using a different method than the DNaseI staining. In our study, when we expressed a β-actin 
construct tagged with mCherry in MKL1 deficient dHL-60 cells, we observed the restoration of 
F-actin to levels close to wild-type cells, although they remain significantly lower. This result 
suggested that the actin polymerisation machinery was not severely impaired in MKL1 deficient 
cells and that the migratory defect could indeed be due to the reduced levels of actin alone. The 
knock down of β-actin has been shown to be responsible for a defective migration of fibroblasts 
and T-lymphocytes (Bunnell et al., 2011; Joseph et al., 2014). These studies were strengthened 
by Salvany’s work which showed that the overexpression of β-actin in MKL1 deficient cells  
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Figure 5-10: Functional annotation clustering of the differentially expressed genes of MKL1 
deficient LCLs 
Functional annotation clustering analysis of RNA-seq results from healthy donor and MKL1 patient B 
lymphoblastoid cells performed using the DAVID software. Using the lists of the significantly 
differentially expressed genes (p < 0.05) for all healthy donor vs. MKL1 cells, clustering was performed 
with a high classification stringency and only clusters with an enrichment score higher than 1.3 were 
considered and reported. A and B) Set of cluster of genes A) downregulated and B) upregulated by the 
absence of MKL1 when compared to healthy donor. A and B: Exploratory experiment aiming at 
identifying possible target gene for future studies. Therefore only one experiment performed. Results 
from a single experiment. One replicate. 
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was enough to rescue the migratory defect of human breast cancer cells and border cells in 
drosophila (Salvany et al., 2014). These works are in line with our results and confirm the 
influence of β-actin expression on cell migration. It would be similarly interesting to investigate 
if the restoration of actin levels in MKL1 deficient dHL-60 cells using a plasmid encoding for 
the gene of β-actin would also restore other dHL-60 functions such as phagocytosis and 
migration. 
2) When uniformly stimulated with fMLP, the dHL-60 cells displayed an elongated uropod. 
This phenotype was similar to the one described by Eddy et al. where they show that the 
inhibition of myosin II induced the formation of extended uropods in neutrophils. The abnormal 
uropod extension in MKL1 deficient dHL-60 was correlated with an increase of elongated 
retraction fibres found in macrophage-like differentiated THP-1 cells suggesting an impairment 
of the retraction of the uropod, for which myosin II activity is required (Worthylake et al., 
2001). It has been shown that the activation of the non-muscle myosin IIa is important for the 
determination of the polarity of migrating cells (Yam et al., 2007) and is localised at the rear of 
the cell in leukocytes (Eddy et al., 2000) where it is essential for the formation of a defined rear 
compartment in the cell. Using blebbistatin, an inhibitor of myosin II light chain (Kovács et al., 
2004), I confirmed that inhibition of myosin II light chain interaction with the actin cytoskeleton 
led to uropod retraction defects in dHL-60 cells. Knowing that MYL9, the gene that encodes the 
myosin IIa light chain, is also a gene regulated by MKL1 (Medjkane et al., 2009) I then 
demonstrated that MKL1 deficient cells displayed an important decrease in the expression of the 
myosin IIa light chain transcript. This was associated with a reduced level of the phosphorylated 
form of myosin IIa light chain which is the active form of the protein. These results showed that 
the MKL1 deficient cell migration impairment was, at least partially, due to the downregulation 
of the myosin IIa light chain expression.  
3) As the integrin CD11b is a marker of neutrophil maturation, I used it to monitor HL-60 
maturation into dHL-60 cells. I could observe that HL-60 MKL1 cells displayed significantly 
higher expression of CD11b at the cell surface compared to the HL-60 SCR cells. This result is 
consistent with the higher cell surface expression of CD11b shown in SRF
-/-
 neutrophils when 
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compared to wild-type cells (Taylor et al., 2014). This high expression of CD11b in MKL1 
deficient cells could be the consequence of reduced myosin light chain activity since it has been 
shown that inhibition of myosin activity is also responsible for the accumulation of integrins at 
the tail of migrating cells (Worthylake et al., 2001). The accumulation of integrins at the cell 
surface could also be the consequence of the impairment of integrin trafficking similarly to what 
has been observed in SRF deficient neutrophils (Taylor et al., 2014). Since the MKL1 deficient 
dHL-60 showed an increased expression of CD11b at the cell surface, we could hypothesise that 
the excessive expression of CD11b was involved in the uropod retraction defect observed in the 
migrating cells. Further investigations would be required to understand by which mechanism 
integrins are overexpressed at the cell surface and what is the impact on cell migration. 
It has been shown that myosin II is not involved in the formation of the lamellipodium and the 
lamellae at the leading edge of the cell (Cai et al., 2006; Vicente-Manzanares et al., 2007) but 
has an important role in the regulation of the retrograde actin flow in the lamellopodium and 
lamellae (Ponti et al., 2004). Thus the absence of clear protrusion at the leading edge of patient 
neutrophils during the migration in the Dunn chamber and the absence of well-defined actin 
structure at the front of uniformly stimulated MKL1 deficient dHL-60 cells (Figure 5-7-A) may 
be attributed to the nearly complete absence of myosin IIa transcript resulting in an alteration of 
the retrograde flow in the lamellipodium and lamellae. This phenotype could also be due to the 
global lack of F-actin in the MKL1 silenced cells preventing a correct accumulation of F-actin 
at the leading edge resulting in actin-poor and probably less stable lamellipodium. To determine 
the consequences of the silencing of MKL1 at the leading edge of neutrophils, it would be 
necessary to study actin structures and its components’ dynamics using super-resolution 
microscopy, Fluorescence Recovery After Photobleaching (Lai et al., 2008) and Speckle 
microscopy techniques (Danuser and Waterman-Storer, 2006). 
Altogether, our results suggest that the migration defect observed in MKL1 deficient neutrophils 
is the result of several components of the migration process: the G-actin pool, the reduced 
myosin IIa light chain activity and the altered expression of integrins. Nevertheless, the results 
presented by Salvany et al. that the sole overexpression of β-actin was able to rescue migratory 
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defects of MKL1 deficient cells may imply that despite the fact that MKL1 drives the 
expression of numerous genes involved in the regulation of the actin cytoskeleton dynamics and 
cell migration, the effect of MKL1 deficiency on all other genes but β-actin may be negligible 
on the migration defect. 
To get a better understanding of the role of MKL1, I analysed an RNA-seq experiment 
performed on patient B LCL. This study showed, as expected, that actin cytoskeleton genes 
were down regulated in the absence of MKL1 but unfortunately I could not correlate these 
preliminary results with our qRT-PCR experiments on the B LCLs. This highlights the 
difficulties to correlate gene expression levels between two experiments made using different 
methods and the necessity to confirm transcript expression results by protein expression 
analysis. Nevertheless, the results from the qRT-PCR on the HL-60 and B LCLs were consistent 
with previously published articles in which the expression of MYL9 and ACTB have been shown 
to be strongly downregulated when MKL1 was silenced (Gilles et al., 2009; Medjkane et al., 
2009).  
Little is known regarding MKL1 and MKL2 expression in human hematopoietic cell lineages, 
but their expression can be estimated from databases, such as Immgen.org, which gather 
microarray results from published studies. Using Immgen results from hematopoieitic cells 
(group: Human hematopoietic (D-MAP), query MKL1 and MKL2), I could see that MKL2 is 
more expressed than MKL1 in megakaryocytes from umbilical cord blood. This would explain 
why the patient displayed mild thrombocytopenia when compared to the mouse model that 
showed more severe thrombocytopenia. In human neutrophils (group: Human Immune Cells, 
query MKL1 and MKL2), there is a near absence of MKL2 expression suggesting that there is 
not compensation of MKL1 loss in neutrophils while in lymphocytes, MKL1 and MKL2 are 
expressed to similar levels suggesting a possible compensation of MKL1 loss of function by 
MKL2. These data fit the patient phenotype as only neutrophils displayed impaired function and 
most of lymphocyte functions did not seemed to be altered. Nevertheless, we could observe that 
the patient’s PBMCs F-actin content was much lower than in the control suggesting that MKL1 
loss was not completely compensated by MKL2. Protein levels of MKL1 and MKL2 in immune 
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cells need to be investigated to confirm microarray results and understand the role of these two 
proteins in the immune system. The hypothesis that MKL2 could compensate MKL1 deficiency 
in most immune cells is strengthened by the role of MKLs in the nervous system. Indeed, 
MKL1 and MKL2 are both expressed in the nervous system and they have been shown to 
redundantly regulate, with SRF, the maturation, migration, apoptosis and neural structure 
growth (Cao et al., 2011; Mokalled et al., 2010a). This would also suggest that a double 
deficiency in MKL1 and MKL2 proteins would have much more dramatic effects on the 
immune response than the MKL1 deficiency already has (and may even be embryonic lethal). 
Keeping in mind that the deletion of SRF has been shown to induce similar defects than the 
silencing of MKL1, this highlights the importance of the MKL1/2-SRF pathway in the immune 
response and the need for further studies to understand the exact role of each player of this 
pathway.  
Here, I showed that MKL1 deficiency had an important impact on immune cells and was 
responsible for phagocytosis and migration defects in MKL1 deficient cells. By driving the 
expression of genes involved in the regulation actin cytoskeletal dynamics, MKL1 potentially 
regulates numerous immune functions in addition to phagocytosis and migration. The alteration 
of β-actin expression in MKL1 deficient cells might also strongly affect other immune processes 
like the formation of the immune synapse or the antigen processing in B cells for example. The 
wide variety of genes regulated by MKL1 may also be directly involved in immune function.  
It has also been shown that MKL1 was involved in neuron and adipocyte differentiation 
(Nobusue et al., 2014) and a similar role could be possible within the immune system. Indeed, 
analysis of the transcripts of MKL1 deficient LCLs showed that clusters of genes involved in T 
cell differentiation and in keratinocyte differentiation were upregulated. A possible role of 
MKL1 in immune cell differentiation may explain how it affects the gene expression in 
neutrophils. Transcription in mature neutrophils is often considered to be very low even if 
hundreds of genes are still transcribed. Most of the genes transcribed in differentiated 
neutrophils are related to the inflammasome but also numerous transcription factors are still 
expressed in mature neutrophils. Due to the early need of the actin cytoskeleton in the extremely 
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fast neutrophil response to an infection, it would be interesting to evaluate if MKL1 is more 
involved in the transcription activity of differentiating cells rather than in fully mature cells that 
change their transcript expression profile in response to a stimulus. Thorough studies of MKL1 
targets in the immune system are needed to better understand the temporal activity of MKL1 
and the immune functions dependent on its activity. 
Finally, some pathogens also hijack the actin cytoskeleton to infect host cells and escape the 
immune system (reviewed in (Bhavsar et al., 2007)). The modification of actin dynamics might 
be sensed by MKL1 resulting in a modification of the expression profile of infected cells. The 
beneficiary of this possible modification of the actin related gene expression would be difficult 
to predict since both the pathogen and the host could use this new environment to either fight 
the invader or to evade defense mechanisms. 
The ability of MKL1 to sense the drop of G-actin level in the cytoplasm due to the activation of 
the actin polymerization machinery in response to extracellular chemicals or mechanical stimuli 
and to shuttle to the nucleus to induce transcription of numerous genes related to the actin 
cytoskeleton make  MKL1 a unique regulator of actin dynamics in the immune system. Its role 
in the highly motile immune cells still need to be understood and might reveal the role of genes 
regulated by its transcriptional activity in the defense of the host. 
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Chapter 6  Screening of immunodeficient patients 
for neutrophil defect using the modified Dunn 
chamber 
 
6.1 Introduction 
Patients with recurrent bacterial infections are considered as possibly immunodeficient. In the 
case of recurrent fungal infections (Candida and Aspergillus species) as well as S. aureus, P. 
aeruginosa, Nocardia asteroides, S. typhi infections, neutrophils and monocytes are the first cell 
types suspected to be defective (Notarangelo, 2010). Several primary neutrophil dysfunctions 
are diagnosable through well-established screen tests: 
Syndrome Molecular mechanism Screen tests 
Chronic Granulomatous Disease Reactive oxygen species 
deficiency 
NBT reduction, detection of 
superoxide by flow cytometry 
Leucocyte adhesion deficiency Integrins and focal 
adhesion 
Detection of integrin CD11a, 
CD11b and CD18 integrins 
expression by flow cytometry, 
chemotaxis and bacterial 
killing 
Specific granule deficiency C/EBPε expression during 
granulocyte maturation 
Chemotaxis and staining of 
lactoferrin in neutrophils 
Actin deficiency Defective actin binding by 
regulators 
Detection of F-actin content 
by flow cytometry, 
chemotaxis, bacterial killing 
and detection of 
phagocytosis by flow 
cytometry  
Table 6-1: Primary neutrophil dysfunctions 
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Neutrophil chemotaxis defects are rarely diagnosed as the only cause of infections and are often 
associated with phagocytosis and/or superoxide production defects (Keszei and Westerberg, 
2014). The Shwachman-Diamond syndrome which is caused by a mutation in the SBDS gene, 
encoding for a protein predicted to be involved into RNA-processing is maybe the only known 
disease causing neutropenia and neutrophil chemotaxis defect towards fMLP (Keszei, 2014). 
The assessment of neutrophil migratory ability of patients with recurrent bacterial infections 
would help to understand the molecular mechanisms of the defect and, for example, when 
associated with a phagocytosis defect could lead the investigators to look more closely to any 
mutation in actin cytoskeleton regulators. 
Following the successful use of the modified Dunn chamber to monitor neutrophil migration 
and in the detection of neutrophil migration defect of the MKL1 patient, it was decided to use it 
to assess the migration of neutrophils from other patients. As the patients had already undergone 
standard immunological testing that excluded common causes of immune defect, it was 
expected that performing this assay would help in the identification of a possible neutrophil 
defect. 
Here, I describe the test of neutrophil migration from four different patients using the modified 
Dunn chamber. The three first cases presented in this chapter are patients with unknown cause 
of immunodeficiency. Therefore, the test was used to evaluate neutrophil migration as a 
possible cause of immunodeficiency. The fourth case that is presented is a patient with a known 
mutation; the patient clinical features matched description from the scientific literature which 
helped the identification of the mutated gene. While each of these tests could be considered as 
successful, meaning they were completed and control cells behaved as expected, they also 
underlined the limitations of the use of the Dunn chamber as a routine assay to detect neutrophil 
migration defects and highlighted the need of a standardised and well-characterised assay. 
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6.2 Results 
6.2.1 Case 1: Patient1 
Once left to adhere on fibrinogen-coated coverslips, patient neutrophils displayed a strikingly 
different phenotype than control cells. Patient cells were indeed much more spread than control 
cells with a dark shape (open arrow head) compared to the bright cells (closed arrow head) from 
the control sample (Figure 6-1). The dark and spread state could be seen in control cells (open 
arrow head) as a transitory state during migration when neutrophils expand their lamellipodia 
and spread before uropod retraction and the cells returning to a more spherical shape. 
Surprisingly, the patient 1 cells did not alternate between these two states: over the course of the 
experiment, most of the cells kept their dark and spread shape and did not move. Only a few 
patient cells were able to change shape and these cells were able to migrate in the direction of 
the fMLP gradient (Figure 6-1-A and D, VideoS6-1 and 6-2) with an average velocity of 9 
μm.min-1 lower than the control neutrophil velocity of 16 μm.min-1 (Figure 6-1-B). Patient 1 
neutrophils also displayed a reduced persistence compared to control cells with a chemotactic 
index of 0.34 and 0.5, respectively (Figure 6-1-C). Overall 62% of control neutrophils were able 
to migrate whereas only 8% of patient cells migrated (Figure 6-1-E). 
6.2.2 Case 2: Patient 2 & 3 
In this assay, two patient samples (P2 and P3 patients) were tested and one healthy donor was 
used as control. All three samples correctly migrated in the direction of the outer well 
containing the fMLP, as shown in the time-lapse snapshots (Figure 6-2, VideoS6-3, -4 and-5), 
and displayed a good directionality (Figure 6-3-C). While P2 patient neutrophils migrated with 
an average velocity of 8.6 μm.min-1, a not significant lower value than control cells, which 
migrated with an average velocity of 10.4 μm.min-1. With an average velocity of 13.5 μm.min-1, 
P3 patient neutrophils were faster than P2 patient and control neutrophils (Figure 6-3-A). 
Analysis of the frequency distribution of the average speed in these three populations showed 
that both control and P2 patient cell velocity had a Gaussian distribution around the average. P3  
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Figure 6-1: Migration of patient 1 neutrophils 
A) Control and patient 1 neutrophil migration towards fMLP (100nM) in the agarose Dunn chamber. The 
cells were imaged at 37
o
C at 1 image/minute for 1 hour using an Axiovert 135 microscope, equipped with 
an Achroplan 10x/0.25 objective, an environmental chamber and a motorised stage. Cells were tracked 
using the ImageJ manual tracking plug-in and tracks were processed in Matlab using an in-house routine. 
B) Average velocity and C) the chemotactic index were calculated from the cell tracks. Control and 
patient 1 cells displayed D) good chemotaxis, but showed E) different motility. A-D: data from a single 
experiment, one replicate. 
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patient cell velocity distribution revealed three distinct populations, one slow with an average of 
8 μm.min-1, one faster with an average of 16.5 μm.min-1 and a very fast one with an average 
speed of 20 μm.min-1. Control, P2 patient and P3 patient neutrophils showed similar persistence 
during migration with a chemotactic index of 0.44, 0.38 and 0.48, respectively (Figure 6-3-B). 
6.2.3 Case 3: Patient 4 with a mutation in the WDR1 gene. 
It is the description of a previously established mouse model with reduced WDR1 function due 
hypomorphic allele that helped identifying the mutated gene responsible for the patient disease. 
The severe loss of WDR1 function was lethal at the embryonic stage whereas mice carrying the 
hypomorphic allele developed macrothrombocytopenia and autoinflammatory disease. In mice, 
macrothromcytopenia was characterised by a failure of megakaryocyte maturation and 
autoinflammation was described as a massive neutrophil infiltration into inflammation lesions 
(Kile et al., 2007). Similarities between the patient and the mouse model facilitated the 
identification of a mutation in the patient WDR1 gene. WD repeat 1 protein (WDR1), also 
known as Actin interacting protein 1 (AIP1), is a highly-conserved protein in eukaryotes that 
interacts with cofilin and is involved in the regulation of actin cytoskeleton turn-over. Cofilin is 
an essential regulator of the actin cytoskeleton and is involved in actin cytoskeleton 
rearrangement during numerous processes such as cell polarity (Dawe et al., 2003), motility 
(Dawe et al., 2003; Hirayama et al., 2007), endocytosis (Okreglak and Drubin, 2007), 
morphogenesis (Zhang et al., 2011), and cytokinesis (Chen and Pollard, 2011). WDR1 interacts 
with the cofilin/actin complex increasing cofilin severing activity and might also cap the 
barbed-end of actin filament hastening its depolymerisation (Tsuji et al., 2009). It has been 
shown that WDR1 has a critical role in the regulation of the actin cytoskeleton during mitosis, 
migration and inflammation (Fujibuchi et al., 2005; Kato et al., 2008; Li et al., 2007; Tsuji et al., 
2009). The role of WDR1 in migration suggested that a migratory defect might be the cause of 
the patient’s immunodeficiency hence I used the modified Dunn chamber to monitor the patient 
neutrophil migration. 
In order to limit intra-assay variations between the Dunn chambers, it was decided to monitor 
patient and control neutrophils in the same Dunn chamber; this would ensure the two  
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Figure 6-2: Patient 2 and 3 neutrophil migration 
Migration tracks of control, patients P2 and P3 neutrophils towards fMLP (100nM) in agarose Dunn 
chambers was monitored over one hour. The cells were imaged at 37
o
C at 1 image/minute using an 
Axiovert 135 microscope, equipped with an Achroplan 10x/0.25 objective, an environmental chamber 
and a motorised stage. Data from a single experiment, one replicate. 
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populations would be subjected to the same protein coating, the same chemoattractant gradient 
and the same conditions of temperature and light exposure. In order to differentiate the two 
populations, either patient or control neutrophils were stained with the cell permeant dye CFSE 
(carboxyfluorescein succinimidyl ester) and mixed with unstained control or patient cells in a 
1:1 ratio. As CFSE is a dye that covalently binds to amine residues and might alter dynamic 
cellular processes, the CFSE staining was swapped between the control and patient samples to 
ensure that the results obtained would not be an artefact due to CFSE treatment. Two 
independent experiments were performed from patient samples: in the first experiment patient 
neutrophils were stained with CFSE and mixed with unstained control neutrophils (Figure 6-4-
A, VideoS-6-6) whereas in the second experiment control neutrophils were stained with CFSE 
and mixed with unstained patient neutrophils. The cells were left to adhere on fibrinogen coated 
coverslips before being assembled in the Dunn chamber. Both control and patient neutrophils 
displayed a good directionality towards the fMLP gradient (Figure 6-4-D) during migration. 
Control cells showed a good persistence with a chemotactic index of 0.37, whereas patient cells 
seemed to display a less persistent migration with a lower, but not significantly different, 
chemotactic index of 0.3 (Figure 6-4-C). Similarly, control cells displayed a higher, but not 
statistically different, velocity compared to patient cells of 11 μm.min-1 and 9.5 μm.min-1 
respectively (Figure 6-4-B). It is to be noted that CFSE might partly affect cell migration as 
CFSE+ control cells migrated slightly slower than CFSE- control neutrophils. To reduce a 
possible bias by the staining, the data from the two experiments were pooled together. 
Staining of F-actin using phalloidin conjugated with Alexa 647 dye revealed that patient cell F-
actin content was two fold higher than that in control cells (Figure 6-5-B, Figure 6-6-B and 
Figure 6-7) which is consistent with the possible loss of actin disassembly activity due to the 
mutation in WDR1 in patient cells. Interestingly, analysis of the total staining intensity (sum of 
the z-stack) from confocal images of patient cells also showed an increase in cofilin (Figure 6-5-  
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Figure 6-3: Characterisation of patient 2 and patient 3 neutrophil migration 
A-D) Analysis of the cell migration shown in Figure 6-2. Cells were tracked using the ImageJ manual 
tracking plug-in and tracks were processed in Matlab using an in-house routine. A and B) The average 
velocity and chemotactic index of control, patient P2 and P3 neutrophils were calculated from the data 
showed in Figure 6-2. The three samples displayed C) good chemotaxis but D) very different distribution 
of the cell velocity. A-D: results from a single experiment, one replicate. 
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A and C) and in WDR1 (Figure 6-6-A and C) content of 138% and 38%, respectively, when 
compared to controls. Increase of WDR1 expression was confirmed by Western blot analysis of 
lysates from patient and control B LCLs (Figure 6-6 D). The Western blot showed two bands: 
one of similar molecular weight as WDR1wt and another one of lower molecular weight which 
could indicate that the mutation was a splice site mutation. The content of the upper band 
together with the lower band indicates an overexpression of WDR1 when compared to controls. 
6.3 Discussion 
Despite the fact that the most well-established primary neutrophil defects are at least partially 
due to chemotaxis impairment, the diagnosis of these neutrophil defects is mainly done by 
detecting cell surface expression or intracellular protein expression by flow cytometry. 
Detecting impaired migration could help to diagnose neutrophil immunodeficiencies by quickly 
narrowing down potential mutated candidates but it could also benefit the detection of new 
deficiencies as demonstrated, in this thesis, for the patient with the mutated MKL1 protein. This 
highlights the need for a well-established and robust migration assay that could be implemented 
in clinical laboratories. We hypothesised that the modified Dunn chamber could fit this need 
and therefore we investigated its potential to screen patients with a possible neutrophil defect. I 
tested several patient samples of which four of them were described above. Through these 
successive assays, I was able to determine that the standardisation of the assay was needed in 
order to establish a robust assay easily usable by other users.  
The P1 patient displayed a dramatic adhesion alteration with more than 90% of the cell 
population showing an important spreading and the inability to migrate. The few cells that were 
able to migrate showed a reduced speed and persistence in their migration towards the fMLP 
gradient. Despite this striking phenotype, the possibility exists that the enhanced adhesion 
resulted from an activation of the cells during their isolation and did not represent a potential 
cause for the patient recurrent bacterial infection. Discussion with clinical scientists involved in  
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Figure 6-4: Migration of patient 4 neutrophils 
A) Migration of control (CFSE+) and patient neutrophils (CFSE-) towards fMLP (100 nM) in agarose 
Dunn chamber. The cells were imaged at 37
o
C at 1 image/minute for 1 hour using an Axiovert 135 
microscope, equipped with an Achroplan 10x/0.25 objective, an environmental chamber and a motorised 
stage. Cells were tracked using the ImageJ manual tracking plug-in and tracks were processed in Matlab 
using an in-house routine. B) Average velocity, C) chemotactic index and D) and chemotaxis of both 
populations. A-D: Results from two independent experiments one replicate per experiment. CFSE 
staining was swapped between the two experiments: in the first experiment control were CFSE positive 
and patient cells were unstained while in the second experiment it was the opposite. 
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the treatment of this patient allowed the comparison of this result with the absence of 
phagocytosis defect and enabled me to rule out the alteration of the actin cytoskeleton as 
possible cause of the phenotype. However, as it was not possible to get more samples to repeat 
the experiment, I was unable to confirm the phenotype observed in the Dunn chamber. 
In the second case, the two patient samples migrated well with a similar directionality and 
persistence as the control. P2 patient neutrophils exhibited a slightly slower, but not 
significantly different, velocity than control cells whereas P3 patient cells showed a 
significantly higher velocity than control neutrophils. The average velocity of P3 patient 
neutrophils was 13.5 μm.min-1 which is in the range of what I observed with control neutrophils 
over the successive assays I performed (10 to 16 μm.min-1) indicating that, despite the 
significant difference with the control, P3 patient neutrophils seemed to have a normal 
migration. Interestingly, the P3 patient neutrophil population was divided in 3 sub-populations 
with different average speed. This is the only time that I observed an average speed frequency 
distribution that is not one Gaussian distribution but that could be described as three successive 
normal distributions. The causes of this phenotype are yet unknown and several hypotheses 
such as variations in the activation state, the integrin expression and activation status or 
variations in the fibrinogen coating could explain it and should be further investigated. It is 
important to mention that the use of only one control in this experiment would have mislead a 
scientist who was not used to the assay and the response you could expect from normal primary 
neutrophils to consider the difference between the control and P3 patient neutrophils velocity as 
a positive result. This stressed the need to define a standard protocol and to evaluate the range of 
the standard response of the cell for this assay so it could be easily used as a screen test for 
neutrophil migration.  
Regarding the patient with the WDR1 mutation, monitoring neutrophil migration in the 
modified Dunn chamber was expected to underline a possible migration alteration due to the 
excess of F-actin. It was previously shown that, despite accumulation of F-actin and 
modification of actin turnover, WDR1 deficient neutrophils massively infiltrated inflammatory 
lesions indicating that migration was not defective. I confirmed this result by showing that  
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Figure 6-5: F-actin and cofilin in WDR1 patient 
A) Confocal images of control (CFSE negative, open arrow head) and patient neutrophils (CFSE positive, 
closed arrow head). Cells were left to adhere on coverslips coated with fibrinogen for 30 minutes at 37
o
C 
before being fixed, permeabilised and stained with DAPI (nuclei), phalloidin-Alexa 568 (F-actin) and 
anti-cofilin antibody. Cells were imaged using a Zeiss LSM710 confocal microscope using an oil 
immersion 63x/1.4 objective. B and C) Quantification of F-actin and cofilin contents in both control and 
patient neutrophils observed in A). Image analysis was performed using CellProfiler: using the DAPI and 
F-actin signals, the cell edges were detected and used to define ROIs in which the F-actin and cofilin 
signals were measured. A-C: Results from a single experiment with a single replicate. 
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patient’s neutrophils normally migrated in the Dunn chamber. To reduce the possible impact of 
CFSE on the result of the experiments, the labelling with the dye was swapped between the two 
experiments (i.e. control cells were CFSE+ in the first experiment and CFSE- in the second 
experiment). However it was difficult to assess the possible impact of CFSE on these results as 
they were collected from two independent experiments. It was then difficult to identify the 
parameter(s) responsible for the small variations observed between the experiments as the cell 
isolation, CFSE labelling and Dunn chamber preparation could influence the outcome of the 
experiment. To be sure that the CFSE did not interfere with cell migration, it would have been 
of interest to label control cells with CFSE and mix them with unlabelled control cell before 
monitoring their migration in the Dunn chamber.  Nevertheless, patient cells seemed to stop 
migrating before control cells which could be consistent with the accumulation of F-actin during 
migration to a level that prevents correct extension of the lamellipodia and/or a reduced 
contractility. WDR1 analysis by confocal microscopy showed that patient cells had a higher 
content of WDR1. This was at first surprising since it was thought that the mutation was a 
nonsense mutation. The increase of WDR1 expression was confirmed by Western blot analysis 
and showed the presence of two bands: a first one similar to WDR1wt and a second band of 
lower molecular weight, suggesting that the mutation was a splice site mutation. However, the 
mutant protein might not be functional since we could observe an increase in F-actin by two 
fold in the patient cells correlated with a strong increase of cofilin expression suggesting a 
possible compensation mechanism due to the reduction of WDR1 related cofilin severing 
activity. The patient had bone marrow transplantation in the weeks after the first experiment. 
The improvement of the Dunn chamber using agarose to stabilise the gradient of fMLP allowed 
me to successfully use it to reveal the migration defect of MKL1 deficient primary neutrophils 
and of dHL-60 expressing CA-WASp. Based on these results, I have used the Dunn chamber to 
monitor neutrophil migration of other patients with unknown immunological defect. While 
being preliminary, this study allowed me to highlight the potency as well as the limitations of 
this assay to be used in routine clinical setting. The Dunn chamber provides a direct functional  
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Figure 6-6:  WDR1 expression and localisation in patient cells 
A) Confocal images of control (CFSE negative, open arrow head) and patient neutrophils (CFSE positive, 
closed arrow head). Cells were left to adhere on coverslips coated with fibrinogen for 30 minutes at 37
o
C 
before being fixed, permeabilised and stained with DAPI (nuclei), phalloidin-Alexa 568 (F-actin) and 
anti-WDR1 antibody. Cells were imaged using a Zeiss LSM710 confocal microscope using an oil 
immersion 63x/1.4 objective. B and C) Quantification of F-actin and WDR1 contents in both control and 
patient neutrophils observed in A). Image analysis was performed using CellProfiler: using the DAPI and 
F-actin signals, the cell edges were detected and used to define ROIs in which the F-actin and WDR1 
signals were measured.  D) WDR1 expression levels were also evaluated by Western blot using B LCL 
lysates. A-D: Results from a single experiment with a single replicate.  
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assessment of the patient cells while in the same time give information about the cell shape 
changes. It also allows differentiating several subpopulations which would not be possible in a 
bulk assay such as the Transwell migration assay. This assay, used in combination with standard 
immunological clinical assays, would allow narrowing down the possible cause of the defect as 
shown in MKL1 patient. Nevertheless, to be applied in routine screening, the Dunn chamber 
would need to be standardised (e.g. determining the range of response of healthy donors’ 
neutrophils). Also, due to limited access to patient samples, it is important to improve the 
robustness of the assay by including internal controls or standards. 
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Figure 6-7: F-actin content in WDR1 neutrophils 
A-C) Measurement of F-actin content in parient 4 and control primary neutrophils by low cytometry. 
Patient 4 neutrophils stained with CFSE and unstained control neutrophils were mixed in the same tube 
before being fixed, permeabilised and stained for F-actin using phalloidin-alexa 647. A) Using flow 
cytometry, both populations were distinguished from each other using the CFSE staining and B and C) F-
actin content was measured. A-C: Data collected from a single experiment and a single replicate. 
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Chapter 7  General Discussion 
Cell migration is an essential process of the immune system. Alteration of this process prevents 
the clearance of infectious agents by immune cells and can be life threatening. Therefore, 
evaluating immune cell ability to migrate in the context of immunodeficiency is important as it 
can both help uncovering the causes of the disease and can provide a better understanding of the 
influence of specific genes/mutations in the mechanism of action of immune cell migration. 
This requires accessibility to reliable and relevant tools that allow both a direct visualisation of 
migrating immune cells and a quantitative assessment of migration.  
I started my PhD research project by working on the establishment of a robust migration 
protocol based on the Dunn chamber (chapter 3), as the direct observation and quantification of 
immune cell migration in the context of immunodeficiency was key to the completion of my 
PhD work. Indeed, I was interested in assessing neutrophil migration with the aim to not only 
decipher the mechanisms of cell migration in immune pathological contexts (chapter 4: the 
constitutively activated WASp, and chapter 5: MKL1) but also to uncover previously unknown 
functional migration defects associated with newly-identified patient immunodeficiencies (as 
shown in chapter 5: MKL1), and to evaluate its potential/limitations for being used for the 
screening of patients with unknown causes of immune defects in the long term (chapter 6: 
screening of patients). 
To study neutrophil migration in 2D routinely, I decided to use the well-established Dunn 
chamber, as a system to study directional migration, which was essential for my projects to 
determine if parameters such as directionality and persistence have been altered in the 
experimental conditions used. The bacterial peptide fMLP was used as chemoattractant since 
my main cell model, the neutrophil like dHL-60 cells, was known to respond well to fMLP but 
poorly to IL-8. However, using the original Dunn chamber setup, in my hands, experimental 
conditions and laboratory setup, the gradient of fMLP was not stable enough, preventing 
directional cell migration. Therefore, I decided to modify the Dunn chamber and I managed to 
stabilise the gradient by pouring an agarose gel containing fMLP in the outer well; the agarose 
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gel working as a reservoir and slowly delivering the chemokine over time. Using fMLP in the 
agarose Dunn chamber, I could observe the directional migration of neutrophil-like dHL-60 
cells as well as primary neutrophils and I developed a semi-automatic MatLab routine using cell 
tracks to calculate all the migration parameters needed for my future studies such as velocity, 
chemotactic index, instantaneous angle, angle variation and average angle.  
As I was interested in determining the reliability of this assay, I evaluated the variation between 
experiments in the agarose Dunn chamber setup and I could establish that there was a 20% 
inter-assay variation. This result was encouraging although it demonstrated the need for further 
development, especially if it was to be used in routine. To first reduce the impact of this 20% 
inter-assay variation on the direct comparison between control and patient/mutated cells, I 
decided to further modify the protocol performed and mix the two populations to monitor them 
together in the same agarose Dunn chamber, a fluorescent marker allowing me to discriminate 
them from each other. Although constituting an improvement, this protocol still requires the 
planning of additional experiments to include the additional controls that ensure that any 
possible bias introduced by the addition of dyes or genetic manipulation are taken into 
consideration, and will necessitate further optimisations (choice of the dye, optimisation of the 
staining conditions, development of adapted transduced fluorescently-tagged controls) to be 
used in routine. 
In a second part of my project, I focused on studying the impact of the expression of the 
constitutively activated WASp on neutrophil function. It was hypothesised that the neutropenia 
observed in patients expressing the mutant WASp might be due to either a migration defect that 
would prevent neutrophils to reach the infection site or a cell division defect that would prevent 
neutrophils from proliferating.  
The hypothesis of a possible impairment of cell division by CA-WASp was based on previous 
data from Dr Dale Moulding’s experiments that showed that the expression of CA-WASp 
resulted in an excess of F-actin surrounding chromosomes during cell division, causing a 
reduction of chromosome movement around the metaphase plate. From these observations, it 
was hypothesised that the excess of F-actin might also alter the kinetochore dynamics during the 
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spindle checkpoint, a critical step during cell division which evaluates the correct attachment of 
microtubules to the chromosomes’ kinetochores. Using a cell line expressing a kinetochore 
protein tagged with GFP, I could track the movement of kinetochores and demonstrate that CA-
WASp expression resulted in an increased period of oscillation due to the decrease of the 
kinetochore movement speed. These results together with the data gathered by Dr Dale 
Moulding and collaborators allowed us to show that CA-WASp altered cell mechanical 
properties leading to cytokinesis failure. 
In parallel to this defect in cell division, I was interested in investigating the possible alteration 
of neutrophil migration by CA-WASp. I used the agarose Dunn chamber with dHL-60 cells as a 
cell model for neutrophils and lentivirus to express CA-WASp in these cells. I observed a 
decrease in CA-WASp cell velocity concomitantly with a reduction of direction variation during 
migration when compared to control cells. Preliminary results showed that dHL-60 expressing 
CA-WASp did not seem to display any alteration in actin cytoskeleton regulator localisation nor 
expression levels but suggested a possible increase of myosin II activity. This possible higher 
myosin activity might be a cellular response to changes in cytoplasmic viscosity due to the 
excess of cytoplasmic F-actin polymerised by CA-WASp. Unfortunately, as the CA-WASp 
project was going on, it became more and more evident that the technical difficulties 
encountered would prevent the in-depth study of the mechanism by which the mutant WASp 
altered neutrophil migration. Indeed, since CK-666 seemed to increase myosin activity and to 
impair cell migration, it became extremely challenging to establish a causal link between the 
excess of F-actin caused by CA-WASp and the phenotype observed. 
Around the same time it was decided to take advantage of the previous establishment of the 
agarose Dunn chamber assay to assess neutrophil migration of a patient with recurrent bacterial 
infections and carrying a mutation in an actin cytoskeleton regulator. The patient’s mutation 
was in MKL1, a regulator of the expression of numerous genes, of which several actin 
cytoskeleton components and regulators. Since the patient neutrophils displayed a phagocytosis 
defect, it was hypothesised that the neutrophils actin cytoskeleton might be affected and lead to 
a migration impairment. As the first results showed a defective migration of the patient’s 
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neutrophils together with a dramatic decrease of the immune cells F-actin content, the focus 
shifted from the CA-WASp project to the MKL1 project.  
Because of the difficulties in obtaining patient samples on a regular basis, I then used, as a 
neutrophil model, dHL-60 cells in which I silenced MKL1 to further study the mechanism of 
MKL1 deficiency. I could show that silencing MKL1 in dHL-60 mimicked the patient cell 
migration phenotype and that the phenotype was likely the result of a strong decrease in β-actin 
and myosin light chain 9 (encoding myosin IIa light chain) expressions together with an 
increase in CD11b expression at the cell surface. I also showed that re-expression of β-actin in 
the cells could nearly completely restore the F-actin content and that actin nucleator expression, 
such as the ARP2/3 complex, the formin Diaph1 or WASp, was not altered by the lack of 
MKL1 suggesting that actin polymerisation mechanisms were probably almost unaffected. 
These data, together with the one gathered by colleagues, allowed to show that MKL1 was 
involved in the regulation of the actin cytoskeleton of immune cells and thus driving neutrophils 
functions. The role of MKL1 in the immune system was previously unknown and it was 
unexpected that a patient carrying a nonsense mutation in MKL1 displayed an 
immunodeficiency syndrome. Since MKL1 is a co-transcription factor for ~30 genes related to 
the actin cytoskeleton, it is very challenging to have a clear and complete overview of the genes 
that are affected by the loss of MKL1 and of the impact that their altered expression would have 
on immune functions. In this work, I focused on neutrophils but data from co-workers showed 
that PBMCs and dendritic cells actin cytoskeleton was affected by MKL1 loss of expression. 
Thus to have a better understanding of the role of MKL1 in the immune system, it will also be 
necessary to evaluate the effects of MKL1 deficiency on actin regulator expression levels in all 
immune myeloid and lymphoid cells. As microarray databases such as Immgen showed that 
MKL2 expression varies a lot between the different immune cells lineages, it would of interest 
to investigate the respective role of MKL1 and MKL2 in the regulation of actin cytoskeleton in 
different immune cells and therefore of their function. It also has been shown that MKL1 has 
known roles in other tissues such as in neuronal migration (Mokalled et al., 2010b) and 
adipocyte differentiation (Nobusue et al., 2014). Therefore, it would interesting to investigate if 
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MKL1 deficiency has any effect on other tissues in the patient especially in neurons since 
neuronal defects might not have appeared yet due to the young age of the patient. 
It is interesting to mention that the phenotypes caused by both CA-WASp and MKL1 mutations 
shared common features. Indeed, despite the fact that CA-WASp lead to an increase of 
approximately 50% of F-actin in the cells while MKL1 mutation had the opposite effect with a 
~30% decrease of filamentous actin, both mutations resulted in a decrease of neutrophil velocity 
during migration in the agarose Dunn chamber. In both cases, no dramatic alteration of the actin 
polymerisation was observed suggesting that the differences observed in F-actin content were 
only the result of the low expression level of actin in MKL1 cells and the high basal level of F-
actin in the CA-WASp cells, respectively. This result also indicated that the defects in migration 
for both these mutations did not seem to be due to an inability of the cells to create new F-actin 
structures in response to the chemoattractant stimulus. 
We could hypothesised that the impaired migration was only the result of the modification of 
actin content due to the alteration of the transcription level of actin in MKL1 deficient cells or 
of the unregulated spatio-temporal activation of WASp in the cells expressing CA-WASp. This 
would be supported by: 1) our result showing that the re-expression of actin in MKL1 deficient 
cells allowed to restore F-actin level to a level comparable as the one of wild-type cells; 2) a 
study showing that the restoration of the expression actin in MKL1 deficient cancerous cells 
restored their ability to migrate (Salvany et al., 2014).  
However, it is more likely that the acto-myosin cytoskeleton needs to be investigated as a whole 
rather than considering the influence of these mutations on the actin content alone. Indeed, CA-
WASp cells seemed to show a possible increase of myosin activity, which was likely a response 
to the alteration of the cell mechanical properties. In parallel, MKL1 deficient cells showed a 
strong reduction of myosin IIa light chain expression both at mRNA and protein levels 
suggesting that the migration defect could be at least partially due to a defective myosin 
activity.  
This highlights that to study actin cytoskeleton defects, it is essential to investigate beyond the 
polymerisation/depolymerisation of actin and aim to understand the consequences of the defect 
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on the whole acto-myosin cytoskeleton. The results obtained in both CA-WASp and MKL1 
projects were interesting and underlined that, by regulating cell shape, the actin cytoskeleton 
also affects cell mechanical properties which could lead to diseases. The study of the immune 
cell mechanics is an on-going field of research whose importance will likely rise in the future 
with the realisation that immune cells need to migrate through different tissues with different 
mechanical properties in order to perform their function and need to adapt quickly to these 
changes of environment. 
While it is likely that the mutations described here would alter cell mechanical properties, which 
may explain the results obtained, it is also not to be excluded that there may be a direct link 
between CA-WASp and MKL1. Indeed, as MKL1 senses the level of monomers of G-actin in 
the cytoplasm, it would be very interesting to study MKL1 expression and activity in the 
context of CA-WASp. We could hypothesise that when CA-WASp is expressed, the excess of 
F-actin in the cytoplasm decreases the G-actin available to interact with MKL1 resulting in an 
accumulation of MKL1 in the nucleus. This would allow the increase of the expression the beta 
actin gene and of several actin cytoskeleton regulators. Another gene regulated by MKL1 is 
MYL9 encoding the regulatory light chain of myosin IIa. An increase of MKL1 activity due to 
CA-WASp could result in an increased expression of myosin which would be in line with the 
preliminary results showing a possible increase myosin activity in CA-WASp cells. 
The MKL1 project also showed that the agarose Dunn chamber was useful to uncover impaired 
migration of neutrophils isolated from patient samples. Therefore, it was decided to further 
evaluate the potential of this set-up to screen PID patients for neutrophil migratory defects. In 
chapter 6, I assessed possible migratory defects in neutrophils from four PID patients. For three 
of these patients, the cause of the PID was unknown, while the fourth patient suffered from a 
mutation in WDR1, which encodes a protein involved in the severing of actin filaments.  
The first patient I tested showed a decreased neutrophil velocity and a reduced chemotactic 
index indicating a possible neutrophil migratory defect. The presence of spread and immobile 
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neutrophils in the Dunn chamber in both the control and patient samples indicated a possible 
over activation of neutrophils during the collection of the samples. 
The second and third patients were siblings and their neutrophils displayed a good migration. 
The third patient neutrophils showed a significantly faster migration than control neutrophils. 
Deeper analysis of the speed revealed three distinct cell populations, each with a specific 
average speed. This is so far the only time that I could observe a non-Gaussian distribution of 
the neutrophil velocity in a patient sample. The causes of this phenotype are still unknown and 
could have been the result of differences in the activation state of the neutrophils, the integrin 
expression and activation status or variations in the fibrinogen coating. This result needs further 
investigations to elucidate if these observations are resulting from a potential issue with the 
setup or if a patient mutation is responsible for the phenotype.  
The neutrophils from the fourth patient with the mutation in WDR1 did not display any 
significant differences in their migration behaviour but I could show that the patient neutrophils 
displayed an increased F-actin content together with a higher expression of cofilin and WDR1. 
Analysis of the WDR1 expression by Western blot showed that both the full length and a 
truncated mutated version of the protein were expressed. The patient then underwent a bone 
marrow transplant preventing us from further studying this mutation. 
The screening of patients showed that the agarose Dunn chamber had limitations in detecting 
differences between samples. To clearly establish a difference between samples, several repeat 
experiments are absolutely necessary and this is unfortunately not always possible due to the 
difficulties to acquire samples from patients.  
The incorporation of agarose in the outer well of the Dunn chamber to stabilise chemokine 
gradients improved the setup and allowed a more reliable study of neutrophil directional 
migration. Nevertheless the assay remained too variable to be used routinely in a clinical lab and 
still needs to be optimised.  
The first step would be to monitor the migration of tens of healthy controls to evaluate 
accurately the limits of the agarose Dunn chamber setup and define the pitfalls from the cell 
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isolation, the cell adhesion, the pouring of the gel and the chamber assembly. From these results 
three directions are anticipated: first the variability is considered adapted for a routine assay and 
the critical steps are reproducibly performed when the setup is used by an experienced user.  
The second option would be to find easy ways to improve the setup reliability. For instance, as 
discussed above, the use of dyes to label one population (control or patient) and monitoring the 
mixed - stained and unstained - population in the same chamber is a good method to reduce 
intra-assay variability since both populations will adhere on the same substrate, will be handled 
identically and be subjected to the same chemokine gradients, and could be optimised to 
eliminate biases.  
Another issue that can be easily avoided is the use of only one control in each experiment. 
Using only one healthy control is risky since no one is absolutely sure that the donor is totally 
healthy. For example, the donor could have a mild neutrophil defect not detected, which will not 
show a significant difference with the patient sample. The establishment of correct statistics, by 
testing tens of healthy donors, would allow us to know the confidence intervals of healthy 
neutrophil velocity, chemotactic index, instantaneous angle and distance and would allow the 
user to quickly determine if the control used is in the good range of values.  
The third possibility may be that the setup could not be improved to fit the requirements to be 
used as a routine assay. As an alternative, it would be interesting to consider a setup with static 
gradient and a ready-assembled chamber. The static gradient is usually easier to setup than a 
dynamic gradient using, for example, a microfluidic device. The fact that the chamber would 
already be assembled would decrease possible operator errors during the chamber assembly. 
The current agarose Dunn chamber allows only the study of neutrophil migration in 2D. In the 
body, neutrophils migrate in 2D on the surface of the blood vessels but the rest of their 
migration in tissues is in 3D environments. The development of a standardized 3D assay for 
clinical diagnostics would also be beneficial as 2D and 3D migration rely on different biological 
and physical processes. Therefore, one assay may reveal a defect that would remain undetected 
using the other method. A good example are neutrophils from patients suffering from leukocyte 
adhesion deficiency 1 which lack expression of CD18 integrins and cannot adhere and migrate 
on 2D but display random and directed migration when compressed between a slide and a 
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coverslip (Malawista et al., 2000). This highlights the need for the creation of a standardized 
assay to assess neutrophil migration as its current lack slows down neutrophil migratory defect 
investigations. 
The work presented here showed that the actin cytoskeleton is a prime actor in the function of 
the immune system. Therefore, the understanding of the actin cytoskeleton regulation in 
immune functions is important and using PID as models is useful as they can provide a better 
understanding of the role of actin regulators in the immune system homeostasis and function. 
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Supplemental Data 
Supplemental video legends 
 
Video S4-1: Migration of a mixed population of dHL-60 control and I294T (red) toward fMLP 
(100nM) loaded in the outer well of the Dunn Chamber. Cells were imaged for one hour with a 
bright field microscope, one brightfield image taken every minute and one red fluorescence 
image taken every 6 minutes . Scale bar = 100μm. 
Video S4-2: Kinetochore oscillations (CENP-A tagged GFP) in HT1080 control cells. A stack 
of 21 slices was took every 7.5 seconds during 5 minutes. 
Video S4-2: Kinetochore oscillations (CENP-A tagged GFP) in HT1080 expressing CA-WASp. 
A stack of 21 slices was took every 7.5 seconds during 5 minutes. 
Video S5-1: Migration of control neutrophils toward fMLP (100nM) loaded in the outer well of 
the Dunn Chamber. Cells were imaged for one hour with a bright field microscope, one image 
taken every minute. Scale bar = 100μm. 
Video S5-2: Patient neutrophils migration toward fMLP (100nM) loaded in the outer well of the 
Dunn Chamber. Cells were imaged for one hour with a bright field microscope, one image taken 
every minute. Scale bar = 100μm. 
Video S5-3: Neutrophil-like dHL-60 SCR migration toward fMLP (100nM) loaded in the outer 
well of the Dunn Chamber. Cells were imaged for one hour with a bright field microscope, one 
image taken every minute. Scale bar = 100μm. 
Video S5-4: Neutrophil-like dHL-60 MKL1 migration toward fMLP (100nM) loaded in the 
outer well of the Dunn Chamber. Cells were imaged for one hour with a bright field 
microscope, one image taken every minute. Scale bar = 100μm. 
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Video S6-1: Migration of control neutrophils toward fMLP (100nM) loaded in the outer well of 
the Dunn Chamber. Cells were imaged for one hour with a bright field microscope, one image 
taken every minute. Scale bar = 100μm. 
Video S6-2: Patient 1 neutrophils migration toward fMLP (100nM) loaded in the outer well of 
the Dunn Chamber. Cells were imaged for one hour with a bright field microscope, one image 
taken every minute. Scale bar = 100μm. 
Video S5-3: Migration of control neutrophils toward fMLP (100nM) loaded in the outer well of 
the Dunn Chamber. Cells were imaged for one hour with a bright field microscope, one image 
taken every minute. Scale bar = 100μm. 
Video S6-4: Patient 2 neutrophils migration toward fMLP (100nM) loaded in the outer well of 
the Dunn Chamber. Cells were imaged for one hour with a bright field microscope, one image 
taken every minute. Scale bar = 100μm. 
Video S6-5: Patient 3 neutrophils migration toward fMLP (100nM) loaded in the outer well of 
the Dunn Chamber. Cells were imaged for one hour with a bright field microscope, one image 
taken every minute. Scale bar = 100μm. 
Video S6-5: Control and patient 4 neutrophils (CFSE
+
) migration toward fMLP (100nM) loaded 
in the outer well of the Dunn Chamber. Cells were imaged for one hour with a bright field 
microscope, one image taken every minute and one green fluorescence image taken every 6 
minutes. Scale bar = 100μm. 
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Appendix A: MatLab routine source code 
function [migFile, ProcessedTracks] = migration_analysis (Calibration,oV) 
% Calibration is the pixel size in um/pixel.  
[filename,path] = uigetfile; % opens up a similar dialog to uiimport to select a file 
migFile = uiimport(fullfile(path,filename)); % directly imports the selected file 
[pathstr, name, ext] = fileparts(fullfile(path,filename)); 
iMax = numel(migFile.x)-1; 
TrackNumber = 0; 
maxTrackNumber = max(migFile.TrackN0xB0); 
for i=1:iMax 
    if (migFile.Distance(i) == -1) && (migFile.Velocity(i) == -1) 
        % index to browse one track only in the original file 
        j = i+1;  
        %index to browse the new created struct. For one track only. 
        RSNumber = 1;  
        % Convert the file form a struct with n parameters (one parameter 
        % by column) to s struct wit x tracks defined by n parameters (one 
        % column by parameter. 
        while  j<=iMax && (migFile.Distance(j) ~= -1) && (migFile.Velocity(j) ~= -1) 
             
            TrackNumber = migFile.TrackN0xB0(j); 
            % Transfert all the value from one tracks to the new struct 
            % dedicated to this track 
            ProcessedTracks(TrackNumber).SliceNumber(RSNumber) = migFile.SliceN0xB0(j); 
            ProcessedTracks(TrackNumber).RelSliceNumber(RSNumber) = RSNumber; 
            ProcessedTracks(TrackNumber).X(RSNumber) = migFile.X(j); 
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            ProcessedTracks(TrackNumber).Y(RSNumber) = migFile.Y(j); 
            ProcessedTracks(TrackNumber).Distance(RSNumber) = migFile.Distance(j); 
            ProcessedTracks(TrackNumber).AbsDistance(RSNumber) = abs(migFile.Distance(j)); 
            ProcessedTracks(TrackNumber).Velocity(RSNumber) = migFile.Velocity(j); 
            ProcessedTracks(TrackNumber).AbsVelocity(RSNumber)= bs(migFile.Velocity(j))*60;  
%Velocity is originally expressed in um/sec in this file, converting in um/min. Need to do a 
variable for that 
            ProcessedTracks(TrackNumber).PixelValue(RSNumber) = migFile.PixelValue(j); 
            j = j+1; 
            RSNumber =RSNumber + 1; 
        end 
        %calculation of the Total distance: the distance between the start 
        %and end point of the track and along the path taken by the cell 
        %during the track. 
        ProcessedTracks(TrackNumber).TotalDistance= 
sum(ProcessedTracks(TrackNumber).AbsDistance); 
        %Calculation of the Net Distance: the direct distance between the 
        %start and end poibnt of the track. 
        trackStart = 1; 
        trackEnd = numel(ProcessedTracks(TrackNumber).SliceNumber); 
        ProcessedTracks(TrackNumber).NetDistance= sqrt((ProcessedTracks(TrackNumber).X(trackEnd)-
ProcessedTracks(TrackNumber).X(trackStart))^2+ (ProcessedTracks(TrackNumber).Y(trackEnd)-
ProcessedTracks(TrackNumber).Y(trackStart))^2)*Calibration; 
%Confinement Ratio (or chemotactic index): defined by NetDistance/TotalDistance. Measure 
        %the straightness or confinement of the cell track.  
        ProcessedTracks(TrackNumber).ConfRatio= 
ProcessedTracks(TrackNumber).NetDistance/ProcessedTracks(TrackNumber).TotalDistance; 
        %Average Distance between to successive points 
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        ProcessedTracks(TrackNumber).AvDistance= mean(ProcessedTracks(TrackNumber).AbsDistance); 
        %Average Instant Velocity between to successive points 
        ProcessedTracks(TrackNumber).AvVelocity= mean(ProcessedTracks(TrackNumber).AbsVelocity); 
         
        [ProcessedTracks(TrackNumber).angleDist,ProcessedTracks(TrackNumber).angleVar]= 
Instant_angles(ProcessedTracks(TrackNumber).X,ProcessedTracks(TrackNumber).Y,oV); 
        %test average angles 
        ProcessedTracks(TrackNumber).avAngle= 
average_angle(ProcessedTracks(TrackNumber).angleDist); 
        ProcessedTracks(maxTrackNumber+1).TotDist(TrackNumber)= 
ProcessedTracks(TrackNumber).TotalDistance; 
        ProcessedTracks(maxTrackNumber+2).NetDist(TrackNumber)= 
ProcessedTracks(TrackNumber).NetDistance; 
        ProcessedTracks(maxTrackNumber+3).CF(TrackNumber)= 
ProcessedTracks(TrackNumber).ConfRatio; 
        ProcessedTracks(maxTrackNumber+4).avDist(TrackNumber)= 
ProcessedTracks(TrackNumber).AvDistance; 
        ProcessedTracks(maxTrackNumber+5).avVel(TrackNumber)= 
ProcessedTracks(TrackNumber).AvVelocity; 
        %ProcessedTracks(maxTrackNumber+7).avAngles(TrackNumber)= 
ProcessedTracks(TrackNumber).AvVelocity; 
        
         
         
         
         
         
 
 
        str = fprintf('Track number: %d Processed!!.\n',TrackNumber); 
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    end 
 
end 
 
ProcessedTracks(maxTrackNumber+6).allAngles = []; 
ProcessedTracks(maxTrackNumber+6).allAnglesVar = []; 
for mT=1:(maxTrackNumber - 1) 
    ProcessedTracks(maxTrackNumber+6).allAngles=  
cat(2,ProcessedTracks(maxTrackNumber+6).allAngles,ProcessedTracks(mT).angleDist); 
end 
 
ProcessedTracks(maxTrackNumber+7).allAvAngles = []; 
for mT=1:(maxTrackNumber - 1) 
    ProcessedTracks(maxTrackNumber+7).allAvAngles=  
cat(2,ProcessedTracks(maxTrackNumber+7).allAvAngles,ProcessedTracks(mT).avAngle); 
end 
 
figure; 
aDistAllAngles = rose(ProcessedTracks(numel(ProcessedTracks)-1).allAngles,24); 
title('\bf Instantaneous angle(\alpha)'); 
set(gca,'View',[-90 90],'YDir','reverse'); 
set(aDistAllAngles,'Color','blue','LineWidth',1); 
 
for mT=1:(maxTrackNumber - 1) 
    ProcessedTracks(maxTrackNumber+6).allAnglesVar=  
cat(2,ProcessedTracks(maxTrackNumber+6).allAnglesVar,ProcessedTracks(mT).angleVar); 
end 
figure; 
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aDistAllAnglesVar = rose(ProcessedTracks(numel(ProcessedTracks)-1).allAnglesVar,24); 
title('\bf Angle Variation(\gamma)'); 
set(gca,'View',[-90 90],'YDir','reverse'); 
set(aDistAllAnglesVar,'Color','blue','LineWidth',1); 
 
figure; 
aAllAvAngles = rose(ProcessedTracks(numel(ProcessedTracks)).allAvAngles,24); 
title('\bf avAngle(\gamma)'); 
set(gca,'View',[-90 90],'YDir','reverse'); 
set(aAllAvAngles,'Color','blue','LineWidth',1); 
 
end 
 
 
function [AnglesDist, AnglesVar] = Instant_angles (X,Y,oV) 
if isequal(numel(X),numel(Y)) == 0 
    disp('Error1') 
end 
iMax = numel(X)-1; 
AnglesDist = []; 
AnglesVar = []; 
 
for i=1:iMax 
    if (X(i)-X(i+1))~= 0 && (Y(i)-Y(i+1))~= 0 
       AnglesDist(i)=mod(atan2((X(i+1)-X(i))*(oV(2,2)-oV(1,2))-(Y(i+1)-Y(i))*(oV(2,1)-
oV(1,1)),((X(i+1)-X(i))*(oV(2,1)-oV(1,1))+(Y(i+1)-Y(i))*(oV(2,2)-oV(1,2)))),2*pi); 
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    end 
end 
iMaxVar = numel(AnglesDist) - 1; 
for j=1:iMaxVar 
    AnglesVar(j) = abs(AnglesDist(j+1) - AnglesDist(j)); 
end 
